In vitro models for cartilage engineering using primary cells and biodegradable scaffolds by Silva, Marta Luísa Sousa Dias Alves da
Marta Luísa Sousa Dias Alves da Silva
Dezembro de 2010
UM
in
ho
|2
01
0
In Vitro Models for Cartilage 
Engineering Using Primary Cells and 
Biodegradable Scaffolds
Universidade do Minho
Escola de Engenharia
M
ar
ta
 L
uí
sa
 S
ou
sa
 D
ia
s 
Al
ve
s 
da
 S
ilv
a
In
 V
it
ro
 M
od
el
s 
fo
r 
C
ar
ti
la
ge
 
En
gi
ne
er
in
g 
U
si
ng
 P
ri
m
ar
y 
C
el
ls
 a
nd
 
B
io
de
gr
ad
ab
le
 S
ca
ff
ol
ds
Tese de Doutoramento em Engenharia de 
Tecidos, Medicina Regenerativa e Células 
Estaminais
Trabalho efectuado sob a orientação do
Professor Nuno João Meleiro Alves das Neves 
e co-orientação do
Professor Rui Luís Gonçalves dos Reis
Marta Luísa Sousa Dias Alves da Silva
Dezembro de 2010
In Vitro Models for Cartilage 
Engineering Using Primary Cells and 
Biodegradable Scaffolds
Universidade do Minho
Escola de Engenharia
É AUTORIZADA A REPRODUÇÃO PARCIAL DESTA TESE APENAS PARA EFEITOS
DE INVESTIGAÇÃO, MEDIANTE DECLARAÇÃO ESCRITA DO INTERESSADO, QUE A TAL SE
COMPROMETE;
Universidade do Minho, ___/___/______
Assinatura: ________________________________________________
  
 
 
 
 
 
 
 
 
 
 
 
 
 
In loving memory of my grandparents 

  
 
 
 
 
 
 
 
 
 
 
 
 
 
“It is not knowledge but the act of learning, not possession but the act of getting there, 
which grants the greatest enjoyment” 
Carl Friedrich Gauss 
  
  
 
 
 
 
 
 
 
 
 
 
 
 
 
“Vem por aqui" — dizem-me alguns com os olhos doces 
Estendendo-me os braços, e seguros 
De que seria bom que eu os ouvisse 
Quando me dizem: "vem por aqui!" 
Eu olho-os com olhos lassos, 
(Há, nos olhos meus, ironias e cansaços) 
E cruzo os braços, 
E nunca vou por ali...” 
 
In Cântico Negro de José Régio 
 
i 
Acknowledgements 
 
When it comes to acknowledgements, I like to cite a Portuguese writer, Virgílio 
Ferreira, who describes words as rocks (“as palavras são como pedras”)…I keep 
stumbling on them and they do not seem to run as smoothly as I would like. So I would 
say that the acknowledgements section is one of the most difficult to write! 
 
During the journey of my PhD, several people helped me and made this achievement 
possible. I would like to thank all the people that direct or indirectly have contributed 
for the development of this work and that helped me to grow as a researcher and as a 
person. If I someway forget to acknowledge somebody, my apologies and please 
consider yourself thanked. 
 
In first place, I would like to acknowledge my supervisor, prof. Nuno Neves, for all 
the valuable help throughout the five years of work for this thesis. His critical review of 
the practical work, as well as his guidance in the writing of projects, papers and this 
thesis contributed for my evolution as a researcher. The multiple brainstorming sessions 
about tissue engineering and cartilage strategies provided me with skills beyond the 
simple research.  
 
I would also like to thank my co-supervisor, prof. Rui Reis, for giving me the 
opportunity to join the 3B´s Research Group. His strong will and perseverance are an 
example for any researcher, and he passes this strength to his students. I have learn so 
much in the dynamics of a research group, I acquired skills for writing projects, 
organizing conferences and so much more, and for that I am sincerely grateful. 
 
To prof. Paul Hatton, my supervisor at the University of Sheffield, I dedicate a very 
special thank you, for everything. He is one of the kindest human beings that came 
across my path, and I will be forever thankful for all the strength, sympathy and his 
restless commitment to simplify my staying at Sheffield. In the personal field, I am 
deeply thankful for your advices and all the support, especially in my second staying at 
Sheffield. In the scientific field, in a first place I would like to thank you the opportunity 
to spend more than one year in your lab. Also, all the sessions of discussion around our 
work and your criticisms were valuable for the improvement of my journey as a 
ii 
researcher and to become a better paper writer. You also gave the opportunity of 
meeting wonderful people, which helped me in the most diverse ways, and also to 
contact with the British way of life. I have to say that is rather fascinating, and that I 
enjoyed Sheffield a lot. But as I always said, I miss the Portuguese sun, the hot summer, 
and mostly, the food!  
What I do miss about Sheffield are the friends, Aileen, Jen, Ana, Becci, Aga, Linda, 
Felora, Zue, Kathrin and many more. A special thanks to Aileen for the valuable help in 
the lab and in the analysis of all the acquired data. Jen and Ana, thank you for all the 
help with the multiple techniques that I was able to learn during my staying. I really 
miss the histology little lab at the 3rd floor! Very special words of friendship to Aga, my 
favourite polish person and a truly good friend. I really miss our escapes to Starbucks, 
our long talks about life…I miss your company! 
 
I would like to acknowledge all my co-authors. Also, an acknowledgement to 
European Project Genostem, to the Marie Curie Actions for my Short Term Fellowship, 
to the Portuguese Foundation for Science and Technology (FCT) for my grant 
(SFRH/BD/28708/2006) financed by POPH - QREN – “Tipologia” 4.1 – Advanced 
Formation, and co-financed by Fundo Social Europeu and MCTES, to the European 
NoE EXPERTISSUES and to the European FP7 Project Find and Bind.  
 
I would like to thank the Institute for Health and Life Sciences (ICVS), University of 
Minho, Braga, Portugal for allowing the use of their research facilities, to Luis Martins 
for his valuable help with the histological procedures as well as Goreti Pinto for the aid 
in the microscopy. Also, a special thanks to the patients of Hospital de São Marcos, 
Braga, Portugal for the biological samples donation, as well to its medical and nursing 
staff.  
 
For all the people in the 3B´s that helped me along the journey, in particular to Ana 
Rita, Analuce, Ana Martins and Helena Lima. Your support has been truly a comfort 
when I was looking at the dark side of things. I would also like to thank my colleagues 
Albino Martins, José Vítor, Pedro Costa, João Oliveira, Vítor Correlo and Simone Silva 
for the valuable help in the lab and the brainstorming sessions. 
 
iii 
A special word for my friend Ana Rita: although my bad temper does not always let 
me see clearly, I know that you were right about many things, and I am truly grateful to 
have you as my friend. Thanks for ignoring my temper and for your valuable advices 
and complicity.  
 
To my best friend Sandra and her lovely family (Zé and David), thank you for all the 
joy you bring in my life! I would be a much worse person if I did not have met you. 
Sandra, you will always be my “sister”, thank you for all the support, in every aspect of 
life. 
 
Thanks to my family, my parents in law and a special acknowledgment to my 
grandparents and great-aunt (titi). Although most of my grandparents are not here 
anymore to see me become a PhD, I know that they are up there cheering for me. A 
word for my grandmother Cila, that passed away in January…you were my model of 
personality and behaviour, and I truly hope that I can follow your example to handle life 
in the bright way that you always did. I miss our talks, but I feel your presence here 
with me all the time. Thank you for always being one step forward! 
 
To my godparents Arlindo and Rosinha, thanks for always being there! 
 
A warm thanks to my parents, for all the support along my life and for allowing me to 
go along my path. This thesis is for you. I know that this was not the job that you would 
have imagined for me, but you had the courage to accept my choices, to let me follow 
my dreams and doing what I always loved to do: science. Sorry Dad, but I am not going 
to be a medical doctor. But maybe the Nobel Prize… as you always say, “I have to be 
the number one”! 
 
And last, but always first in my heart, a deeply thank you to Simão. Thank you for 
being who you are, and for making me a better person. I could write multiple things 
about all that you mean to me, how you are my rock in a storming sea, but you already 
know all of them by heart. So, I just wanted to say thank you for shaking me when I was 
numb with regret, to always make me see the bright side of things, and to be my partner 
in every single thing in this world, and hopefully, in the next. 
iv 
v 
IN VITRO MODELS FOR CARTILAGE ENGINEERING USING 
PRIMARY CELLS AND BIODEGRADABLE SCAFFOLDS 
 
Abstract 
 
Cartilage tissue engineering investigation has been developing strongly in the last 
years. The main difficulty in cartilage regeneration is its restricted self-repair capacity. 
Thus, investigation has been focused in promoting the regeneration of functional 
tissues. There are already products in the market using tissue engineering concepts to 
promote cartilage regeneration. The results of these treatments, although positive, still 
need improvements. Current treatments with joint implants are not long lasting and 
frequently require revision. Tissue engineering thus may provide different solutions 
based on tissues repair, contrarily to substitution by joint implants. 
This thesis comprises the investigation of three in vitro models aiming to produce 
cartilage extracellular matrix (ECM), using primary cultures and scaffolds as supports 
for cell growth and ECM deposition. The scaffold is one of the key points in a tissue 
engineering strategy, thus several morphologies and formulations based on 
biodegradable scaffolds were explored herein. Moreover, different culture conditions 
were also investigated, either by using dynamic cultures (stirred and flow perfusion) or 
static cultures. Therefore, the thesis is divided in 3 sections concerning each of the in 
vitro models tested and cells used: bovine articular chondrocytes (BAC), human bone 
marrow derived mesenchymal stem cells (hBMSCs), and co-cultures of human primary 
culture of articular chondrocytes (hACs) and MSCs. 
The first studies of this thesis were developed with BACs using two types of 
electrospun scaffolds: polycaprolactone (PCL) and starch compounded with PCL 
(SPCL) nanofiber meshes and microporous scaffolds. Those were composed by a blend 
of chitosan-poly(butylene succinate) (CPBS) with two different pore sizes and 
morphologies. Overall, we concluded that BAC model allowed the production of 
cartilage ECM on all tested scaffolds. For electrospun nanofiber meshes, no significant 
differences were found between PCL and SPCL as supports for the cells in terms of 
ECM deposition. However, results were positive in terms of the matrix deposition in 
both substrates. Concerning CPBS scaffolds, 80 CPBS formulation presenting larger 
pores with random distribution proved to have a stronger performance when compared 
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to 60 CPBS formulation. Those results showed the importance of larger pores for cells 
to colonize the scaffolds structure and deposit ECM. 
In our second model we studied the chondrogenic differentiation of hBMSCs when 
cultured onto nanofibers (PCL) or chitosan-based microfiber meshes, using an in house 
developed flow perfusion bioreactor. Human MSCs were able to grow and differentiate 
when cultured either seeded in electrospun nanofiber meshes or in microfiber meshes. 
The use of dynamic culture with nanofiber meshes did not provide solid evidences of an 
enhancement of hBMSCs chondrogenic differentiation. Conversely, microfiber meshes 
indeed showed being adequate for this type of culture, as chondrogenic differentiation 
was enhanced when hBMSCs were seeded and cultured on those scaffolds in the 
bioreactor, compared to the static control. The results may even be further enhanced by 
the optimization of the flow rate used in those experiments. 
Finally, co-cultures using hACs and hMSCs seeded onto chitosan-based microfiber 
meshes were established. We selected two different sources of hMSCs (hBMSCs or 
human Wharton´s jelly mesenchymal stem cells - hWJSCs) and compared their 
chondrogenic potential when co-cultured in direct contact with hACs, or indirectly co-
cultured with conditioned medium derived from hACs cultures. Results showed that 
indirect co-cultures using conditioned medium promoted more cartilage ECM 
formation, both with hBMSCs or with hWJSCs. Additionally, hWJSCs demonstrated a 
higher chondrogenic potential than hBMSCs that produced an ECM containing higher 
expression levels of collagen type I. This result is very interesting because it is believed 
that has a higher potential to be used in clinic to treat patients, since unrelated 
chondrocytes may be used to induce the chondrogenic differentiation of autologous 
adult stem cells. 
Overall, the work on this thesis presents some valid concepts for cartilage tissue 
engineering. We were able to obtain cartilage like tissue using primary cultures, either 
differentiated or undifferentiated. Deposition of cartilage ECM was observed in all the 
tested 3D biodegradable scaffolds either in static or in dynamic culture conditions. The 
advantages of co-culturing differentiated and undifferentiated cells for cartilage 
engineering were also demonstrated. 
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MODELOS IN VITRO PARA ENGENHARIA DE CARTILAGEM 
UTILIZANDO CÉLULAS PRIMÁRIAS E “SCAFFOLDS” 
BIODEGRADÁVEIS 
 
Resumo 
 
A investigação em engenharia de cartilagem teve um desenvolvimento muito intenso nos 
últimos anos. Uma das maiores dificuldades em regenerar cartilagem prende-se com o facto de 
este tecido ter uma capacidade de auto-regeneração muito limitada. Actualmente, já existem no 
mercado alguns produtos para a regeneração de tecido cartilagíneo, baseados em conceitos de 
engenharia de tecidos. Apesar de trazerem resultados positivos, estes tratamentos ainda 
necessitam de ser muito optimizados. A aplicação actual de implantes para recuperar a 
funcionalidade das articulações não é duradoura, e frequentement os implantes necessitam de 
revisão após alguns anos. A engenharia de tecidos pode desenvolver soluções mais duradouras, 
baseadas na regeneração de tecidos e não na substituição da área afectada por implantes 
articulares. 
Esta tese engloba o estudo de três modelos in vitro desenvolvidos com o objectivo de produzir 
matriz extracelular de cartilagem (ECM), utilizando culturas celulares primárias e “scaffolds” 
como suportes para o crescimento das células e deposição da referida matriz. O “scaffold” é um 
dos aspectos críticos numa estratégia de engenharia de tecidos, por isso vários “scaffolds” 
biodegradáveis com morfologias e formulações diferentes foram avaliados. Várias condições de 
cultura foram também investigadas, usando culturas dinâmicas (agitação ou fluxo de perfusão) 
ou estáticas. Consequentemente, a tese está dividida em três secções correspondentes a cada um 
dos modelos in vitro testados, e agrupados segundo o tipo de células utilizadas: condrócitos 
articulares bovinos (BAC), células estaminais mesenquimais derivadas de medula óssea 
(hBMSCs) e co-culturas de células primárias humanas: condrócitos articulares (hACs) e células 
estaminais mesenquimais (hMSCs). 
Os primeiros estudos apresentados nesta tese foram desenvolvidos com BACs e dois tipos de 
malhas de nanofibras: nanofibras de policaprolactona (PCL) ou de amido composto com 
policaprolactona (SPCL), e também com um “scaffold” com microporosidade. Estes últimos 
“scaffolds” foram produzidos com uma mistura de quitosano e de polibutileno succinato 
(CPBS), apresentando dois tamanhos de poros características e morfologias diferentes. Em 
geral, concluimos que o modelo com BACs permitiu a produção de ECM em todos os 
“scaffolds” e malhas de nanofibras testados. Não foram observadas diferenças significativas em 
termos de deposição de ECM entre as malhas de PCL e de SPCL. No entanto, os resultados 
foram considerados positivos, pois houve deposição de ECM em ambos os substratos. No que 
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diz respeito aos “scaffolds” de CPBS, a formulação 80 CPBS (com poros maiores de 
distribuídos aleatoriamente) demonstrou um desempenho biológico mais expressivo quando 
comparada com a formulação 60 CPBS. Estes resultados mostraram a importância de poros de 
maior tamanho na estrutura dos “scaffolds” para facilitar a colonização celular e a deposição de 
ECM. 
O segundo modelo explorado é referente ao estudo da diferenciação condrogénica de 
hBMSCs cultivadas em malhas de nanofibras (PCL) ou de microfibras (formadas por misturas 
de quitosano), usando para tal um bioreactor de perfusão desenvolvido pelo nosso grupo. 
Observou-se crescimento e diferenciação das células cultivadas quer nas malhas de nanofibras, 
quer nas malhas de microfibras. A cultura dinâmica não evidenciou facilitar a diferenciação 
condrogénica das hBMSCs. Por outro lado, foi demonstrado que as malhas de microfibras são 
adequadas para este tipo de culturas dinâmicas, pois a diferenciação condrogénica foi 
potenciada nas culturas destes “scaffolds” no bioreactor, comparativamente com os controlos 
estáticos. Estes resultados poderão ainda vir a ser melhorados através da optimização das 
condições de fluxo de meio de cultura utilizadas nestas experiências. 
Finalmente, realizaram-se co-culturas de hACs e hMSCs em malhas de microfibras. Foram 
seleccionados dois tipos de hMSCs: hBMSCs ou células estaminais mesenquimais derivadas da 
geleia de Wharton (hWJSCs). Comparou-se o potencial condrogénico dos dois tipos de células 
estaminais quando co-cultivadas em contacto directo com hACs, ou em contacto indirecto, 
usando para tal meio condicionado proveniente das culturas de hACs. Os resultados 
demonstraram que as culturas indirectas com meio condicionado promoveram uma maior 
formação de ECM, usando quer hBMSCs, quer hWJSCs. Adicionalmente, as hWJSCs 
revelaram um potencial condrogénico mais elevado do que as hBMSCs, que produziram uma 
ECM rica em colagénio tipo I. O resultado com os meios condicionados é muito interessante 
porque consideramos que poderá ter um elevado potencial para futuras aplicações clínicas. A 
utilização de condrócitos heterólogos para obtenção de meios condicionados que promovam a 
diferenciação condrogénica de células estaminais autólogas parece-nos importante no contexto 
da engenharia de tecidos da cartilagem. 
O trabalho apresentado nesta tese revelou alguns conceitos válidos para a engenharia de 
cartilagem. Obteve-se tecido cartilagíneo usando quer culturas primárias de células 
diferenciadas, quer de células indiferenciadas. A deposição de ECM ocorreu em todos os 
“scaffolds” 3D biodegradáveis testados, quer em condições estáticas, quer em condições 
dinâmicas. Por fim, demonstraram-se também algumas vantagens relativas à utilização de co-
culturas de células diferenciadas com células indiferenciadas para a engenharia de tecidos de 
cartilagem. 
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Introduction to the thesis format 
 
 
The present thesis is divided in eight chapters intended to provide a comprehensive 
report of the progress achieved during this PhD work. The chapters are organized in 
such a way that show the sequential progress obtained in the various works reported. 
The obtained results originated five scientific papers presenting new data and one 
review paper, already published or under submission for publication. The papers were 
organized in thematic sections, based on their contents and their biological and 
experimental design. Therefore, the new data presented in the thesis was organized in 
three sections corresponding to the type of cells used. The first section reports were 
performed with primary bovine chondrocytes. The second section presents data 
obtained with primary human mesenchymal stem cells. The last section is based in co-
cultures of human chondrocytes and mesenchymal stem cells. The section based in the 
review paper was adapted to become the thesis introduction, and to provide an extensive 
overview of cartilage tissue engineering strategies and background information, 
enabling to analyse in context the progress obtained during this PhD programme. 
 
Section I (Chapter 1) 
The first section is adapted from a published review paper and presents an extensive 
literature survey on the field. This section is focused in discussing in detail the problems 
related to cartilage diseases or trauma injuries. It also analyses the potential role of 
tissue engineering in obtaining new solutions and alternative strategies for cartilage 
regeneration and repair. The literature review presented in this section is intended to 
provide an in depth perspective of the progress achieved in the community, as well as to 
stimulate the discussion in context of the works developed in this thesis.  
 
Section II (Chapter 2) 
This section provides a detailed description of the materials and methods used. 
Materials, methods and the basic principles behind the methodologies used in the 
context of the experimental work developed are all covered. The materials processing 
and scaffolds production methods are explained in this section. Moreover, the biological 
assays performed are described thoroughly. The methodologies herein described 
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provide more details in some specific tests, but more importantly, provide a general 
framework for the in vitro testing of new scaffolds, and in vitro culturing methods 
aimed for cartilage tissue engineering. By reading this chapter, it is not required to 
follow closely the materials and methods sections of chapters 3 to 7. 
 
Section III (Chapters 3 and 4) 
The third section includes two published papers using bovine articular chondrocytes 
as a model to test the biological performance of new scaffolds in vitro. This section 
describes the influence of scaffolds composed of electrospun nanofiber meshes (chapter 
3), or microporous scaffolds obtained by compression moulding and salt leaching 
(chapter 4), on bovine articular chondrocytes. The two works complement themselves 
and show that the bovine chondrocytes can be successfully cultured in both scaffolds. 
 
Section IV (Chapters 5 and 6) 
This section includes two papers, one published and the other accepted for 
publication, relating the influence of nanofiber meshes (chapter 5) and microfiber 
meshes (chapter 6) in the chondrogenic differentiation of human bone marrow derived 
mesenchymal stem cells (hBMSCs), using a flow perfusion bioreactor. Both works 
show the positive effect of the flow perfusion provided by the bioreactor in the 
chondrogenic differentiation of hBMSCs. Both scaffolds support successfully the 
chondrogenic differentiation of human bone marrow derived mesenchymal stem cells, 
showing that both the structure and the material composition are adequate for the 
successful culture of relevant cells. 
 
Section V (Chapter 7) 
Section V includes one chapter proposing an advanced co-culture strategy for 
cartilage repair. After using two types of primary cells in the previous sections, we 
studied the outcome of co-culturing human articular chondrocytes and mesenchymal 
stem cells. This chapter describes the use of direct and indirect co-cultures of human 
chondrocytes and adult mesenchymal stem cells, either isolated from bone marrow or 
from umbilical cord Wharton´s jelly. The objective was to study the influence of the 
chondrocyte secreted factors and cell-cell contact over the chondrogenic differentiation 
of adult mesenchymal stem cells, cultured in 3D microfiber meshes. The results show, 
somewhat surprisingly, that the indirect co-cultures are more effective, opening new 
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perspectives for the development of clinically relevant strategies for cartilage tissue 
engineering. 
 
Section VI (Chapter 8) 
The final section of the thesis highlights the contributions and conclusions derived 
from the presented works, including a discussion on the future perspectives and work to 
be developed to achieve the aimed clinical progress in the long lasting regeneration of 
articular cartilage. 
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Chapter 1 
 
 
 
Tissue engineering as a remarkable tool for cartilage repair in the 
context of joint diseases 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
This chapter is based on the following publication: Alves da Silva ML, Martins A, Teixeira AA, Reis RL, Neves 
NM. Impact of biological agents and tissue engineering approaches on the treatment of rheumatic diseases. Tissue 
Engineering: Part B. 2010. 16(3): 331-339 
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1. Introduction 
 
Cartilage development is characterized by a series of temporal events, in which the 
chondrocytes undergo sequential morphological and genetical changes. These 
modifications involve complex signalling and regulatory networks that link cell-matrix 
and intercellular interactions with a strongly regulated gene expression pattern [1]. 
Cellular condensation is a requirement for the beginning of chondrogenesis in the 
embryonic limb bud and in mesenchymal stem cells (MSCs) cultures [2]. The 
knowledge of the events that lead to articular cartilage formation is of utmost 
importance to understand the mechanisms involved in the chondrogenic pathway. 
Articular cartilage is a very specialized tissue with outstanding load-bearing capacity. It 
consists mainly of a dense extracellular matrix (ECM) with chondrocytes embedded on 
it. The ECM binds to a large amount of water that is a key element for the load-bearing 
capacity of cartilage. Cartilage has very low capacity of self-repair and regeneration 
after traumatic, degenerative or inflammatory injury. This factor often leads to end-
stage osteoarthritis (OA) after repeated damage causing a strong limitation in the 
mobility of patients. Additionally, these defects are difficult to treat and to fully repair 
by traditional surgery techniques like mosaicoplasty or microfracture. Tissue 
engineering (TE) is a very promising approach to achieve articular cartilage repair by 
obtaining a long lasting and fully functional recovery of the lost tissue. 
When a tissue is damaged, the body responds by triggering a cascade of events to 
repair it, being the vascular access critically important to provide the needed cues. In the 
case of cartilage lack of vascularisation may prevent this natural response. Cartilage 
defects can be categorized as chondral or osteochondral, depending on the depth of the 
defect. Chondral injuries are restricted to the articular cartilage. Osteochondral injuries 
penetrate deeper into the underlying subchondral bone, opening a path for the inflow of 
bone marrow mesenchymal cells (BMSCs) into the defect. When this type of injury 
occurs, the defect is usually filled with fibrocartilage that provides temporary relief [3]. 
With time, patients will experience pain and an orthopaedic condition will evolve, 
leading to a cartilage-related disease. The major part of rheumatic disorders is caused by 
rheumatoid arthritis (RA) or osteoarthritis (OA). Currently, OA affects more than 200 
million people worldwide and, just in Europe, 350.000 arthroscopic surgeries are 
performed annually [4]. The prevalence of arthritis and other rheumatic diseases among 
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adults over 18, in the United States (US), was of 46.4 million, between 2003 and 2005 
[5].  
More than half of the unintentional injuries that occur annually in the US are of the 
musculoskeletal system, corresponding to 60-67% of the total annual injuries [6]. These 
injuries are caused either by trauma or by diseases related with this system. Orthopaedic 
conditions affect not only elder people, but also a large number of young people. These 
conditions are result of sports injuries, car or motorcycle accidents or other traumas. For 
example, there are annually 1.3 million fractures that require hospital admission, only in 
US [6]. 
More than 100 types of rheumatic diseases, arthritis and related conditions were 
already identified. Examples of inflammatory rheumatic diseases include RA, 
ankylosing spondylitis (AS), psoriatic arthritis (PsA), systemic lupus erithematosus 
(SLE), juvenile idiopatic arthritis (JIA) and OA [7, 8]. These diseases affect people of 
all ages and genders, and until today, its causes remain elusive, as well as its cure. 
Conventional drug treatment for rheumatic inflammatory diseases combines basically a 
symptom-modifying anti-rheumatic drug (SMARDs) with disease-modifying anti-
rheumatic drugs (DMARDs). The combination of SMARDs with DMARDs can slow 
down the progression of inflammation and, in some cases, modify the disease 
progression [9]. Current available surgical treatments for cartilage repair present several 
drawbacks, such as possible implant rejection or infection, or the need for revision after 
some years of implantation. Autologous chondrocyte implantation (ACI) is an 
autologous therapy that was proposed as a basis for TE strategies to repair cartilage 
[10]. The clinical procedure uses chondrocytes obtained from a biopsy collected from 
the donor healthy cartilage and then expands autologous cells in vitro. Chondrocytes are 
further re-implanted at the injured site by injection and using a periosteal flap to close 
the defect [10]. One of the main criticisms to this technique is the need to perform two 
surgical interventions in a short period [11]. In ACI, a small biopsy must be collected 
from a non weight bearing area, and this procedure may lead to donor site morbidity or 
inflammation [11]. Besides, the technique outcome frequently involves formation of a 
fibrous tissue rather than the desired and functional articular neo-cartilage [11]. 
Modifications on various aspects of this surgical technique have been developed, for 
example the use of alternative patches to close the defect, or the use of biomaterials as 
supports for chondrocyte expansion. These modifications originated the matrix 
autologous chondrocytes implantation technique (MACI), recently approved by the 
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FDA (Food and Drug Administration) in the US. In MACI, a previously cultured 
chondrocyte/scaffold construct is implanted in the lesion site. This technique comprises 
a TE strategy, since a biodegradable scaffold is used for supporting cell growth in vitro 
and in vivo. Hyalograft®C, a hyaluronan-based scaffold has been also proposed and 
developed for clinical use, associated with MACI procedure [12, 13]. Collagen 
membranes have also been proposed as a scaffold for clinical application of the MACI 
technique [14]. An overview of current biological treatments and surgical procedures, as 
well as their outcomes, will be further discussed in this section. 
The challenge behind TE is to coordinate the materials properties and scaffolds 
production methods, resulting morphologies and structure, with the proper type of cells. 
Those components should be matured in vitro under adequate culture conditions to 
generate a construct that can be used to fully repair the injured cartilage tissue. One of 
the most important aspects for TE is the development of the proper scaffold. The 
material used for its production, as well as its cytocompatibility and biodegradability, 
must be considered since they are critical for the strategy success [15, 16]. The type of 
material is very important, since natural or synthetic polymers have very different 
properties [17]. Some natural and synthetic polymers will be herein explored, and their 
outcomes for cartilage regeneration will be studied. We will discuss all those 
parameters, detailing its role in the general strategy of obtaining cartilage tissue in vitro. 
Also, in vivo reports from the literature will be discussed. Selection of the proper 
scaffold structure, porosity and pore size is very important to enable cell attachment and 
to promote proliferation and differentiation of cells, leading to ECM production. The 
role of scaffold and cells in the construct, as well as cell types used for cartilage TE 
strategies will be extensively discussed. Moreover, dynamic culture conditions will be 
analysed, as well as the influence of different microenvironments for chondrocytes 
culture. The aim of this review is to provide a general perspective of cartilage TE and its 
application for the fully functional and long lasting regeneration of this tissue. 
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2. Basics of cartilage biology 
 
2.1. Chondrogenesis and growth plate 
 
The growth plate formation is one of the major events in skeletal development. The 
growth plate of long bones is a very organized structure composed by chondrocytes in 
dissimilar stages of proliferation and differentiation, placed in a complex network of 
collagens that compose a scaffold of oriented ECM [18]. 
Cartilage is formed when some mesenchyme cells aggregate to form the blastula, 
during embryo development. Mesenchymal cells in this structure produce an ECM rich 
in collagen type I [19]. Blastula cells begin to differentiate into chondrocytes and to 
secrete cartilage matrix, rich in collagen type II and aggrecan (two of the main 
components of cartilage ECM) [20]. In general, a specific genetic program driven by 
Sox9 and other transcriptional factors is expressed for ECM formation [21]. Sox9 is 
critical for all phases of chondrocyte development, from early condensations to 
conversion of proliferating chondrocytes into hypertrophic chondrocytes [22]. However, 
Sox9 is down regulated in hypertrophic chondrocytes [23]. In cultured chondrocytes, 
Sox9 stimulates the transcription of a number of cartilage matrix genes, such as 
Collagen type II [21] and Aggrecan [1]. Cells in the periphery of the mesenchymal 
condensations do not differentiate into chondrocytes, they form the perichondrium, 
continuing to produce collagen type I [24]. Gradually the produced ECM begins to push 
chondrocytes apart [25]. Eventually, these cells exit the cell cycle and become 
hypertrophic, producing collagen type X, instead of the usual collagen type II [23] and 
undergo the mineralization process.  
 
2.2. Joint development 
 
The ends of mammalians long bones are covered by articular cartilage that allows 
friction and load distribution between bones. During post-natal development, articular 
cartilage undergoes a reorganization process [26]. At this stage of development, 
articular cartilage layer undergoes a process of growth and elongation involving the 
underlying bone [26]. Synovial joints development comprises the formation of the 
cartilagineous rod followed by the formation of the joint cavity, articular cartilage, 
synovium and other joint structures such as the meniscus [26]. Some aspects of this 
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development still remain to be elucidated, such as the events occurring in cavitation to 
form joints [27]. It is normally assumed that continuous cartilage formation in the early 
stages of development is interrupted and cartilage specific zones are formed [27]. 
During maturation of articular cartilage, its components such as collagens and 
proteoglycans rearrange themselves within the various cartilage zones, and this 
orientation evolves from an immature arrangement to a fully “arcade” arrangement, 
present in the mature tissue [28]. Most of the cartilage formed in the early stages of 
development undergoes segmentation to produce individual bones separated by the 
synovial joints [28]. Joints formation is initiated with a joint specification phase, where 
the joint future place is defined. Then, the joint cavity forms in a process called joint 
cavitation [28]. In the places where joints will develop, chondrocytes flatten and 
originate transversal stripes called joint interzone [28]. The central layer of the interzone 
then becomes the joint cavity, while the proximal and distal areas become continuous 
with the perichondrium of cartilage [28]. The perichondrium will form the articular 
cartilage superficial layer that coats the ends of long bones. The Hox genes have been 
reported to have a major role in the limb patterning, as they can specify a cells fate 
within the limb [29]. Bone morphogenic proteins (BMP) are expressed in the early 
stages of joint specification and are reported to be involved in limb movement and joint 
development [30]. There are many signalling proteins involved in these events, and 
some of the interactions still need to be clarified. 
Both growth plate and joint formation events are very important to help to understand 
the processes involved in cartilage formation in nature, as well as formation of its 
stratified structure. Their understanding may be valuable for transposing those processes 
to the laboratory, in an attempt to mimic them in vitro and to produce cartilage tissue. 
 
2.3. Cartilage structure 
 
Articular cartilage is composed only by a single cell type, the chondrocyte. In humans, 
these cells correspond to 1% of the tissue volume. The remaining 99% is formed by a 
highly specialized ECM [31]. The chondrocytes are located in small lacunae within the 
cartilage tissue. These cells synthesize all ECM compounds necessary for tissue 
structure maintenance (collagen type II, proteoglycans and non-collagenous proteins), 
and are responsible for matrix stability. Chondrocytes obtain their nutrients through a 
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double diffusion barrier, survive on low oxygen conditions and thus depend on an 
anaerobic metabolism [25]. 
The matrix components are tightly organized in a zone specific way in cartilage. 
Articular cartilage comprises four zones: superficial, middle, deep and calcified zone.  
ECM unique viscoelastic properties are due to its nanoarchitecture and to the referred 
zone-specificity [32]. Cartilage zones of are illustrated in Figure 1.1.  
 
 
Figure 1.1 – Schematic representation of articular cartilage structure showing the 
different zones of cartilage. Chondrocytes present in the superficial zone are discoidal 
and in the deep zones their shape changes to spherical. Tidemark zone separates the 
deep zone and the calcified zone. 
 
ECM of articular cartilage (as wet mass) is composed by 60-85% of water and 
dissolved electrolytes [33]. The solid framework is composed by collagens (10-30%), 
proteoglycans (3-10%) and non-collagenous proteins and glycoproteins [34]. The 
principal component of the macrofibrilar framework of ECM is composed mainly by 
collagen type II, which provides tensile strength to the articular cartilage [34]. The 
different types of collagens present in the articular cartilage are summarized on Table 
1.1. 
 
Cartilage tissue engineering: a remarkable tool 
10 
Table 1.1 – Collagens present in the ECM of articular cartilage and their functions. 
Collagen type Morphological location Function 
II Principal component of macrofibrils; 
characteristic of ECM basic architecture 
Tensile strength 
VI Pericellular matrix; around cells of the middle 
zone in small amounts 
Forms elastic fibers; attachment of 
chondrocytes to the matrix 
IX Surface of macrofibrils; characteristic of ECM 
basic architecture 
Inter fibrillar connections; tensile 
properties 
X Calcified cartilage layer ; associated with 
hypertrophic cartilage 
Aid in cartilage mineralization ; 
structural support 
XI Within or on macrofibrils; characteristic of 
ECM basic architecture 
Nucleates fibril formation 
Table adapted from Bhosale and Richardson, 2008 [25] and Schultz and Bader, 2007 
[4]. 
 
Proteoglycans provide compressive strength to the tissue and maintain the electrolyte 
balance [25]. Chondrocytes produce these protein polysaccharide molecules and secrete 
them into the matrix [25]. There are two major classes of proteoglycans in the tissue: 
aggrecans (large monomers) and small proteoglycans such as decorin or biglycan [35]. 
Proteoglycans subunits are named glycosaminoglycans (GAGs), which are bound to 
form the larger aggrecan molecule [35]. 
The cartilage unique structure provides this tissue with the necessary elements for 
load bearing and movement functions. It is important to understand the way the various 
elements relate to each other, but also their specific function in the organization of 
articular cartilage. These elements, such as GAGs or collagens, can be detected by 
several laboratory methodologies for identification of cartilage like tissue. 
 
 
3. Cartilage diseases and trauma injuries 
 
Currently, no reliable and durable strategy for complete and fully functional cartilage 
regeneration has been validated in the clinic, as discussed in the next sections. Thus, 
there is an urgent need for clinically appropriate strategies that provide a full 
regeneration of cartilage function. Due to the epidemiological importance and the high 
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social costs of joint diseases, cartilage engineering holds remarkable potential in 
orthopaedic surgery as an alternative to current surgical methods. 
 
3.1. Biological agents for the management of cartilage diseases and TE approaches 
 
Advances in biotechnology have led to the development of agents that therapeutically 
target specific components of the deregulated immune system, known as “biological 
agents” [36, 37]. Among them, tumour necrosis factor alpha (TNF), interleukin-1 
alpha and beta (IL-1, IL-1) have a significant role in the pathogenesis of rheumatic 
diseases [38, 39]. Biological agents are partially or fully humanized recombinant 
proteins that target different pathways of the immune response. Further information on 
the safety and efficacy of TNF blockers can be obtained e.g. in reference [40]. The most 
used biological agents for the treatment of rheumatic diseases, their characteristics and 
secondary effects are also presented on Table 1.2.  
 
Table 1.2 – Biological agents used in clinical practice for the management of rheumatic 
diseases. 
Trade name Type 
Mechanism 
of action 
Application Secondary effects 
Abatacept CTLA4 Ig Costimulation 
inhibitor 
RA; CV; 
SLE 
Serious infection 
Adalimumab Anti-TNF TNF inhibitor RA; AS; 
PsA 
Infections, fatal sepsis and 
demyelinating events 
Anakinra IL-1ra IL1 inhibitor RA; AS Severe infection 
Etanercept TNF R/Fc 
fusion protein 
TNF-inhibitor RA;AS ;SA ; 
PsA; JIA 
Infections, bronchitis 
Infliximab Anti-TNF TNF inhibitor RA;AS; SA; 
PsA; 
DM/PM 
Tuberculosis, Lupus-like syndrome, 
heart failure, pancreatitis, liver 
failure 
Rituximab Anti-CD20 
mAb 
B-cell 
deplection 
RA;CV;SLE Cardiac arrest, infections, immune 
toxicity 
 
Legend: RA, rheumatoid arthritis; CV, cryoglobulinemic vasculitis; SLE, systemic 
lupus erythematosus; AS, ankylosing spondylitis; PsA, psoriatic arthritis; SA, secondary 
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amyloidosis; JIA, juvenil idiopatic arthritis; DM, dermatomyositis; PM, polymyositis. 
Table adapted from Bertele et al. [41] and Diaz-Borjon et al. [40]. 
 
From the different biological agents used in clinical practice, TNF inhibitors have 
proven to be highly effective in the treatment of advanced rheumatic diseases, such as 
RA, AS, PsA or JIA [7, 36, 38, 42, 43], reducing their symptoms, improving the 
physical function of joints and inhibiting joint damage progression [39]. The cost of 
TNF inhibitors is one of the main limitations associated with this therapy: they are 
considerably more expensive than the traditional DMARDs. Considering the high cost 
of those drugs, several strategies of combination of these agents with DMARDs are 
being increasingly studied [37, 40, 44]. Also, TE strategies for local administration of 
these drugs or biological agents have been focus of recent advances. To reach effective 
drug concentrations in the affected joint tissues, high doses of the therapeutic agent 
must be administered systemically, which may lead to significant adverse systemic and 
extra-articular side effects. Currently, most of the available therapies for rheumatic 
diseases do not have tissue specificity and have a ubiquitous distribution of the 
molecular targets. Reduction in drug doses may attenuate toxicity, being a plausible 
solution, but may lead to reduced therapeutic efficacy. To overcome these limitations, 
targeted drug delivery systems may provide excellent solutions by incorporating the 
available anti-rheumatic drugs and releasing them at the target sites [45].  
Drug delivery systems have been developed in several emerging research fields such 
as TE and regenerative medicine, as a method to address the problems associated with 
conventional drugs and improve their pharmacological properties. The means by which 
a drug is released may have a considerable effect on its efficacy and therapeutics. Drug 
delivery systems have been designed using different polymers either of synthetic or 
natural-origin. In order to achieve a better control over the drug release, several 
technologies have been developed. Most of these procedures are based on a 
combination of bioactive agents and biomaterials by bonding. Many examples of those 
strategies were reported in recent literature  [46]. Materials used in these processes 
include poly(lactic-co-glycolic acid) (PLGA) [47], poly(ε-caprolactone) (PCL) [48], 
chitosan [49] or starch [50]. These materials have also been proposed for controlled 
release in the context of tissue regeneration [50-53], as described in the previous 
section. Starch-based materials and composites are among those biomaterials and have 
shown to induce lower inflammatory cytokines, compared to poly(L-lactide) (PLA) 
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[51]. Several studies show the efficiency and the utility of starch in different systems for 
drug delivery, such as fibers [54], microspheres [55] or nanoparticles [56]. Starch-based 
microparticles were developed in our group for drug delivery systems [57] and showed 
to be viable as carriers for the incorporation and release of corticosteroids [50], growth 
factors [48, 58, 59], and as supports for cells [53].  
The future generation of regenerative medicine for rheumatic diseases is focused on in 
situ therapies. This strategy consists in cell-free chondroinductive scaffolds 
implantation combined with chemotactic molecules that allow the recruitment of joint-
inherent and –surrounding cells to traumatic or arthritic diseased joints, and their 
subsequent contribution for growth and differentiation factor-guided joint repair [60]. It 
is believed that the biological agents and anti-inflammatory drugs will complement the 
in situ therapy of chronic joint diseases enhancing joint tissue regeneration and 
preventing the degradation of the native and of the neo-tissues formed [61]. 
 
3.2. Current surgical treatments for cartilage defects 
 
Numerous treatments have been explored to repair damaged articular cartilage, such 
as microfracture, mosaicoplasty, grafts and ACI. In the microfracture technique the 
subchondral bone is disrupted to allow bone marrow to flow into the defect [62]. A 
blood clot will eventually form and cells from bone marrow may migrate into it, 
differentiating into chondrocytes [62]. However, these derived chondrocytes are not 
phenotypically similar to the articular ones, and tend to originate a fibrous tissue rather 
than the desired articular cartilage tissue [25, 62]. 
The ACI technique is a technique developed for treatment of large full-thickness 
chondral defects, where a small biopsy of articular cartilage is collected from a low-
weight-bearing area in the joint [63]. Cells are isolated and expanded in vitro, and then a 
suspension of the cultured chondrocytes is injected underneath a periosteal patch or a 
by-layer collagen membrane [63]. ACI has been widely used in clinic, but still there are 
limitations associated to the technique, which do not allow patients to achieve full 
recovery. This technique has shown promising results for human cartilage defects in 
early clinical studies, but little difference in the efficacy was observed in a randomized 
clinical trial designed to obtain a comparison to surgical procedures such as 
mosaicoplasty [64] There are several complications associated to ACI, such as a non-
uniform repair in different areas of the joint, formation of fibrocartilage after cell 
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implantation, or even loss of chondrocyte phenotype [11]. Furthermore, ACI has been 
associated with significant donor-site morbidity and initiation of osteoarthritic changes 
in the joint, simply due to the harvest of donor cartilage, indicating the need for 
alternative cell sources for tissue-engineered repair of cartilage [65].  
Various modifications to ACI are currently being attempted, focusing in a minimal 
invasive surgery, and combination with three dimensional (3D) scaffolds and growth 
factors [25], for example the MACI technique. This technique employs 3D biomaterials, 
different cell sources and growth factors. Chondrocytes are cultured in these structures 
prior to implantation. Their function is to sustain cells for inducing and maintaining the 
chondrocyte phenotype and to form ECM before implantation. In the MACI technique, 
other sources of autologous cells besides chondrocytes may be used. Those sources 
include MSCs, periosteum-derived cells and synovial fibroblasts [33]. Differentiation of 
these cells in 3D scaffolds can be further enhanced by using growth factors or anti-
inflammatory cytokines, to help phenotype stabilization and protection of the newly 
formed cartilage [33]. Different resorbable transplants were also tested in clinic and 
showed promising results [66]. Hyalograft®C was used for MACI, and patients were 
followed after implantation during 2 years, by magnetic resonance imaging [67]. The 
post-operative observations showed dynamic processes in cartilage repair over time, 
with positive effects. Another report of a 5 years follow-up of MACI technology also 
showed good results: 8 out of 11 patients rated the function of their knees as much 
better or better than before the surgery [68]. Although the outcomes of MACI have been 
positive, this is a very cost-intensive alternative for the treatment of knee cartilage 
defects still showing limitations, thus novel strategies and alternatives should be 
explored. In the next pages, we will describe some TE based alternatives that in our 
opinion should be explored to provide other therapeutic solutions for cartilage 
regeneration. 
 
 
4. Cartilage tissue engineering 
 
The modern society and evolution on medicine have brought us many improvements 
in our daily lives and a longer life expectancy. However, problems associated with 
orthopaedic conditions also increased dramatically, associated with obesity, sports 
injuries, car accidents and many inflammatory conditions, as referred before on section 
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3. Therefore, long term orthopaedic repair solutions are needed, since traditional 
prosthesis require revision after several years post surgery, not providing a long term 
solution. The previous aim, to replace, has become in the actual need for repair. TE can 
answer this need. The goal of TE is to design new functional components that can be 
used to regenerate living tissues and fully restore their function. TE comprises three 
basic premises: the use of a scaffold to support cell growth and formation of the tissue, a 
source of cells, and growth factors to induce cells differentiation into the desired tissue 
(Figure 1.2).  
 
Figure 1.2 – Tissue engineering strategy comprises the use of scaffolds, optimal 
culture conditions, the maintenance of cell-cell interactions and their microenvironment, 
as well as the culture parameters. 
 
The understanding of all the mechanisms underlying the interactions between cells 
and cells-materials is of extreme importance in a TE context. In fact, cell-biomaterial 
contact is one of the key points for a successful TE approach, and therefore scaffolds 
surface properties are subject of intense study and modifications [69-71]. The aim of 
these modifications is to create the most suitable environment for cell attachment, 
proliferation, phenotype maintenance or cell differentiation. Moreover, the way of 
culturing constructs has a major influence in the outcome of the neo-formed tissue. In 
terms of cartilage, dynamic culture conditions have proved to be preferable, as opposed 
to static ones [72-76] Extensive research effort was recently focused in the development 
of bioreactors that can stimulate cartilage formation similar to native tissue [74, 77-82]. 
Another important aspect to consider in cartilage TE approaches is cell-cell interactions. 
The interest in cells cross-talk and communication has been growing in the past years, 
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revealing that signalling pathways are pivotal elements when understanding the tissue 
formation and its repair mechanisms [83]. Chondrocytes release morphogenetic signals 
that influence the surrounding cells, for example, stem cells, to differentiate into the 
chondrogenic lineage [83]. Therefore, the study of co-cultures using chondrocytes and 
undifferentiated cells is a very interesting strategy to develop engineered cartilage. 
Finally, oxygen levels and the environment in which the culture is performed are a main 
issue in terms of articular cartilage neo-formation. Chondrocytes are the only cell type 
present in cartilage, being supplied of oxygen and nutrients by the surrounding synovial 
fluid. Compared to other cell types, they experience a hypoxic environment in vivo, as 
local oxygen tension ranges from 1% to 10% [84]. The study of hypoxic conditions to 
sustain chondrocytes culture and cartilage formation in vitro is therefore another 
important aspect to be considered in TE. 
 
4.1. Scaffolds for cartilage repair 
 
Biodegradable materials have been widely used for regenerative medicine, because 
they are degraded and metabolized by the body after repairing the injured site or tissue 
[85]. These materials can be applied for the most various purposes, such as adhesion 
and fixation of tissues, shape maintenance, guidance of tissue regeneration or as a 
temporary scaffolding for tissue developed [85]. An implantable scaffold should ideally 
recapitulate many of the salient features of native ECM in the target tissue promoting 
the required conditions for tissues regeneration. Ideally, the scaffold should be 
biocompatible, have a highly interconnected porous network to allow for cell ingrowth 
and nutrient and medium exchange [86]. Also the mechanical properties should be 
compatible with those of the tissue, and allow a degradation rate according to cell and 
tissue growth in vitro or in vivo [86]. 
Scaffolds interconnectivity directly influences the diffusion of nutrients to cells and 
the waste removal of their by-products [87]. Therefore, scaffolds should possess a 
highly porous and interconnected structure with a large internal surface area to volume 
ratio to allow cell proliferation, differentiation and even distribution throughout the 
entire structure [88]. Surface properties are also important parameters to consider, as it 
is demonstrated that they influence cell adhesion, proliferation and differentiation [89]. 
Scaffolds mechanical properties may influence tissue formation, as these structures will 
support the cells while the tissue reorganization occurs, and ideally begin to degrade 
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when tissue is regenerated [90]. Scaffolds degradation rate affects cell behaviour [91] so 
it is an important aspect to be considered. 
Materials processing techniques have evolved tremendously in the past years, and a 
large spectrum of methodologies for scaffold development are currently available. Some 
examples of these methods are solvent casting and salt leaching [92-94], electrospinning 
[95-99], fiber bonding [100-102], melt-based technologies [103-106] or hydrogels [107-
112]. Scaffolds processing techniques are expected to provide a maximum control of the 
scaffolds structure, without affecting the materials properties.  
Natural materials, synthetic or a combination of both types of materials may be used 
for scaffolds production. Natural polymers used in cartilage TE include for example, 
chitosan [113-117], starch [118-120] and silk [121-123]. Synthetic polymers for 
cartilage TE applications include for example, short chain saturated aliphatic polyesters, 
such as PLA [124, 125] or aliphatic linear polyesters such as PCL [126, 127] and 
poly(butylene succinate) (PBS) [103, 117]. The work present in this thesis is focused 
mainly on blends of natural and synthetic materials. The rationale was to test a range of 
scaffolds produced with different materials, blended or not, and further develop those 
showing stronger biological performance for the strategy of cartilage tissue formation in 
vitro. 
 
4.1.1. Natural based materials 
The availability in Nature of natural based materials makes them easily accessible, 
and allows taking advantage of specific properties of interest for the application 
envisaged. Chitosan is a natural polymer that has interesting properties for TE 
applications. It is biodegradable, biocompatible and has many structural similarities to 
GAGs [128]. Chitosan is obtained from chitin, the second most abundant 
polysaccharide, which is the major element of the shells of many crustaceans, such as 
shrimps or crabs [128]. Chitosan is obtained by a de-N-deacetylation of chitin [128]. 
This process is usually made in alkaline conditions, resulting into chitosans with 
different degrees of deacetylation (DD) and molecular weight [129]. The source of 
chitosan and the chemical modification may influence both parameters. The DD has 
been shown to be important for cell biocompatibility, attachment and growth [130]. The 
importance of DD, ranging between 76 and 90%, in cellular response of two cell lines 
was studied [130]. This work concluded that, in chitosan scaffolds with high DD, cells 
were able to attach, grow and proliferate. On the contrary, when seeded onto chitosan 
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scaffolds with low DD, cells were not able to attach. The amount of N-acetyl groups in 
chitosan has also influence in its solubility, viscosity and cristallinity [131]. Degrees of 
deacetylation of chitosan scaffolds ranging from 88 to 95% were tested in a study with 
buffalo embryonic stem cells and they have promoted a higher cell proliferation and 
mechanical strength of the scaffold, as well as lower biodegradation compared to the 
scaffolds with low DD [132]. These results may indicate that higher DD of chitosan 
scaffolds may be positive for biological performance. 
One of the interesting properties of chitosan is its ability to be processed into porous 
structures, which support cell growth and ECM deposition [103]. Additionally, chitosan 
is reported to degrade in vivo mainly by enzymatic hydrolysis [129, 133]. Lyzozyme, 
one enzyme present in the human body, has been used to enhance the formation of pores 
in situ, in chitosan scaffolds coated with calcium phosphate [134].  
Bilayered chitosan-based scaffolds were produced by particle aggregation and 
cultured with a L929 cell line. The scaffolds were shown to be cytocompatible and 
biodegradable, supporting cell growth and proliferation, and were proposed as an 
alternative for osteochondral TE applications [115]. Chitosan-based scaffolds have been 
studied for cartilage TE, and showed to promote chondrocyte proliferation and 
metabolic activity [113], as well as MSCs chondrogenesis in vitro [135] and in vivo 
[136]. Chitosan blends have been explored, combining this material with other natural 
or with synthetic polymers for cartilage TE. Three dimensional porous scaffolds 
produced with chitosan hyaluronic acid hybrid fibers were shown to support the culture 
and ECM deposition by rabbit chondrocytes [137].  
Hydrogels have also been extensively studied for cartilage regeneration in the context 
of developing minimally invasive strategies. New gellan gum injectable hydrogels have 
been explored recently by our group for treatment of cartilage defects, with very 
promising results [111, 138, 139]. Our group demonstrated that gellan gum hydrogels 
were able to support growth of human articular chondrocytes, as well as to promote 
ECM deposition, when implanted subcutaneously in nude mice [138]. Our group has 
been developing several natural-based hydrogels, using starch [140], gellan gum [141] 
or chitosan [142], being the last two specifically intended for cartilage regeneration. 
Chitosan has also been explored for preparing hydrogels, namely a gene-activated 
chitosan-gelatin matrix was developed [143]. The referred matrices were capable of 
releasing in a controlled fashion transforming growth factor-beta 1 (TGF-β1), and 
promoted chondrocyte proliferation. Moreover, in a study using bovine articular 
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chondrocytes (BAC) encapsulated in a composite chitosan-hyaluronic hydrogel for 
injectable TE application, cells were able to retain their chondrocytic morphology [144]. 
Chondrogenic differentiation has also been observed in a hydrogel composite of 
oligo(poly(ethylene glycol) fumarate) with encapsulated rabbit bone marrow MSCs and 
gelatine microparticles loaded with TGF- β1 [145]. The same system was proposed for 
an intra-articular injection of chondroitin sulphate in the treatment of chondral defects in 
adult rabbit models [146]. Recently, a novel injectable carrageenan/fibrin/hyaluronic 
acid-based hydrogel with in situ gelling properties was used for cartilage tissue 
engineering [147]. When seeded with human articular chondrocytes (hACs), this 
injectable hydrogel was able to regenerate and repair a lesion made in bovine articular 
cartilage, showing the great potential of this novel delivery system for cartilage tissue 
engineering [147]. 
Another natural polymer extensively used in TE is starch. Starch is the major 
polysaccharide constituent of plants, being its function to store energy in form of 
carbohydrates. Starch is composed by 10-20% of amylase and 80-90% of amylopectin 
[148]. The degradation of starch based polymers is mediated by α-amylase, and their 
main degradation products are glucose and its derivatives, which are proved not to be 
harmful for cells [149]. Moreover, the degradation kinetics of starch based polymers can 
be controlled by the concentration of α-amylase present. In a recent work by Azevedo 
and Reis, 2009, α-amylase was encapsulated into starch –compounded polycaprolactone 
(SPCL) discs produced by compression moulding, demonstrating that the degradation 
kinetics of this polymer can be controlled by the amount of encapsulated enzyme into 
the matrix [150]. This polysaccharide can be processed by several techniques, and 
blended with other biomaterials and therefore, has been proposed for a wide range of 
biomedical applications [16, 97, 151-153]. 
Starch based scaffolds have been studied for bone TE [154, 155], vascularisation and 
endothelial cells culture [156, 157], or cartilage TE applications [119, 158]. Particularly, 
different types of starch scaffolds have been used in these applications, namely fiber 
meshes [155], combined nano- and micro-fibrous scaffolds [156] or injectable 
hydrogels [158]. The suitability of starch-based scaffolds for cartilage TE has been 
demonstrated using BAC, using dynamic culture conditions, either using SPCL fiber 
meshes [119] or SPCL nanofiber meshes [118]. 
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4.1.2. Synthetic polymers 
Synthetic polymers are very versatile being conveniently processed into the desired 
shapes. Also, they present predicable properties that can be modified according to the 
intended application. Poly(ε-caprolactone) is an aliphatic linear polyester, and is 
amongst the most utilized synthetic polymers for biomedical applications. It is 
biodegradable and allows several modifications aiming scaffolds production, such as for 
drug controlled release. The degradability of PCL is very slow [159]. However, PCL 
characteristics allow tailoring its degradation rate, for example by combined with 
natural polymers, such as starch [160]. One of the most common applications of PCL is 
for electrospun scaffolds, namely for cartilage applications. PCL nanofiber meshes were 
extensively studied for cartilage TE applications, and showed the suitability of these 
matrices to support the chondrogenic differentiation and ECM production either using 
chondrocytes [127, 161] or MSCs [126, 162]. 
Our group has been exploring PCL nanofiber meshes for cartilage and bone TE 
applications. The surface of PCL nanofiber meshes has been modified by plasma 
treatment, and it has been concluded that the modified nanofiber meshes effectively 
supported cells growth and proliferation, improving cells performance [163]. Moreover, 
PCL nanofiber meshes were integrated into 3D scaffolds obtained by rapid prototyping. 
The integration of the nanofiber meshes substantially improved the biological 
performance of the hierarchical scaffolds, for bone TE [164]. PCL and SPCL nanofiber 
meshes have also been used for the culture of BAC. It was demonstrated that both 
nanofiber meshes were able to sustain ECM production [118]. 
Poly(butylene succinate) is an aliphatic polyester presenting good mechanical 
properties and melt processability [104]. This polyester has been proposed by our group 
for the engineering of connective tissues, in form of blends with chitosan [165, 166]. 
The referred blends were tested for bone TE applications. It has been shown that 
chitosan-PBS (CPBS) scaffolds produced by compression moulding and salt leaching 
effectively promoted adhesion, proliferation and osteogenic differentiation of a murine 
mesenchymal stem cell line [167], as well as the osteogenic differentiation of human 
MSCs [105]. The same blend was tested for cartilage regeneration, successfully [103]. 
Bovine ACs have been seeded onto the same CPBS scaffolds, and a cartilagineous 
ECM deposition was observed [103]. Fiber meshes produced with the same blend 
proved to sustain BAC culture and enhance ECM deposition [168]. 
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The scaffold is one of the key elements in our strategy for cartilage regeneration, as 
explained in the next section. However, other elements are essential in the strategy 
proposed herein, that will be further explored. 
 
4.2. Cell types 
 
The choice of the ideal cell type for cartilage tissue engineering is still a matter of 
debate in the community. Different strategies based either on chondrocytes or MSCs 
have been designed for cartilage TE. In the following sections we will discuss these 
strategies and their reported outcomes. 
 
4.2.1. Chondrocytes 
Chondrocytes, as already referred, are the only cell type present in cartilage tissue. 
Different types of chondrocytes have been used depending on the type of cartilage 
regenerative application, for example nasal [169, 170] or articular [111, 171-174]. One 
of the drawbacks of using chondrocytes is that these cells dedifferentiate when 
expanded in vitro using two-dimensional (2D) cultures [175, 176]. After several days in 
culture, chondrocytes in monolayer acquire a fibroblastic-like morphology [177]. 
Biomaterials providing a 3D environment enable the chondrocytes redifferentiation 
[178], being a valuable support for chondrocytes expansion in vitro. 
The use of human chondrocytes isolated from biopsies collected from patients is a 
current clinical procedure. Some of these biopsies are from patients suffering from 
cartilage diseases, such as OA. The obtained chondrocytes are therefore osteoarthritic, 
and this phenotype may have some influence on the outcome of cartilage repair [179]. 
Human OA chondrocytes have been studied using 3D structures aiming to understand 
their biology and phenotype development [180-182]. OA chondrocytes retain some 
ability to undergo chondrogenic differentiation, but it is inferior when compared to age-
matched normal chondrocytes, when in pellet cultures [180]. However, when cultured 
using scaffolds, their response may be different. For example, when human OA 
chondrocytes were seeded onto collagen scaffolds and implanted in SCID mice, no 
significant differences were found between the neo-cartilage derived from OA 
chondrocytes and the one from healthy donors [181]. Relevant results were also 
obtained when using a Hyaff®-11 membrane with normal and OA chondrocytes that 
were grown in this membrane [183]. The growth of chondrocytes in Hyaff®-11 
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membranes in this study seemed to suppress the differences between normal and OA 
chondrocytes. 
Chondrocytes have been extensively studied in cartilage TE approaches, using the 
most diverse types of scaffolds [107, 110, 122, 127, 161, 184-191]. For example, a 
cancellous bone matrix gelatine scaffold has been proposed recently for cartilage TE 
[192]. The scaffold was able to support New Zealand white rabbit’s chondrocyte 
proliferation and sustained their phenotype for up to 6 weeks. As referred previously, 
blends of synthetic and natural polymers have been used for cartilage TE. PLGA/ 
collagen hybrid scaffolds with three different structural designs were studied, 
comparing their effect on in vivo chondrogenesis of BAC [193]. Constructs were 
implanted subcutaneously in athymic nude mice, and the results showed a spatially even 
cell distribution, abundant ECM deposition and degradability in vivo, for all the tested 
scaffolds [193]. A chitosan-alginate-hyaluronate complex whose surface was modified 
by an Arg-Gly-Asp (RGD)-containing protein and seeded with rabbit chondrocytes was 
tested [194]. In vitro and in vivo cartilage formation was observed. Moreover, it was 
observed a complete repair of the cartilage defects in vivo after 6 months of 
implantation when using those systems. 
For cartilage repair, chondrocyte-seeded 3D scaffolds already reached the clinic [195]. 
The biomaterial ensures initial mechanical stability and an appropriated 3D environment 
for cell proliferation and differentiation. Thus, scaffolds avoid the need to use chondral 
sutures, one of the major drawbacks of the ACI technique and provided the possibility 
of obtaining stable transplant fixation [61].  A second generation ACI TE cartilage graft 
based on autologous chondrocytes embedded in a 3D bioreasorbable two component 
gel-polymer scaffold, BioSeed®-C, has been proposed for clinical treatments of 
cartilage defects [196]. The implantation of this scaffold in focal osteoarthritic defects 
showed a significant improvement in the knee-related quality of life two years post 
implantation [196]. Results suggest that the implantation of BioSeed®-C may be an 
effective treatment option for this kind of pathologies [196]. 
 
4.2.2. Mesenchymal stem cells 
Stem cells have become one the main cell source for tissue repair, as they present 
major advantages for regenerative medicine when compared to differentiated cells. 
MSCs can be isolated from many types of adult tissues, and are characterized by their 
ability to undergo extensive self-renewal in vitro and to go through multilineage 
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differentiation [197]. Unlike chondrocytes, these cells are available in virtually 
unlimited numbers, and do not loose their phenotype during expansion [198]. Those 
cells were already tested successfully in animal models of arthritis [199]. Importantly, 
they secrete or can be genetically manipulated to secrete immunosuppressive factors 
and therapeutic agents that target inflammatory tissues [200]. This ability enables MSCs 
to migrate into a damaged site, supporting their interest to be included in tissue 
engineered constructs. More details in those issues can be obtained in references [201] 
and [202]. The challenge in using MSCs as a cell source for articular cartilage repair is 
to maintain the MSC-derived chondrocytes in the pre-hypertrophic state and prevent 
them from undergoing terminal differentiation onto the osteogenic phenotype [203]. 
Different scaffolds have been designed to support and stimulate MSCs chondrogenic 
differentiation. The scaffold configuration is believed to be very important for the tissue 
formation and maintenance of its integrity. Recently, three types of scaffolds of poly 
(ethyleneglycol-terephtalate) - poly (butylene terephtalate) (PEGT/PBT) with various 
configurations were analysed for the support of adipose derived MSCs [204]. This study 
showed that manipulation of the scaffolds configuration allows controlling a uniform 
tissue formation at a microscale. Modification of the scaffold surface can be used to 
enhance MSCs performance [204]. Recently, a collagen surface modification of PCL-
based porous scaffolds was studied for supporting MSCs chondrogenic differentiation 
[205]. It was shown that surface modification enhanced chondrogenic differentiation of 
MSCs, when compared to PCL scaffolds without modification. PCL nanofiber scaffolds 
were tested in vivo for cartilage TE using periosteal cells of rabbits [206]. These 
membranes were implanted under the periosteum of 6 months old rabbits. After 
different time periods, constructs were removed, separated from the periosteum and 
cultured for 6 weeks under chondrogenic conditions. This work showed that is possible 
to produce engineered cartilage in vitro from PCL nanofibrous scaffolds with periosteal 
cells, after a period of in vivo pre-culturing [206]. 
Hydrogels and injectable systems have been a subject of intense investigation for the 
repair of cartilage and/ or osteochondral defects [109, 111, 112, 114, 139, 207-210]. The 
rationale of these systems is to provide a minimally invasive technique to repair 
cartilage defects. Hydrogels or injectable particles combined with MSCs may be 
introduced into the injured site, avoiding invasive surgery techniques. Microcarriers 
have been proposed for this approach [211]. Pharmacological active microcarriers 
(PAM) were prepared from PLGA, coated with fibronectin and engineered to release 
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transforming growth factor – beta 3 (TGF-β3) [211] and provide an appropriate 
environment for cartilage formation in vivo. Human MSCs were incubated with these 
particles, and afterwards were implanted in intramuscular or subcutaneous sites in SCID 
mice. These particles were shown to provide a suitable environment for MSCs 
chondrogenic differentiation and to be a feasible carrier for biomedical cartilage repair 
applications [211]. 
The type of cell chosen for a TE strategy may influence the outcome of the 
regenerative strategy. In the case of cartilage both chondrocytes and MSCs are the most 
used types of cells. The reported results for chondrocytes and/ or MSCs indicate that 
these cells are able to produce cartilage ECM in vitro, but a long road lies ahead until 
the objective of regenerating in vitro a fully functional articular cartilage, similar to the 
native one, is achieved. 
 
 
5. In vitro enhanced culturing conditions 
 
5.1. Bioreactors 
 
The use of bioreactors may substantially enhance the maturation of constructs in vitro. 
There are multiple types of bioreactors, aiming different applications such as bone [212-
214] or cartilage [79, 215-217]. Bioreactors are very useful in providing biophysical 
stimulation and facilitating nutrient diffusion for the cells. Additionally, bioreactors 
provide a closed and controlled environment for cell culture, enhancing the supply of 
oxygen and nutrients. The mechanical stimulus of a bioreactor may also have beneficial 
effects over cell growth or ECM production. Different bioreactors have been developed 
for various TE applications, such as spinner flasks, rotating wall vessels or perfusion 
bioreactors. Further details on this topic can be found elsewhere in [218], [219] or 
[220].  
 
5.1.1. Basic bioreactor systems 
Spinner flasks are one of the simplest types of bioreactor. They are mainly used for 
cell seeding of scaffolds [103, 119, 221], although some published reports cover its use 
for subsequent culture of constructs [73, 204, 222]. In spinner flasks, a magnetic stirrer 
is used to swirl a cell suspension in a plastic or glass bottle, composed by metallic 
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harms that hold the scaffolds static in respect to the moving medium (Figure 1.3). 
Spinner flasks can provide a controlled and reproducible method for cell seeding. 
However, when using scaffolds with low porosity, cells may have difficulty in penetrate 
inside the scaffold structure, remaining at its surface and therefore resulting in non-
uniform cell distribution [223]. During the seeding stage, cells are driven into the 
scaffold, and the medium mixing enhances mass transfer of nutrients, but also generates 
turbulence that may be detrimental for the cultures [224]. The culture of bovine 
chondrocytes in spinner flasks using poly(glycolic acid) (PGA) scaffolds, compared to 
static culture conditions resulted in higher fractions of released GAGs, but the net level 
of accumulated GAGs in the construct was reduced [225]. Some studies show that 
constructs exposed to turbulent flow originated a fibrous capsule at the construct surface 
[215, 226]. However, culture of the same constructs in rotating bioreactors having 
laminar flow, increased the amount of GAGs and showed improved results in terms of 
cartilage production [226, 227].  
Other simple device commonly used to seed cells is the orbital shaker (Figure 1.3C), 
where petri dishes are placed and constructs are subjected to fluid flow. This device 
may be used either for cell seeding and/or for dynamic cultures [103, 118, 221, 228, 
229], but presents similar limitations to the ones referred for spinner flasks. 
 
 
Figure 1.3 – Basic systems for cell seeding and dynamic culture of constructs. A – 
Individual spinner flask containing a cell suspension in culture medium and holding 
CPBS scaffolds. B – Spinner flasks in culture inside an incubator. C – Orbital shaker in 
culture. 
 
Rotating wall vessel (RWV) bioreactors are based in the culture medium rotation 
coordinated with the scaffold floating in the culture medium. These bioreactors are 
composed by a rotating cylinder, which is completely filled with culture medium, and 
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the fluid rotates horizontally by the friction at the cylinder wall (Figure 1.4). The 
oxygen is provided by a silicone membrane that is wrapped around the central cylinder.  
 
 
Figure 1.4 – Rotating wall vessel bioreactor. 
 
The RWV presents advantages relatively to spinner flasks systems [215]. The 
dynamic flow in these bioreactors is laminar, and not turbulent as opposed to the stirring 
in spinner flasks, eventually supporting the formation of more homogenous 
cartilagineous tissues [215].  
 
5.1.2. Perfusion bioreactors 
Perfusion bioreactor systems apply a direct flow of culture medium across the scaffold 
porous structure facilitating mass transfer. These systems allow overcoming the 
limitations of the previously referred systems and provide a continuous exchange of 
culture medium. Different variants of perfusion bioreactors have been proposed, such as 
column, hollow-fiber or microfluidic bioreactors [220]. One of the main concerns when 
using perfusion systems is the washing out of the cells. To avoid this undesired effect, 
cells are usually previously seeded and cultured in the scaffolds or encapsulated, and 
when the fluid passes through the construct, cells keep attached to the scaffold. The 
flow in perfusion bioreactors may be bidirectional or unidirectional, depending on the 
bioreactor design. Our group has recently developed a bidirectional flow perfusion 
bioreactor, consisting of a common inlet and outlet, dividing the flowing medium by 20 
individual culture chambers. The bioreactor was designed in a way that allows culture 
medium circulation throughout the chambers and thus, across the scaffolds in culture, 
ensuring an even distribution by the individual flow chambers (Figure 1.5). The referred 
bioreactor is currently protected by a Portuguese patent, and an European patent is 
pending. Detailed information about the device can be found elsewhere [230]. The 
bidirectional flow perfusion bioreactor was used for cartilage TE applications, using 
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human MSCs. PCL nanofiber meshes were seeded with human BMSCs for 
chondrogenic differentiation, by the stimulation provided by the bioreactor, and it was 
demonstrated that this is a valid model for this type of culture [231]. Additionally, when 
using chitosan-based scaffolds seeded with human BMSCs for chondrogenic 
differentiation, the bioreactor samples displayed significantly lower collagen type I 
expression, compared to the static controls [232]. The expression of several cartilage 
related genes, as well as the level of ECM deposition were positively affected in the 
referred samples [232]. 
 
 
Figure 1.5 – Bidirectional flow perfusion bioreactor developed in the 3B´s Research 
Group [230]. 
 
Dynamic culture conditions were shown in the literature to improve the chondrogenic 
differentiation and ECM production when compared to static culture conditions [73, 
224, 227, 233]. In a work using perfusion-type of recirculation bioreactors operated 
with periodic medium flow reversal, chondrogenic differentiation of human adipose 
MSCs in PGA scaffolds was successfully achieved [217]. When compared to pellet 
cultures, dynamic culture conditions were shown to produce significantly higher 
amounts of GAGs and collagen [217]. Dynamic culture conditions may also help in 
maintaining the phenotype of differentiated chondrocytes, without undergoing 
hypertrophy. Those results were shown in a study using ATDC5 cell line seeded onto 
chitosan scaffolds and cultured in a rotating bioreactor with perfusion (RCMW) [75]. A 
rotating wall vessel bioreactor was used for chondrocyte cultures onto nanofibrous 
scaffolds, showing that constructs grown in the bioreactor produced more GAGs and 
expressed higher levels of cartilage related genes, compared to static cultures [76]. The 
applicability of electrospun nanofiber meshes for flow perfusion bioreactors was 
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recently reported, when using electrospun PCL microfiber scaffolds coated with 
cartilagineous ECM [234]. Flow perfusion bioreactors are being studied for the scale-up 
of human cartilage grafts for joint repair [82]. Recent results shown the large-scale 
production of cartilage grafts in bioreactors for clinical treatments, and that in 
combination with specific surgical therapies may support the long term development 
and engrafting of the implant [82]. 
A different concept for the culture of autologous cartilage was proposed recently, 
being named as “in vivo bioreactor” (IVB) [235]. The referred strategy for de novo 
engineering of articular cartilage in the subperiosteal space involves the injection of a 
biocompatible gel. The obtained results were considered very promising, and authors 
claim that this can be a valid clinical option for obtaining successful cartilage repair 
[235]. 
The importance of the correct stimulus in a cartilage regeneration strategy has been 
herein described. In our point of view, bioreactors are a source of mechanical stimulus 
that should be explored for cartilage cultures in vitro. 
 
5.2. Hypoxia 
 
The application of hypoxia has been explored attempting to mimic the in vivo 
cartilage niche microenvironment. Oxygen levels in this tissue are low and when a 
change in oxygen levels occurs chondrocytes experience several effects on their 
phenotype, genetic expression and morphology [236]. Hypoxia conditions have been 
reported to stimulate chondrogenesis and synthesis of ECM components. It was shown 
to be beneficial for chondrocytes and augmented ECM deposition, either seeded in 
scaffolds [237] or not [238]. The same positive effect were also observed for the 
chondrogenesis of human MSCs [239, 240], as well as for other species MSCs, like rat 
or bovine [241-244]. 
Low oxygen levels have been shown to strongly influence the chondrogenic 
differentiation of stem cells [245]. The manipulation of oxygen levels has proved to be 
useful in directing stem cell through specific cell lineages, namely chondrocytes and 
cardiomyocytes [246]. As the oxygen plays a central role in chondrocyte metabolism, 
exploration of oxygen levels in cultures opens a large window of study. There are still 
many questions involving the application of low oxygen levels when inducing 
chondrogenic differentiation of stem cells. Under 5% of oxygen, human adipose MSCs 
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proliferative potential decreases, while their chondrogenic ability increases [247]. Some 
studies sustain that a hypoxic pre-conditioning step may be useful to improve stem cell 
differentiation into the chondrogenic lineage [241, 248, 249]. This aspect is not 
consistent in the literature, since other authors showed that the chondrogenic ability of 
human adipose MSCs cultured in pellets did not improve on hypoxic pre-conditioning 
[250].  
 
 
6. Co-cultures 
 
Tissues are highly complex and organized structures that comprise cells and matrix, 
and that interact with each other to maintain the tissue function and integrity. Moreover, 
cells and matrix are constantly interacting with surrounding tissues and environment. 
Thus, it is believed that those conditions may help developing a successful TE 
approach. So, it is relevant to understand and recreate as close as possible this 
environment, to study those interactions and use them actively to obtain a full tissue 
repair. Co-cultures allow the study of cell-cell communication and interactions, helping 
to understand the way different types of cells interact with each other in their niche. 
Thus, it is important to understand the influence of differentiated cells over 
undifferentiated cells. Chondrocytes in the cartilage tissue are distributed in four distinct 
zones or layers, thus their cellular interactions in vivo depend on their spatial location. 
Cartilage comprises the superficial, transitional, radial and tight zones [251]. 
Chondrocytes in the superficial zone interact with the synovial fluid and cells, whereas 
chondrocytes in the transitional and radial zones interact mainly with each other and 
with the ECM. Chondrocytes in the tide mark zone are located in the cartilage-bone 
interface, thus contacting with osteoblasts and bone matrix [252]. The cell-cell contact 
between chondrocytes and other cell types occurs also in the transition with other 
neighbouring tissues. Understanding the communication mechanisms underlying these 
contacts may provide valid and new strategies for cartilage regeneration. Table 1.3 
describes different co-culture studies for cartilage TE, using several types of cells and 
diverse ways of co-culturing them. There are two main approaches for performing co-
cultures: direct contact of cells (when the culture involves mixing both types of cells), 
or indirect (using conditioned media). Conditioned medium from chondrocytes has been 
successfully used to induce undifferentiated cells to follow the chondrogenic lineage 
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[172, 253-256]. The principle behind using conditioned culture medium is the ability of 
chondrocytes to release morphogenetic signals to the culture medium, that may be able 
to induce the chondrogenic differentiation of MSCs [83, 253, 257]. 
Cartilage inflammatory diseases such as OA or RA have been studied by co-culturing 
chondrocytes with synovial fluid cells [258-261] or with osteoblasts [80, 262-265]. In 
RA, formation of the chondrosynovial pannus causes modifications on the 
chondrosynovial joint, as some layers of cells begin to deposit covering the cartilage 
surface [266]. Both chondrocytes and synovial cells get in close contact by the 
deposition of these layers. Evidence of positive direct intercellular communication 
between these cells was previously reported [267]. Later, it was demonstrated that 
synoviocytes release factors to the culture medium that can stimulate chondrogenic 
differentiation [268, 269]. A recent study using direct and indirect co-cultures of bovine 
synovial fibroblasts and chondrocytes suggests that synovial supernatants and synovial 
fibroblasts may modulate chondrocytes biosynthetic activity and matrix deposition 
[259]. Direct contact co-cultures of human BMSCs and articular chondrocytes (ACs) 
using alginate/chitosan scaffolds in static conditions or using bioreactors have been 
established for the study of chondrogenesis and osteogenesis [80, 263]. The influence of 
cells on different degrees of osteogenic differentiation over the chondrogenic 
differentiation of MSCs was recently demonstrated [262]. The results shown that MSCs 
in different states of osteogenic preculture and encapsulated in a biodegradable hydrogel 
could positively influence the chondrogenic differentiation of rat MSCs, both in the 
presence or in the absence of growth factors [262]. 
These studies showed the importance of a 3D microenvironment in the 
communication of different cell types, indicating the potential of controlling these 
interactions to create specific tissues. 
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Table 1.3 – Outcome of in vitro co-cultures with several types of cells and different 
culture systems intended to promote cartilage tissue engineering. 
Cells involved Type of culture Outcome Ref. 
Human dermal 
fibroblasts and 
porcine ACs 
Direct contact in PLA/ PGA 
biphasic scaffolds  
Some dermal fibroblasts induced 
cartilage lacuna structure 
formation 
[124] 
Murine myoblasts 
(C2C12) and rat 
chondrosarcoma 
(RCS) cell lines 
2D; 3D cultures in collagen gels 
using conditioned medium from 
muscle cells 
Muscle cells conditioned 
medium led to increased 
cartilaginous ECM production 
[256] 
Human embryonic 
stem cells and 
human 
chondrocytes 
Indirect co-culture using well 
inserts (conditioned medium from 
chondrocytes) 
Culture micro-environment 
influences embryonic stem cells 
differentiation to chondrocytes 
[270] 
Bovine MSCs and 
ACs 
a) Micromass cultures of MSCs 
incubated with chondrocytes 
conditioned medium 
b) MSCs expanded in 
chondrocytes conditioned medium 
encapsulated in agarose hydrogels 
and implanted subcutaneously in 
athimic mice 
a) Incubation with conditioned 
medium enhanced cartilage 
production by MSCs 
 
b) ECM deposition characteristic 
of neocartilage formation 
[83] 
Murine embryonic 
stem cells and 
human 
hepatocarcinoma 
cell line 
Micromass pellets of embryonic 
stem cells cultured with 
conditioned medium from cell line 
Enhanced chondrogenic 
differentiation of embryonic 
stem cells [271] 
Human ACs and 
human periosteal 
tissue 
Co-cultures of ACs and periosteal 
tissue, cultures of ACs with 
conditioned medium from 
chondrocytes in agarose gels 
ACs formed clones in agarose; 
the periosteum can stimulate 
ACs clonal growth and 
differentiation 
[172] 
Human ACs in 
different passages  
Indirect co-cultures in filter inserts  The addition of primary 
chondrocytes to passaged cells 
resulted in an increase in 
cartilage formation  
[272] 
Equine MSCs and 
equine ACs 
Direct co-cultures of equine MSCs 
and ACs 
MSCs chondrogenic 
differentiation was enhanced by 
coculture with ACs 
[273] 
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7. Concluding remarks 
 
Cartilage regeneration is a demanding task that until now has not been fully 
accomplished. Some treatments based on TE concepts are available in the market, but 
still need improvement.  
To regenerate fully functional articular cartilage using a TE strategy, several 
components need to be brought together, such as the scaffold, the culture conditions, 
cell-cell contacts and signalling pathways or oxygen tension. In this chapter, we 
highlighted the most important aspects that, in our point of view, need to be considered 
and optimized. From the literature review we could draw some conclusions and also to 
identify some key points that should be object of further study, in a cartilage 
regeneration approach. The scaffold morphology and composition, as well as the 
material in which it is based were explored herein, and will be studied in the works 
developed in the present thesis. Moreover, culture conditions have been proved to have 
positive or negative effects on cell cultures. We will explore dynamic cultures to 
determine their effect on the models proposed in this thesis. The referred models consist 
on different types of primary cultures of differentiated or undifferentiated cells, induced 
for chondrogenesis. The outcomes of using either chondrocytes or MSCs have been 
highlighted in this chapter.  
This literature review is intended to provide a background perspective of the progress 
of the scientific community, and introducing to the main topics that will be further 
explored in the experimental work reported in the next sections of this thesis. 
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Materials and Methods 
 
The objective of this chapter is to describe the materials and methods used in the 
experimental work presented in this thesis. Each chapter contains the materials and 
methods used, but herein we intend to explain in more detail the experiments that were 
performed, as well as the techniques used. 
 
 
1. Materials 
 
One transversal issue in the work presented in this thesis is the use of three 
dimensional (3D) structures as scaffolds for primary cell cultures. Those structures are 
intended to promote the attachment, proliferation and chondrogenic differentiation or 
chondrocyte phenotype maintenance. The objective was to understand the way different 
materials and structures, either natural or synthetic, processed with various techniques 
(either in blends or alone), would interact with the established primary cultures and 
influence formation of tissue engineered cartilage in vitro.  
 
1.1. Chitosan-based blends 
 
Chitosan is a natural polymer derived by the deacetylation of chitin. Chitin is usually 
extracted from crustaceous exoskeleton, like crabs or shrimps. Chitosan is obtained by a 
de-N-deacetylation of chitin, and is composed of β(14)-linked glucosamine and N-
acetyl-D-glucosamine (Figure 2.1) [1]. Chitosan used for blends production was 
supplied by France Chitin (Orange, France) and had a degree of deacetylation of 85 %. 
The deacetylation process is usually made in alkaline conditions, resulting in different 
chitosans depending on the degrees of deacetylation and on the molecular weight [2].  
 
 
 
Figure 2.1 – Representative chemical structure of chitosan.  
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Most of chitosan properties of are affected by its molecular weight and the degree of 
deacetylation, as was already discussed in section I. In the present thesis, chitosan was 
blended with synthetic biodegradable polymers to enhance the processability of 
chitosan and provide better mechanical properties to the final material. The synthetic 
biodegradable material enables melt processing and acts as the continuous phase of the 
blend, enhancing its mechanical properties. In previous works by our group, several 
innovative blends were produced, with different percentages of natural and synthetic 
polymer but always keeping the biodegradability [3, 4]. The synthetic polymers used in 
the referred works were not previously tested for biomedical applications, only for 
environmental ones. This innovative approach resulted in several blends of chitosan 
with synthetic aliphatic polyesters, produced by compression moulding followed by 
particulate leaching [3, 5]. A biological screening was performed to test the blends 
cytocompatibility and biological performance when in cell culture [3]. From this study, 
two chitosan – polyester blends were selected for the work herein presented: chitosan 
and poly(butylene succinate) (CPBS) (50/50 % by weight), and chitosan and 
poly(butylene terephthalate adipate) (CPBTA) (50/50 % by weight).  
Poly(butylene succinate) is a biodegradable aliphatic polyester commercialized under 
the trade name Bionolle™ 1000 (Showa Highpolymer, Japan), and its chemical 
structure is shown in Figure 2.2. It possesses a crystallinity of 35-45 % and a melting 
temperature of 114-115 ºC [6]. PBS is a semi-rigid polyester (elongation at break of 
170-250 %) that can be processed under conventional melt processing techniques, and 
its applications are mainly for industry purposes, such as food packaging, clothing or 
industrial trays [7]. The biodegradation of the material is achieved in composting and 
also by hydrolysis of the ester link, eventually mediated by lipase [8] (an enzyme found 
in the human body). 
 
 
 
Figure 2.2 – Chemical structure of poly(butylene succinate). 
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Poly(butylene terephthalate adipate) is another biodegradable aliphatic polyester used 
for the production of chitosan-based blends, but presenting elastomeric mechanical 
properties. PBTA is an Eastar Bio Copolyester 14766™ butanediol, adipate and 
terephthalate copolymer obtained from Eastman Chemical Company, Kingsport, 
Tennessee. It presents elastic properties similar to those of a rubber (elongation at break 
of 600 %), being more flexible than PBS [7]. PBTA is formed by the reaction of 
butanediol with adipic and terephthalic acids [6]. PBTA is degraded into various 
aliphatic and aromatic oligomers by the action of microorganisms in compost [9]. The 
material, being a polyester, is also degraded by the action of enzymes. 
 
 
 
Figure 2.3 – Chemical structure of poly(butylene terephthalate) that will be modified 
to produce PBTA. 
 
1.2. Poly(ε-caprolactone) 
 
Poly(ε-caprolactone) is also an aliphatic polyester, semicrystalline and with a melting 
temperature (Tm) of 59-64 ºC (Figure 2.4), which degrades at slow rates, being used to 
produce resorbable sutures (for example Monoderm®) or for implantable drug delivery 
systems [6]. PCL is water stable and can undergo hydrolysis [10]. It is a very versatile 
polymer, being proposed for several tissue engineering applications [11-15], either 
alone or in blends with other polymers.  
 
 
 
Figure 2.4 – Chemical structure of poly(ε-caprolactone). 
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The PCL used for scaffolds production was acquired from Union Carbide Chemicals 
and Plastic Division, Bound Brook, New Jersey, and it is commercially available as 
TONE™ polymer. 
 
1.3. Starch – polycaprolactone blend  
 
Starch is the major polysaccharide used to store energy by many types of plants. It 
occurs in nature in the form of non-soluble granules. It is composed of a variable 
mixture of amylase and amylopectin. Amylase is a linear polysaccharide whereas 
amylopectin is a branched polysaccharide (Figure 2.5). Depending on the type of plant, 
the biosynthesis mechanisms differ, as well as their shape, size or composition [10]. 
Starch is transformed into a thermoplastic starch by disruption of its natural structure by 
the hot processing in water in the presence of glycerol. It has been blended with other 
synthetic polymers, for example polyhydroxybutyrate, cellulose or PCL [16]. Starch 
blends with PCL, poly-L-lactic acid or ethylene vinyl alchool have been studied in our 
group for tissue engineering applications, either in vitro or in vivo, showing low 
cytotoxicity and good cytocompatibility [17-23]. 
 
Figure 2.5 – Chemical structure of amylase and amylopectin. Their ratio in starch 
granules varies according to their origin. 
 
The starch-polycaprolactone blend used in the framework of this thesis was supplied 
by Novamont (Novara, Italy), in the ratio of 30 % starch (Mater-BI ZI01U, Novamont, 
Novara, Italy) and 70 % PCL. 
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2. Scaffolds production 
 
2.1. Compression moulding and particulate leaching 
 
Depending on the scaffold material and its intended application, different production 
techniques and methodologies may be used. The procedure used should not modify the 
materials chemical properties or its cytocompatibility. However, it should allow for 
tailoring in a controlled and reproducible way its pores and structure to meet the 
intended requirements of the TE application. Several techniques have been used, such as 
solvent casting combined with salt leaching, freeze drying, fiber bonding, melt bonding 
or combination of these techniques [24, 25]. 
The scaffold porosity plays a very important role in tissue formation in vitro, as the 
pores will potentially enhance cell-cell interactions. In the particular case of cartilage, 
pores may provide an ECM like structure that mimics cartilage environment. Therefore, 
scaffold porosity and consequent pore shape and size were studied in the context of the 
present thesis to assess interactions between cells and porous scaffolds. Our group has 
been exploring melt based techniques for porous scaffolds production, namely for 
chitosan and starch blends. CPBS (50/50 % wt) blends were produced and processed 
into scaffolds, using a methodology based in hot compression moulding followed by 
NaCl particle leaching [5, 26]. The porous structure of these scaffolds was created by 
solid powder mixing with salt particles. The solid blend was loaded into a mould, 
heated and compression-moulded into large and thick discs. Those discs were sliced to 
obtain cubes of 5 mm. These cubes were further immersed in distilled water to leach out 
the NaCl particles, during 6 days (Figure 2.6). The time period was previously 
optimized and is the time required to ensure that salt particles are dissolved. 
 
Materials and Methods 
63 
 
Figure 2.6 – Illustration of the procedure followed for the production of scaffolds by 
compression moulding followed by NaCl particle leaching.  
 
In the present work, a CPBS (50/50 % wt) blend was first compounded and processed 
into scaffolds using this methodology. For achieving a high degree of mixing, the 
blends were produced using a twin screw extruder (Leistriz LSM 36). More detailed 
information about the characteristics of the blends can be found elsewhere [3, 4, 27]. 
Common salt (NaCl) was used as the porogen agent. Two different groups of scaffolds 
were produced: one using 80 % by weight (wt) of salt with particle size ranging 
between 63-125 µm (80 CPBS). The second group of scaffolds was produced using 60 
% by weight of salt with a particle size range of 250-500 µm (60 CPBS). In both cases, 
large discs were processed from where cubes of 5 mm were sliced. These cubes were 
immersed in distilled water to leach out the salt, in a process optimized to take 6 days. 
Water was changed every day to facilitate the complete dissolution of the porogen 
agent. By the end of this procedure, cubes were dried until a constant weight was 
obtained.  
 
2.2. Fiber bonding 
 
CPBS scaffolds produced by compression moulding and salt leaching were shown to 
be suitable for cartilage TE, when seeded with bovine articular chondrocytes [28]. 
However, the cells show some difficulty in penetrating inside the scaffolds porous 
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structure, suggesting that an optimization of the porous structure was needed. The same 
blend was used for the production of fiber meshes, by fiber bonding technique. This 
technique allows the production of highly interconnected and larger scaffolds having a 
large surface area to allow cell attachment and proliferation [25].  
The previously compounded chitosan blends were processed by fiber extrusion, using 
a prototype single screw micro-extruder coupled to a capillary die. Two blends were 
herein used: CPBS and CPBTA, both in the ratio of 50/50 % (wt). Extruded fibers were 
chopped into 1 cm sections and then were loaded into a mould. The mould was heated 
above the thermoplastic blend Tm during 10 minutes. Immediately after removing the 
moulds from the oven, fibers were slightly compressed by a Teflon cylinder to pack and 
promote bonding between the fibers. Finally, standardized scaffolds of 2 mm thick 
discs, with diameter of 8 mm were obtained by cutting the fiber bonded meshes with a 
circular die (8 mm in inner diameter). Scaffolds were further sterilized by ethylene 
oxide. 
 
2.3. Electrospinning 
 
In recent years, the electrospinning technique has been extensively explored for 
producing fibrous mesh scaffolds that are composed of fibers with diameters ranging 
from micro to nanoscale. The characteristic morphology of those meshes resembles the 
native ECM of many tissues. It is a very versatile technique that allows a fine control 
over the scaffold geometry, allows obtaining different fiber diameters and meshing 
morphologies, and also enables processing different materials. The individual fiber 
diameter can be adjusted by optimizing the spinning parameters and the polymeric 
solution properties. The obtained nanofiber meshes have a high surface area volume that 
promote cell attachment, and also allows a higher density of cells [29]. 
Over the past decade, electrospinning has gained popularity as a means of fabricating 
scaffolds with micro to nanoscale features similar to the hierarchical structure of 
extracellular matrix (ECM). The ability to mimic the ECM structural organization is an 
important consideration in rational design of a cell-responsive scaffold platform upon 
which additional functionalities can be incorporated. Electrospinning offers great 
flexibility in terms of choice of scaffold material, as well as fine control over the 
scaffold morphology. Fibers with diameters ranging from tens to hundreds of 
nanometers can be easily produced. The diameter is adjusted empirically via modulation 
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of spinning parameters such as the voltage used, flow rate, collecting distance and 
polymer solution properties. A schematic of the electrospinning apparatus is shown in 
Figure 2.7. 
 
Figure 2.7 – Electrospinning setup composed by an electric power supply, a syringe 
pump and a collector. Different collectors can be used, depending on the intended fiber 
mesh morphology.  
 
2.3.1. SPCL and PCL nanofiber meshes production 
In the present work, PCL and SPCL nanofiber meshes were produced. Polymeric 
solutions of PCL and SPCL were prepared by dissolving the polymer or the blend into 
an organic solvent mixture of chloroform/dimethylformamide (70:30) (Sigma-Aldrich, 
USA), at concentrations of 17 % and 24 % (w/v), respectively. Polymeric solutions 
were placed into syringes with blunted metallic needles attached to it. The selected 
needles had an internal diameter of 0.8 mm. Furthermore, the syringe was coupled to a 
syringe pump (model KDS100, KD Scientific, USA) to control the flow rate. A flat 
aluminium foil connected to the ground was used as the fiber mesh collector. The high 
voltage power supply (0-25 kV) was applied in the needle, generating the electric field. 
The capillary tip-to-collector distance and the flow rate were fixed at 20 cm and 1.0 
mL/h, respectively. Nanofiber meshes production lasted 1 hour, and for that it was 
needed 1 mL of polymeric solution. The applied voltage was kept at 9 kV. Nanofiber 
meshes were collected and cut in squares with 1 cm2. Experiments were performed at 
room temperature and the conditions were optimized for the two materials. After 
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production and prior to the seeding procedures, nanofiber meshes were sterilized under 
ultra-violet (UV) light. 
 
2.3.2. PCL nanofiber meshes clamping system for culture in the bioreactor 
A clamping system to fixate the produced PCL nanofiber meshes in the multichamber 
flow perfusion bioreactor used in chapters 5 and 6 had to be assembled, as shown in 
Figure 2.8. The PCL nanofiber meshes meshes were clamped in between two silicon 
rings (with 8 mm outside diameter and 5 mm inside diameter), which were then 
clamped with nylon stitches [30]. The membranes were then sterilized under UV light 
for 1 hour in each side, with the meshes already mounted between the rings. 
 
 
 
Figure 2.8 – Clamping system used for culturing PCL nanofiber meshes in the 
bioreactor. 
 
 
3. Scaffolds characterization 
 
3.1. Scaffolds morphology 
 
As referred previously, we intended to work herein with different types of scaffolds 
morphology. Therefore, to clarify about the different porous morphologies of scaffolds, 
we include a figure with an example of each structure used: microporous scaffolds, 
nanofiber meshes and microfiber meshes (Figure 2.9). 
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Figure 2.9 – Morphology of the scaffolds used in this thesis. A – Microporous 
scaffolds. B – Nanofiber meshes. C – Microfiber meshes. 
 
3.2. Scanning electron microscopy for morphological analysis 
 
Scanning electron microscopy (SEM) is a technique that allows analysing the surface 
structure and topography of a specimen at very large magnifications. It is possible by 
this technique to analyse details at submicron level. SEM provides a direct assessment 
of pore size and structure. Interconnectivity of a scaffold can also be estimated, as well 
as examination of scaffold interior by sectioning the specimens. Usually it is necessary 
to coat the samples with conductive materials such as gold or carbon, to provide 
conductivity and avoid charge accumulation or damaging the specimen surface. Herein, 
we used SEM for morphological analysis of the scaffolds surface. The different 
scaffolds were sputter-coated with gold (Fisons Instruments, model SC502; England). 
Then, samples were analyzed using a Leica Cambridge electron microscope, model 
S360 (Cambridge, England).  
PCL and SPCL nanofibers diameter was assessed by quantification based in SEM 
micrographs with the software ImageJ (version 1.38X, Wayne Rasband Nacional 
Institutes of Health, USA). Pore sizes were also characterized using this software, and 
SEM micrographs. 
 
3.3. Microcomputed tomography 
 
Microcomputed tomography (µCT) is a non-destructive technique for the 
characterization of the structures with micrometer resolution, allowing the study of the 
interior of the structure in detail. Samples used in this technique can be used for futher 
tests because the technique is non destructive, providing a clear advantage relative to 
SEM analysis. Additionally, µCT provides a 3D imaging of the specimen and a close up 
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view of its interior and surface. Detailed information about scaffold characterization 
using µCT technique may be obtained e.g. in reference [31].  
In the present work, a µCT equipment (SkyScan, Belgium) was used for a very 
detailed analysis of the morphology of the developed CPBS porous scaffolds. Four 
scaffolds of each condition were scanned in high-resolution mode of 8.7 µm x/y/z and 
an exposure time of 1792 ms. The energy parameters defined in the scanner were 63 
keV with a current of 157 µA. Isotropic slice data were obtained by the system and 
captured into 2D images. These slice images were compiled and analyzed to render 3D 
images and obtain quantitative architecture parameters. A µCT analyser and a µCT 
Volume Realistic 3D Visualization, both from SkyScan, were used as image processing 
tools for both µCT reconstruction and to create/visualize the 3D images. Regions of 
interest (square of 4.5 x 4.5 mm2) were selected in each slice image and a threshold was 
set to eliminate background noise. This threshold (to distinguish polymer material from 
pore voids) was chosen and maintained constant for all the scanned specimens and 
samples. The threshold was also inverted to obtain the volume of the pore and to 
analyze both the pore morphology and interconnectivity. The analysis was performed to 
obtain quantitative data on the level of porosity and interconnectivity of the studied 
scaffolds.  
 
 
4. Cell isolation and expansion 
 
4.1. Culture medium 
 
In the context of the work developed during the PhD, several types of primary 
cultures were used, both from bovine and human origin samples. Chondrocytes and 
mesenchymal stem cells (MSCs) isolation procedures were studied and optimized, for 
both bovine and human samples. The culture medium used was similar for both types of 
cells, as we tested and validated the efficiency of the medium cocktail in both cultures.  
 
4.1.1. Culture medium for chondrocytes primary cultures 
For chondrocytes, two culture media were used, having a common basic cocktail 
named basic medium. For chondrocyte expansion in monolayer cultures basic medium 
supplemented with basic Fibroblast Growth Factor (bFGF) was used. For chondrocyte 
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culture in the 3D structures and to enhance cartilage ECM deposition, basic medium 
was supplemented with insulin and ascorbic acid. The culture media composition used 
for bovine and human chondrocytes in monolayer expansion and in 3D culture was 
prepared as follows: 
 
 Basic Medium: Dulbecco’s modified Eagle’s medium (DMEM) (Sigma, D5671), 
containing 10 mM Hepes buffer (Sigma, H0887), L-alanyl-L-glutamine (Sigma, 
G8541), Non Essential Aminoacids (Sigma, M7145) 10000 units/ml penicillin, 
10000 μg/ml streptomycin (Sigma, P0781), 10 % foetal calf serum (Biosera, 
S1810). 
 
 Expansion medium for articular chondrocytes: medium composed by basic 
medium supplemented with 10 ng/ml of bFGF (PeproTech, 100-18B).  
 
 Differentiation medium articular chondrocytes: this medium is composed by basic 
medium supplemented with 1 mg/ml of insulin (Sigma, I5500) and 1 mg/ml of 
ascorbic acid (Sigma, A4544).  
 
4.1.2. Culture medium for MSCs primary cultures 
Different culture media were used for the isolation and expansion of MSCs, and for 
chondrogenic differentiation of these cells. 
 
 Expansion medium for MSCs: this medium was composed by Alfa Minimum 
Essential Medium (α-MEM) (Invitrogen, 12000-063), supplemented with 
antibiotic/ antimycotic solution (Gibco, 15240062), 20 % fetal bovine serum 
(Baptista Marques, BSC0115/0943k). 
 
 Chondrogenic differentiation medium: this medium consisted of a mixture of α-
MEM supplemented with antibiotic/antimycotic solution, ITS liquid media 
supplement (Sigma, I2521), dexamethasone 1 mM (Sigma, D1756), sodium 
pyruvate 0.1M (Sigma, P4562), ascorbate-2-phosphate 17 mM (Sigma, A4544), 
L-proline 35 mM (Sigma, P5607) and 1 ng/ml of human recombinant TGF-β3 
(PeproTech, 100-36). 
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4.2. Articular chondrocytes isolation and expansion 
 
Isolation of articular chondrocytes was performed from bovine (chapters 3 and 4) or 
from human samples (chapter 7). The method applied for isolation and expansion of 
articular chondrocytes was performed according to the method previously reported [32]. 
This method is based on the enzymatic digestion of cartilage ECM for release of 
chondrocytes, using collagenase type II for the degradation of ECM. The procedure was 
similar for both types of samples. 
Bovine legs were acquired at the local abattoir, in Sheffield, UK. Full thickness 
hyaline cartilage was harvested from the metacarpophalangeal joint (Figure 2.10A). 
Human samples were collected at the local hospital, in Braga (Figure 2.10B). Articular 
cartilage was isolated from human patellae collected under informed consent from 
patients undergoing knee arthroplasties at the Hospital de São Marcos, Braga, Portugal. 
During surgeries, the knee was collected into a container with phosphate buffer saline 
(Sigma, D8537) and maintained in ice until the isolation procedure. 
 
 
 
Figure 2.10 – Example of bovine and human samples used for isolation of articular 
chondrocytes. A – Bovine leg exposing the metacarpophalangeal joint. B – Human knee 
sliced in pieces. 
 
Cartilage was dissected in small full-depth pieces and washed twice with phosphate 
saline buffer. Then, it was digested with 0.25 % (w/v) of trypsin solution (Sigma, 
E5134) for 30 minutes at 37 ºC on a rotator. The solution was removed, cartilage was 
washed again in phosphate saline buffer and then incubated in a collagenase type II 
solution (2 mg/mL) (Sigma, C6885) overnight at 37ºC on a rotator (Stuart mini orbital 
shaker SSM1). The following day, cells were washed twice with phosphate saline 
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buffer, counted and platted at a density of 2x106 cells per Petri dish in the case of 
bovine cells and in culture flasks, in the case of human cells. Cells were cultivated with 
expansion medium prepared as described previously. 
 
4.3. Human bone marrow mesenchymal stem cells isolation and expansion 
 
Isolation of human bone marrow derived mesenchymal stem cells (hBMSCs) was 
based on these cells ability to adhere to plastic. The referred cells present a spindle-
shape morphology and colony forming unit capacity (CFUs). The procedure employed 
in this thesis was based on a method previously described in the literature [33]. Human 
BMSCs were isolated from bone marrow aspirates collected under informed consent 
from patients undergoing knee arthroplasties in Hospital de São Marcos, Braga, 
Portugal (Figure 2.11). During surgeries, bone marrow was collected into a container 
with α-MEM medium, supplemented with antibiotic/ antimycotic solution and 5000 
units of heparin (Sigma, H3393) and maintained in ice until the isolation procedure. 
Aspirates were homogenised, diluted in phosphate buffer saline (1:1) and incubated for 
5 minutes at room temperature. Then, bone marrow was diluted in lyses buffer (1:10) 
and left under agitation for 10 minutes. Lyses buffer was prepared with 10 mM of Tris-
HCl (Sigma, T3253), 1.21 g of Tris Base (Sigma, T1503) and 8.3 g of NH4Cl (Merck, 
1011455000), in 1L of distilled water.  Afterwards, the suspension was centrifuged at 
1200 rpm, for 15 minutes at room temperature. Cells were ressuspended in α-MEM 
medium, supplemented with antibiotic/ antimycotic solution and 20 % fetal bovine 
serum. Cell suspension was filtered for disposal of debris, using 100 µm and 70 µm Cell 
Strainer (BD Falcon™, 352360 and BD Falcon™, 352350). Cells were counted and 
plated at the density of 4.7x103 cells/cm2. Cells were expanded in expansion culture 
medium for MSCs as described previously. 
 
 
Figure 2.11 – Human bone marrow sample for isolation of mesenchymal stem cells. 
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4.4. Human Wharton´s jelly mesenchymal stem cells isolation and expansion 
 
Human umbilical cords (UC) were obtained from informed consent full-term 
caesarian sections, under the cooperation agreement established between the 3B´s 
Research Group and the Obstetrics Department of the Hospital de São Marcos, Braga, 
Portugal and approved by the Ethics Committee of the same hospital (Figure 2.12). 
Human WJSCs (hWJSCs) were isolated according to the procedure originally described 
by Sarugaser et al. [34]. Briefly, UC were cut into 3–5 cm segments. These segments 
were then dissected by separation of the UC section epithelium along its length, 
exposing the underlying Wharton’s jelly. Each vessel, with its surrounding Wharton’s 
jelly matrix, was pulled away, and the ends of each dissected vessel were tied together 
with a suture creating “loops”. Following, the loops were digested using a 1 mg/ml 
collagenase type I solution (Sigma, C0130) prepared with phosphate buffer saline 
(Sigma, D8537). After 18–24 hours, the loops were removed. The remaining suspension 
was diluted with phosphate buffer saline to reduce its viscosity, followed by a 
centrifugation at 1200 rpm for 5 minutes. Cells were ressuspended in 10 mL of 
expansion culture medium for MSCs and counted in a hemocytometer. Finally, cells 
were plated and expanded until reaching 80–90 % confluence.  
 
 
Figure 2.12 – Example of an umbilical cord sample for isolation of human Wharton´s 
jelly mesenchymal stem cells. 
 
4.5. Analysis of the “stemness” of isolated mesenchymal stem cells 
 
Flow cytometry (FCM) is a technique that allows counting of cells or particles, 
suspending them in a fluid and passing them in a flow cytometer. Flow cytometry 
analysis was used herein to characterize surface markers of the isolated potential MSCs. 
It is well established that MSCs show non-haematopoietic surface markers such as 
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CD29, CD73 or CD166 and present colony forming unit –fibroblast (CFU-F) ability 
[35, 36].  
To evaluate cell-surface marker expression, and the stemness of the isolated cells, 
some studies were performed, namely FCM and cell differentiation into several 
lineages. Cultured hBMSCs and hWJSCs were incubated for 20 min at 4 ºC with 
fluorescein isothiocyanate (FITC)- or phycoerythrin (PE)-conjugated monoclonal 
antibodies specific for human markers associated with mesenchymal or haematopoietic 
lineages. All the antibodies were purchased from BD Pharmingen. The samples were 
analysed using a BD FACSCalibur flow cytometer (BD Biosciences, Portugal). The 
stemness character of both of these cells was studied in a previous work by our group 
[37]. Cells were studied by flow cytometry for MSCs markers (CD31, CD34, CD45-
negative and CD13, CD29, CD73, CD90, CD105, CD166-positive cells), and by 
differentiation studies into osteogenic, chondrogenic, and adipogenic lineage, being 
considered stem cells. 
 
 
5. Cell and materials culture 
 
5.1. Bovine articular chondrocytes (BAC) culture under static and dynamic conditions 
 
In this first approach to cartilage tissue formation in vitro (corresponding to chapters 3 
and 4), we employed a model using primary cultures of BAC, comparing static and 
dynamic (stirred) culture conditions. Those studies used nano or macro structures as 
scaffolds for support and enhancement of cartilagineous ECM deposition.  
  
5.1.1. BAC seeding and culture onto SPCL and PCL nanofiber meshes 
Dynamic cell seeding was performed using Petri dishes placed in a rotator inside the 
incubator. Three nanofiber meshes were placed in each Petri dish, and the cell 
suspension was added to obtain 6.5x106 cells per nanofiber mesh. We used the 
expansion culture medium for articular chondrocytes described previously for this step.  
We used 20 nanofiber meshes per experimental condition, for each material. Petri dishes 
were placed in the rotator, inside the incubator, at 60 rpm, for 72 hours. Afterwards, cell 
seeding was complete, and half of the constructs were kept in the rotator inside the 
incubator (dynamic conditions), whereas the others were placed in the incubator (static 
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conditions).  Culture medium was changed for differentiation medium prepared as 
described in 4.1.1. The medium was changed every three days. 
 
5.1.2. BAC seeding and culture onto CPBS scaffolds 
Bovine AC were harvested, counted and ressuspended in expansion medium. We used 
this method for dynamic seeding of CPBS scaffolds with different porosities, as 
described in chapter 4 of this thesis. Twenty scaffolds were used in each experiment, for 
each type of scaffold. Materials were seeded with a cell suspension containing 6.5x106 
cells per scaffold. Seeding was performed in spinner flasks in order to allow the cell 
penetration into the porous structure of the scaffolds. After 72 hours, the constructs 
were removed from the spinner flasks and divided by static and dynamic cultures, as 
described for PCL and SPCL nanofiber meshes.  
 
5.2. Human BMSCs culture in a flow perfusion bioreactor 
 
In the second part of the present PhD (corresponding to chapters 5 and 6), we used 
primary cultures of human mesenchymal stem cells, in static and dynamic culture 
(bioreactor) conditions to assess chondrogenic differentiation of hMSCs. The aim was 
to verify if the bioreactor would enhance ECM production and accumulation when 
using 3D structures produced with nano or microfibrous as scaffolds for cells. 
 
5.2.1. Human BMSCs seeding onto PCL nanofiber meshes 
Human BMSCs were harvested, counted and ressuspended in basic medium for MSCs 
in order to obtain a cell suspension of 200.000 cells/nanofiber mesh. The seeding 
method was previously described in detail and published by our group [30]. Each 
scaffold was seeded with a 10 µL drop of the prepared cell suspension in 24 well plates. 
Afterwards, constructs were maintained at 37 ºC and 5 % CO2, during 4 hours in an 
incubator to allow cell attachment to the nanofiber meshes. After this time period, 1 mL 
of expansion medium for MSCs was added to each culture well and left in the incubator 
for 24 hours. The constructs were then transferred to the bioreactor. In the next day, the 
flow perfusion bioreactor was fully sterilized in the autoclave. Then, it was assembled 
inside the hood and the constructs to be cultured were transferred into the bioreactor. 
The bidirectional flow perfusion bioreactor (PT patent nº 104155; European patent 
pending [38]) has a maximum of 20 individual culture chambers. According to the 
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study plan, 20 constructs were transferred to the bioreactor. The flow rate was set to 70 
µl/min/nanofiber mesh. The bioreactor was transferred into the incubator and kept in 
those conditions during the whole experiment.  
Another set of 20 identical constructs was transferred to new culture plates and 
maintained in static conditions to be used as control. Chondrogenic differentiation 
medium was added to the bioreactor and to the new culture plates for static culture, for 
promoting chondrogenic differentiation. Culture medium in the bioreactor was 
completely changed every week (100 mL each time). Control samples were cultured in 
24 well plates, and were fed every other day with 1 mL of culture medium, until the end 
of the experiment (28 days). 
 
5.2.2. Human BMSCs seeding onto CPBTA fiber meshes 
Human BMSCs were harvested from culture and counted. A cell suspension of 1x106 
cells/ fiber mesh was prepared to seed each scaffold. Cell seeding was performed in 
static conditions, inside the incubator, at 37ºC, during 24 hours. All the procedure 
follows the previous description presented in section 5.2.1, except for the bioreactor 
flow rate. For this work, the established flow rate was 100 µl/min/microfiber mesh.  
 
5.3. Co-cultures of human ACs and MSCs onto CPBS fiber meshes 
 
In the last part of this thesis (corresponding to the chapter 7), we studied the influence 
of chondrocytes onto the chondrogenic differentiation of human MSCs, using a 3D 
structure to facilitate the cell differentiation. We performed these experiments in static 
culture conditions, as we did not obtain conclusive results herein on the positive 
influence of dynamic culture conditions on chondrogenic differentiation and ECM 
production, compared to static conditions (chapters 5 and 6). We selected in this case 
the scaffold morphology that, based in previous results, showed the highest performance 
in having a positive influence over the chondrogenic differentiation of MSCs (CPBS 
microfibrous structure). 
Cells were expanded, split, counted and then seeded onto the CPBS fiber meshes. 
Two study groups were established: direct co-culture using with each source of hMSCs 
(hBMSCs or hWJSCs) and hACs; indirect co-culture using conditioned medium 
obtained from the culture of hACs. This indirect co-culture method herein described is a 
variation of the transwell inserts technique [39, 40]. In this case, instead of separating 
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the two cultures with a transwell, we cultured separately the chondrocytes and the stem 
cells. As discussed in the introduction of this thesis, it is known that the scaffolds 3D 
structure can positively influence the chondrogenic commitment of MSCs. We 
hypothesised that by providing the microenvironment and the soluble factors present in 
chondrocytes medium we would be able to influence the chondrogenic differentiation of 
both types of MSCs used in the present work. Thus, as the medium provided was 
previously consumed by chondrocytes, we used conditioned medium mixed (50/50 in 
volume) with fresh medium. By diluting the factors secreted by the chondrocytes in 
fresh medium, it was intended to provide the required nutrients to the MSCs indirect co-
cultures, avoiding the risk of nutrient deprivation. 
 
5.3.1 Direct co-cultures 
A suspension of 1x106 cells (5x105 hBMSCs and 5x105 hACs) per scaffold was used 
for seeding the fiber meshes using the dynamic culture method in a rotator, for 24 hours. 
Afterwards, constructs were changed into new culture plates and fed with chondrocytes 
differentiation medium. Constructs were placed inside the incubator in static culture 
conditions and cultured for 28 days. Medium was changed every other day. The same 
procedure was used for the direct co-cultures of hWJSCs. 
 
5.3.2 Indirect co-cultures 
Indirect co-cultures were performed using conditioned medium, obtained from hACs 
in culture. First, a cell suspension containing 1x106 cells per scaffold was prepared for 
each type of cells (hBMSCs or hACs). Each cell type was seeded onto different 
scaffolds, in different culture plates. The seeding procedure was similar to the one 
described above for the direct co-cultures. Afterwards, cells were placed in new culture 
plates containing differentiation medium. After two days, medium was changed. The 
human BMSCs medium was completely removed, and replaced by conditioned 
medium. This consisted of a mixture of the medium which was removed from the 
chondrocytes culture, mixed with fresh differentiation medium (50/50 in volume). 
Medium of these cultures (hBMSCs) was changed every other day, using this mixed 
conditioned medium. For the hACs cultures, fresh differentiation medium was used, and 
changed every other day. The two types of cultures were maintained for 28 days, in an 
incubator, at 37ºC and 5% CO2. The same procedure was used for the indirect co-
cultures of hWJSCs. 
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6. Biological assays 
 
6.1. Cell proliferation assay 
 
Viability and proliferation of cells is an important parameter to consider when using 
cell cultures. Cell proliferation can be assessed indirectly by quantifying its metabolic 
activity. The PicoGreen dsDNA assay allows the detection of double stranded DNA. 
The number of cells is directly correlated with the quantity of protein or DNA present in 
cells. The kit used herein is composed with fluorescent solutions that bind to DNA, 
allowing its indirect detection by fluorescence, using a microplate reader. The 
evaluation of the cell proliferation was performed using the PicoGreen dsDNA 
quantification Kit (Molecular Probes, P7589), according to the manufacturer 
instructions. Samples were collected at several time points. Triplicates of every time 
point were used. A standard curve ranging from 0.0 to 1.5 µg/ml was established. 
Fluorescence of both samples and standard curve was read with an excitation of 485/20 
nm and an emission of 528/20 nm. DNA concentration was extrapolated from the 
standard curve. This method was used to evaluate cell proliferation in chapters 5, 6 and 
7. 
 
6.2. Evaluation of cell morphology and distribution 
 
Evaluation of cell morphology and distribution was performed using SEM. In the 
present thesis we used two different microscopes for constructs analysis: a Philips XL-
20 and a Leica Cambridge S360, Leica Cambridge, Cambridge, UK. Preparation of 
samples was different, depending on which SEM used. All samples were collected at 7, 
14, 21 and 28 days of experiments. Samples from chapters 3 and 4 were prepared as 
follows. Samples were washed in sterile phosphate buffer saline and immersed in 3 % 
glutaraldehyde (Sigma, G5882) with 0.1 M cacodylate buffer at pH 7.4 (AGAR R1103) 
at room temperature for one hour. Afterwards, they were washed in phosphate buffer 
saline and osmium tetra oxide was added and left for 2 hours. Finally, samples were 
dehydrated in increasing alcohol concentrations and let to dry. Then, they were sputter 
coated with gold and analysed.  
Samples from chapters 5 and 6 were washed in sterile phosphate buffer saline and 
immersed in 3 % glutaraldehyde (Sigma, G5882) at room temperature for one hour. 
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Samples were washed in phosphate buffer saline, dehydrated in increasing alcohol 
concentrations and the procedure continued as described above. 
 
6.3. Glycosaminoglycans quantification 
 
Glycosaminoglycans (GAGs) quantification was based on the use of proteolytic 
enzymes able to degrade cartilage ECM and a colorimetric assay to measure the 
quantity of GAGs released [41]. Enzymes will degrade proteoglycans and the released 
GAGs will be quantified indirectly. The basic die 1,9 dimethylmethylene blue will link 
to the negatively charged GAGs and allow their detection by measuring the solution 
absorbance. Herein, GAGs quantification was performed using two different methods, 
differing mostly in the enzyme used for digestion of the produced ECM. 
 
6.3.1. GAGs quantification using papain digestion 
Samples were collected, freeze/dried overnight and then digested. Digestion solution 
was prepared by adding papain (Sigma, P4762) and N-acetyl cysteine (Sigma, A8199) 
at the concentrations of 0.05 % and 0.096 %, respectively, to 50 ml of digestion buffer 
(200 mM of phosphate buffer containing 1 mM EDTA (Sigma, E5134), pH 6.8). 
Samples were incubated with 600 μl of the referred solution, overnight at 60ºC. 
Afterwards, they were centrifuged at 13000 rpm for 10 minutes. Supernatant was 
collected and stored at -20 ºC until the assay was performed. Dimethymethylene Blue 
(DMB) stock solution was prepared dissolving 16 mg of DMB powder in 900 ml of 
distilled water containing 3.04 g of glycine and 2.73 g of NaCl. pH was adjusted to 3.0 
with HCl and volume adjusted to 1L. The solution was stored at room temperature 
covered by alumin foil. Chondroitin sulphate (Sigma, C8529) solution was prepared in 
water, in a 5 mg/ml stock solution and kept refrigerated. Dilutions of this solution were 
performed in order to make a standard curve. Samples were also diluted as appropriated, 
with distilled water. Optical density was measured in a microplate reader, at 530 nm. 
Unseeded nanofiber meshes and CPBS scaffolds (chapters 3 and 4) were used as 
controls. They were treated in the same way than the seeded ones for the GAG assay 
procedure. We used three samples per each GAG assay. 
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6.3.2. GAGs quantification using proteinase K digestion 
DMB assay was performed according to the method described elsewhere [42]. 
Briefly, samples (Chapter 7) were collected at 1 and 4 weeks of culture, frozen 
overnight and then digested. This digestion allowed separating the formed ECM from 
the scaffold. Digestion solution was prepared by adding 1 mg/mL of proteinase K 
(Sigma, P8044) diluted in 50 mM Tris-HCl, at pH of 7.6. Tris-HCl solution was 
prepared using the appropriate amount of Tris-HCl, adding sodium azide (Sigma, 
13412) to a final concentration of 0.05 % (w/v). The pH was corrected for the final 
value of 7.6. Samples were placed in 1.5 ml tubes and incubated with 1 mL of the 
referred solution, overnight at 60 ºC. The procedure followed the same steps before 
mentioned in 6.3.1. 
 
6.4. Histological analysis 
 
Prior to sectioning, samples need to be processed. In the case of cells or tissues, 
several embedding media are available for covering the structure and preserving its 
integrity. Depending on the sample its characteristics, various embedding media can be 
selected, such as paraffin, OCT compound or glycol methacrylate. The main difference 
between these media is on the processing technique. Paraffin samples are processed 
using high temperatures (between 60-80 ºC) whereas OCT samples are processed in 
cold conditions using liquid nitrogen. Glycol methacrylate embedded samples are 
processed using intermediate temperatures (4 ºC).  
Herein, due to the different materials used, two inclusion procedures were applied for 
processing samples for histology. Nanofiber meshes and CPBS constructs (from 
chapters 3, 4 and 5, respectively) were included in OCT compound. This compound is 
used for embedding sections prior to be frozen and sectioned in cryogenic conditions. 
Samples from chapters 6 and 7 were collected at the end of the experiment and 
processed for histology using Technovit, which is an embedding kit based in glycol 
methacrylate. 
 
6.4.1. Samples inclusion and processing using OCT compound 
Samples were collected at the end of the experiment, included in OCT (OCT 
compound BDH, Gurr®) and stored at -20 ºC. Eight µm thick sections were cut and 
placed in microscopy slides. They were further fixed during 30 minutes at 4 ºC, in a 
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fresh 4 % paraformaldehyde (Sigma, P6148) solution in phosphate buffer saline. The 
samples were futher washed twice in distilled water and let overnight to air-dry. Slides 
were stored at 4 ºC until they were used for the staining procedures. 
 
6.4.2. Samples inclusion and processing using Technovit 
Samples were fixed in 10 % neutral buffered formalin and then dehydrated through 
increasing ethanol concentrations. The samples were immersed in infiltration solutions 
and embedded in Technovit® glycol methacrylate (kit 8100, Heraeus Kulzer, 
EBSciences, CO, USA) and polymerized. Specimens were cut to obtain longitudinal 
cross-sections of 7 µm of thickness, using a modified microtome equipped with a 
tungsten blade (Leica RM 2155). 
 
6.4.3. Staining 
Hematoxylin-eosin (H&E) staining is a method widely used for the analysis of cells 
distribution and morphology. The combination of two stains (hematoxilyn and eosin) 
allows detecting cells nuclei and cytoplasm. This stain was performed to evaluate the 
cells distribution within the scaffolds. H&E staining was conducted in an automatic 
machine (Fume Cupboard; X219/E11/LEV1) Sections were washed in running water 
for 5 minutes, and then dipped in 1 % acid alcohol for 5-10 seconds. They were washed 
again in water and stained in eosin for 10 minutes. Another washing with water was 
performed, for 5 minutes, and sections were afterwards dehydrated through crescent 
concentrations of alcohol. After staining, slides were cleared in xylene and mounted in 
DPX (BDH 36029 2F).  
Toluidine blue staining was also performed. This method allows a metachromatic 
staining of cartilage matrix and specifically of its proteoglycan content. It stains 
proteoglycans and GAGs. This procedure was used for all samples in the results 
chapters. Staining solution was prepared by adding 1 % of toluidine blue (Sigma, 
T0394) dissolved in distilled water containing 0.5 g of sodium borate, followed by 
filtering. One drop of this solution was added to each section for 2-3 seconds. Then, 
sections were rinsed with distilled water and let to air dry. They were cleared in xylene 
and mounted in DPX.  
Alcian blue stain was performed for samples studied in chapters 3 and 4 to detect 
cartilage formation. This dye stains acid mucopolysacharides and GAGs. Alcian Blue 
stain was performed by rinsing the sections in 3 % acetic acid and keeping them in 1 % 
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alcian blue solution prepared as described in the referred chapters. Sections were 
counterstained with aqueous neutral red (Sigma, N6634) and then washed with water, 
let to dry and then rinsed in absolute alcohol. Mounting of slides was processed as 
previously described for the other staining procedures. 
Safranin O staining is another technique to detect cartilage components. This is a 
cationic dye that in dehydrated cartilage sections gets its orthochromatic form, and is in 
this form that safranin O links to tissues GAGs. This stain was performed was used for 
samples in chapters 5 to 7. A detail description of the procedure can be found in the 
referred chapters. By the end of the stain, sections were cleared in xylene and mounted 
as previously described.  
 
6.5. Immunolocalisation of collagens type I and type II 
 
Immunolocalisation is a technique performed to detect and identify specific protein 
markers on in vitro cultures cells and in tissues. The methods used in the present thesis 
were performed according to the instructions of the manufacturer of the Vectastain and 
DAB kits, but some of the solutions employed in the procedure were different. 
Therefore, two methods are described in this section. The principle of this method relies 
on the incubation of the sample section with a specific primary antibody for the antigen 
of interest. Then, the secondary antibody is added. This antibody is biotin-labeled, 
introducing many biotin molecules in the section and in the location of the primary 
antibody. An avidin-biotinylated enzyme complex in then added that binds to the 
secondary antibody. Localisation of the antigen is obtained by adding an enzyme 
substrate. 
 
6.5.1. Immunolocalisation method I 
Immunolocalisation of type I and type II collagens was performed in frozen sections 
of samples in chapters 3 and 4. Sections were pre-treated in 10 mg/ml hyaluronidase 
(Sigma, H4272) for 30 minutes at 37 ºC and in 2 mg/ml pronase (Sigma, P6911), for 30 
minutes, at 37 ºC. Sections were washed in phosphate buffer saline and endogenous 
peroxidase activity was quenched with 3 % hydrogen peroxide in 50 % methanol (BDH, 
101586 6B) for 5 minutes. This step is justified by the need to block tissues intrinsic 
endogenous peroxidases that produce a reaction product from the substrate alone. 
Sections were washed in Tri-buffered saline (TBS) and blocked with 3 % bovine serum 
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albumin (BSA) (Sigma, A2153) in TBS/ Tween 20 (Sigma, P7949) for 1 hour to avoid 
non-specific staining. Sections were further incubated with primary antibodies (collagen 
type I and collagen type II) (UNLB 1310-01 and UNLB 1320-01) overnight at 4 ºC, in a 
humidified atmosphere. Then, sections were washed once with high salt wash solution 
and twice in TBS/Tween 20, 10 minutes each and then incubated with the secondary 
antibody from the kit during 1 hour at room temperature, again in a humidified 
atmosphere. The remaining protocol is similar to the one described in the Vectastain 
Elite ABC Kit PK-6105 (Vector Laboratories Ltd, UK) and in the Vector DAB Kit 
(Vector Laboratories Ltd, UK). Slides were washed in water for 5 minutes and then 
counterstained with hematoxylin for nuclei visualization. Finally, slides were mounted 
in DPX. Controls were performed using normal goat serum instead of primary 
antibodies, which was also included in the kit.  
 
6.5.2. Immunolocalisation method II 
For chapters 5 to 7, a variant of this method was used. Immunolocalisation of type I 
and type II collagens was performed in technovit sections. Endogenous peroxidase 
activity was quenched with 0.3 % hydrogen peroxide solution for 30 minutes. Sections 
were rinsed in phosphate buffer saline for 5 minutes. R.T.U. Vectastain® Universal 
Elite ABC Kit (Vector, VCPK-7200) was used for antibody incubation, according to the 
instructions of the manufacturer. Shortly, sections were incubated with primary 
antibodies (collagen type I and collagen type II) (UNLB 1310-01 and UNLB 1320-01) 
overnight at 4 ºC, in a humidified atmosphere. Incubation was revealed by using the 
Peroxidase Substrate Kit DAB (Vector, VCSK-4100). Slides were washed in water for 
5 minutes and then counterstained with hematoxylin for nuclei visualization. Finally, 
slides were mounted in Histo-clear®. Controls were performed using normal goat serum 
instead of primary antibodies, which was also included in the kit. 
 
6.6. RNA isolation  
 
The first and often most critical step in performing fundamental molecular biology 
experiments such as RT-PCR, is the RNA isolation. The method herein used for RNA 
extraction and isolation was based on the Trizol reagent. This reagent is ready-to-use for 
isolation of total RNA from cells and tissues. Trizol disrupts cells and dissolves their 
components while maintaining RNA integrity. Then, chloroform is added, which allows 
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the separation of the solution into two distinct phases: aqueous and organic. RNA will 
remain in the aqueous phase and it is recovered by precipitation with isopropyl alcohol. 
Three samples were collected for each time point and each condition used herein, in 
chapters 5, 6 and 7. Samples were washed in phosphate buffer saline, immersed in 
TRIzol reagent (Invitrogen, 15596-018) and kept at -80 ºC for posterior RNA 
extraction. To perform the RNA extraction, samples were taken from the freezer, and 
kept in ice until complete thawing. Chloroform (Sigma, C2432) was added; samples 
were vigorously agitated for 15 seconds and then incubated in ice for 15 minutes. After 
that incubation, samples were centrifuged at 13000 rpm, for 15 minutes, at 4 ºC. 
Afterwards, the supernatant was collected for a sterile 1.5 mL tube, and an equivalent 
volume of isopropanol (Sigma, I9516) was added. Samples were incubated at -20 ºC 
overnight, to precipitate the RNA. In the next day, samples were centrifuged at 13000 
rpm, for 15 minutes, at 4 ºC. Then, the supernatant was removed and 800 μl of ethanol 
70 % was added, in order to wash away the isopropanol. The ethanol 70 % solution was 
prepared from absolute ethanol (Merck, 1.00983.2511) and ultra pure water. The 1.5 
mL tubes were agitated vigorously and centrifuged again, at 9000 rpm for 5 minutes, at 
4 ºC. The supernatant was again removed, and the pellet was left to air dry. Finally, the 
pellet was ressuspended in 50 μl of DNase, RNase free water (Gibco, 10977-015). The 
concentration and purity of the extracted RNA was evaluated using the NanoDrop ND-
1000 Spectrophotometer (NanoDrop Technologies Inc, USA). 
 
6.7. Real-Time Polymerase Chain Reaction (RT-PCR) 
 
Real-time PCR (RT-PCR) is a quantitative technique based in the Polymerase Chain 
Reaction (PCR) procedure. PCR is a widely used technique that allows the 
amplification of a copy of a DNA fragment million of times amplifying its number to 
detectable quantities (amplicon). This technique relies on thermal cycling and enzyme 
(DNA polymerase) replication of DNA. One major drawback of PCR is that the 
amplicon can only be visualized when the reaction finishes. In RT-PCR this does not 
happen, since this technique allows the amplification and simultaneous quantification of 
the amplicon. RT-PCR is usually combined with reverse transcription to quantify 
messenger RNA in cells or tissues. In the present thesis, we used this combination for 
detecting gene expression of cartilage related genes. We used a reverse transcriptase 
RT-PCR, consisting of a two step fluorogenic assay. In the first step, isolated RNA was 
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reversed transcribed into complementary DNA (cDNA), followed by RT-PCR for 
detection of cartilage related genes. 
Samples from chapters 5 and 6 were studied using the SyberGreen system (Bio-Rad). 
All the reagents used in this procedure were from Bio-Rad, following the instructions of 
the manufacturer. Thermocycler reaction conditions used were also the ones proposed in 
the kits. In the first step, RNA was reversed transcribed into cDNA, using the iScript 
cDNA synthesis kit (1708891). A MiniOpticon real-time PCR detection system 
(BioRad Laboratories, USA) was used to perform the reaction. Afterwards, the cDNA 
obtained was used as template for the amplification of the target genes (aggrecan, 
collagen type I, II and X, Sox9 and Runx2), with the Syber Green Kit (1708884). The 
number of amplification cycles used for every reaction was of 45.  
Samples in chapter 7 were analysed using a different thermocycler and different kits. 
In the Real Time-PCR procedure the PerfeCta™ SYBR® Green system (Quanta 
Biosciences) was used. All reagents used in this procedure were purchased from Quanta 
Biosciences, following the instructions of the manufacturer. Thermocycler reaction 
conditions used were also the ones mentioned in the kits. In the first step, RNA was 
reversed transcribed into cDNA, using the qScript cDNA Synthesis Kit (95047-500). A 
MasterCycler EP Gradient detection system (Eppendorf, USA) was used to perform the 
reaction. Afterwards, the obtained cDNA was used as template for the amplification of 
the targets genes (Table 2.1), with the PerfeCta™ SYBR® Green FastMix™ kit 
(95072-05K).  
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Table 2.1 – Primer sequences used for RT-PCR procedures. 
Genea Forward (5´-3´) Reverse (5´-3´) 
AGC TGAGTCCTCAAGCCTCCTGT TGGTCTGCAGCAGTTGATTC 
COL II CGGTGAGAAGGGAGAAGTTG GACCGGTCACTCCAGTAGGA
COL I AGCCAGCAGATCGAGAACAT ACACAGGTCTCACCGGTTTC 
COL X CCAGGTCTCGATGGTCCTAA GTCCTCCAACTCCAGGATCA 
Runx2 TTCCAGACCAGCAGCACTC CAGCGTCAACACCATCATTC 
Sox9 TTCATGAAGATGACCGACGC GTCCAGTCGTAGCCCTTGAG 
GAPDH ACAGTCAGCCGCATCTTCTT ACGACCAAATCCGTTGACTC 
aAGC = Agreccan; COL II = Collagen type II; COL I = Collagen type I; COL X = Collagen type X; 
Runx2 = Runt-related transcription factor 2; Sox9 = Sry-type high mobility group box 9; GAPDH = 
Glyceraldehyde 3-phosphate dehydrogenase 
 
GAPDH was used as reference gene, and the expression of all the target genes was 
normalized to the GAPDH expression of that sample. All the primer sequences were 
generated using Primer3 software [43] and acquired from MWG Biotech AG, Germany. 
Primers sequences used are shown in Table 2.1. Obtained results were analyzed with 
CFX Manager Software – version 1.5 (BioRad Laboratories, USA).  
 
6.8. Statistical analysis 
 
Statistical analysis was performed for data of GAGs quantification in chapters 3 and 4 
using One-way analysis of variance in conjunction with Tukey’s test. Data from 
triplicates of GAG quantification are present as averages ± standard errors.  
Statistical analysis for chapters 5 and 6 was performed using the SPSS statistic 
software (Release 15.0.0 for Windows). Firstly, a Shapiro-Wilk test was used to 
ascertain about the data normality and variance equality. The normality was rejected 
and, consequently, nonparametric tests were used in further comparisons between static 
and dynamic culture conditions. A Mann-Whitney U-test was applied to compare 
independent groups of samples for each variable. P values lower than 0.01 were 
considered statistically significant in the analysis of the results. A Kruskal-Wallis test 
was applied to compare data between the different time points in each group. P values 
lower than 0.01 were considered statistically significant in the analysis of the results. 
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For chapter 7, statistical analysis was performed as described above using the SPSS 
statistic software. Nonparametric tests were used in comparisons between direct and 
indirect co-cultures. A Kruskal-Wallis test followed by Tukey’s HSD test was applied 
to compare data between the different time points. P values lower than 0.001 were 
considered statistically significant in the analysis of the results. 
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Abstract 
 
Repair of cartilage defects is still a major health problem. Tissue engineering has 
developed different strategies and several biomaterials morphologies, including natural-
based ones, for repairing these defects. We used electrospun polycaprolactone (PCL) 
and starch-compounded polycaprolactone (SPCL) nanofiber meshes to evaluate 
extracellular matrix (ECM) formation by bovine articular chondrocytes (BAC). The 
main aim of this work is to evaluate the suitability of PCL and SPCL nanofiber meshes 
in chondrocyte cultures, and their capability to produce ECM when seeded onto these 
nanostructured materials. Furthermore, the effect of culture conditions (static vs. 
dynamic) over ECM formation was also assessed. BAC were seeded onto PCL and 
SPCL nanofiber meshes using a dynamic cell seeding procedure and cultured under 
static or dynamic conditions for 4 weeks. Constructs were characterized by scanning 
electron microscopy (SEM), histology, immunolocalisation of collagen types I and II, 
and glycosaminoglycans (GAG) quantification. Results show an extensive cell 
colonization of the entire nanofiber meshes, for both materials, and that chondrocytes 
presented typical spherical morphology. It is noticeable some degree of cell infiltration 
inside nanofiber meshes, again for both materials. ECM formation throughout the 
materials and GAG were detected, evidencing typical construct maturation. It is shown 
that PCL and SPCL nanofiber meshes are suitable as supports for ECM formation, and 
therefore, adequate for cartilage tissue engineering approaches. 
 
 
1. Introduction 
 
Joint diseases due to cartilage degeneration are a major health problem concerning 
people of all ages, but particularly elder people. Osteoarthritis, for example, affects 80% 
of people over 60 years. One therapeutic option is non steroid ant-inflammatory drugs 
(NSAID) treatment, aiming the delay and control of cartilage loss [1]. Other options 
involve surgical procedures, like arthroplasty with implantation of joint prosthesis [2]. 
These procedures are able to improve joint function considerably. However, patients´ 
mobility may be limited, and some problems concerning the interface of bone and 
implant may arise, causing the need for revision [2]. Although surgical outcome is very 
good at the beginning, durability of solutions and improvement of patients’ quality of 
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life is still far from ideal. Tissue engineering represents an alternative route to current 
treatments.  Its strategy may be based in cells injection into the defect and fixation with 
a membrane [3] or implantation of combinations of cells, scaffolds and growth factors 
[4] that may result in ECM production.  
Articular hyaline cartilage is an avascular tissue that covers the joint and acts as a 
load-bearing and wear-control structure. As cartilage is subjected to mechanical 
stimulus in its natural environment, it is typically followed a strategy to regenerate 
cartilage under the action of similar stimulus. It has been shown in vitro that the culture 
environment deeply affects chondrocytes proliferation in a 3D scaffold [5]. Bioreactors 
including spinner-flasks, rotating-wall vessels or direct perfusion are designed to 
provide a controlled environment for tissue engineered cartilage production [6]. 
Biomaterial morphology [7], as well as culture conditions and cell source [8], can also 
influence the quality of tissue engineered cartilage constructs. 
Biodegradable biomaterials, either natural or synthetic, have been processed into 
scaffolds for tissue engineering [9, 10]. PCL is a biodegradable polymer, belonging to 
the aliphatic polyester family. Currently, this class of materials is among the most 
attractive polymers which meet various medical and physical demands for safe clinical 
applications. PCL is used in clinical practice as a biomaterial due to its good mechanical 
properties, ability to form compatible blends and copolymers with a wide range of other 
polymers, including natural-based polymers, low toxicity, biocompatibility and 
biodegradability [11-13]. Nevertheless, its composition with starch offers new 
opportunities for controlling its degradation kinetics [14], release of growth factors and 
new surface chemistry [15, 16]. SPCL combines the affinity of starch and the 
processability and mechanical properties of the synthetic polymer (PCL) [17]. Several 
works with SPCL have been conducted with cells, for instance, in osteoblast-like cells 
[18], MSCs [19, 20], or leucocytes [21]. Dynamic culture conditions [22] and in vivo 
implantation in murine animal models [23] were also explored. 
Electrospinning allows producing polymeric ultrafine fibres with diameters ranging 
from few microns down to tens of nanometers [24]. Due to their very small diameter, 
polymeric nanofibers exhibit unusual properties like high specific surface area, 
flexibility in surface functionality and superior mechanical properties [25]. 
Additionally, nonwoven mesh structures produced by electrospinning physically mimic 
the structure and morphology of ECM components of a great variety of native tissues, 
including bone and cartilage [26-28].  The aim of the present study is to assess ECM 
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formation in PCL and SPCL electrospun nanofiber meshes, evaluating the effect of 
starch in the material formulation and also the effect of static or dynamic culture 
conditions. 
 
 
2. Materials and Methods 
 
2.1. Nanofiber meshes processing 
 
Polymeric solutions of PCL (PCL 787, TONETM polymer, Union Carbide Chemicals 
and Plastics Division, Bound Brook, New Jersey, with 80kD) and SPCL ((30% starch, 
70% PCL); Novamont: SPCL (Mater-BI ZI01U, Novamont, Novara, IT)) were prepared 
by dissolving the polymer or the blend into an organic solvent mixture of 
chloroform/dimethylformamide (70:30) (Sigma-Aldrich, USA), at concentrations of 
17% and 24% (w/v), respectively. Polymeric solutions were placed into syringes with 
blunted metallic needles attached to it. Used needles had an internal diameter of 0.8 
mm. Furthermore, the syringe was coupled to a syringe pump (model KDS100, KD 
Scientific, USA) to control the solution flow rate. A high voltage power supply (0-25 
kV) was applied to the needle to generate the electric field. An aluminium foil 
connected to the ground was used as the fiber mesh collector. The capillary tip-to-
collector distance and the flow rate were fixed at 20 cm and 1.0 ml/h, respectively. 
Nanofiber meshes production lasted 1 hour, and for that it was needed 1 mL of 
polymeric solution. The applied voltage was maintained at 9 kV. Nanofiber meshes 
were collected and cut in squares with 1 cm2. Experiments were all performed at room 
temperature and the conditions were optimized for the two materials. 
 
2.2. Isolation of BAC and culture on nanofiber meshes 
 
Isolation and expansion of BAC was performed according to the method previously 
reported [29]. Cells were cultured with expansion medium: Dulbecco’s modified 
Eagle’s medium (Sigma, D5671), containing 10 mM Hepes buffer (Sigma, H0887), L-
alanyl-L-glutamine (Sigma, G8541), Non Essential AminoAcids (Sigma, M7145) 
10000 units/ml penicillin, 10000 μg/ml streptomycin (Sigma, P0781), 10% foetal calf 
serum (Biosera, S1810) and 10 ng/ml of basic Fibroblast Growth Factor (bFGF) 
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(PeproTech, 100-18B). Dynamic cell seeding was performed using Petri dishes. Three 
nanofiber meshes were placed in each Petri dish, and cells suspension added in order to 
have 6,5x106 cells per nanofiber mesh. We used 20 nanofiber meshes per experimental 
condition, for each material. Petri dishes were placed in a rotator, inside the incubator, 
at 60 rpm, for 72 hours. 
After 72 hours, cell seeding was complete, and half of the constructs were kept in the 
rotator (dynamic conditions), whereas the others were placed in the incubator (static 
conditions). Differentiation medium was changed every 3 days, and was composed of 
expansion medium without bFGF and with 1 mg/ml of insulin (Sigma, I5500) and 1 
mg/ml of ascorbic acid) (Sigma, A4544). Samples were taken in different time points: 
1, 2, 3 and 4 weeks of culture. 
 
2.3. Scanning Electron Microscopy (SEM) 
 
For SEM analysis, nanofiber meshes were collected at each time point: 1, 2, 3 and 4 
weeks. They were washed in sterile PBS and immersed in 3% glutaraldehyde (Sigma, 
G5882) with 0.1 M cacodylate buffer at pH 7.4 (AGAR, R1103) at room temperature 
for one hour. Afterwards, they were washed in PBS, osmium tetra oxide was added and 
left for 2 hours. Finally, samples were dehydrated in crescent alcohol concentrations and 
let to dry. SEM micrographs were taken at different time periods and with several 
magnifications. 
 
2.4. Histological analysis 
 
Samples were collected at the end of the experiment, included in O.C.T. (OCT 
compound BDH, Gurr®) and stored at -20ºC. Sections were cut 8 µm thick and placed 
in microscopy slides. Then, they were fixed during 30 minutes at 4ºC, in a fresh 4% 
paraformaldehyde (Sigma, P6148) solution in PBS buffer, washed twice in distilled 
water and let overnight to air-dry. Slides were stored at 4ºC until they were used for 
staining procedures. Hematoxylin-eosin staining was conducted in an automatic 
machine, Fume Cupboard; X219/E11/LEV1. Sections were washed in running water for 
5 minutes, and then dipped in 1% acid alcohol for 5-10 seconds. They were washed 
again in water and stained in eosin for 10 minutes. Another washing with water was 
performed, for 5 minutes, and sections were afterwards dehydrated through crescent 
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concentrations of alcohol. They were cleared in xylene and mounted in DPX (BDH, 
36029 2F). Toluidine blue staining was also performed. Staining solution was prepared 
by adding 1% of toluidine blue (Sigma, T0394) dissolved in distilled water containing 
0.5g of sodium borate, followed by filtering. One drop of this solution was added to 
each section for 2-3 seconds. Then, sections were rinsed with distilled water and let to 
air dry. They were cleared in xylene and mounted in DPX. Alcian Blue staining was 
performed by rinsing the sections in 3% acetic acid and keeping them in 1% alcian blue 
solution (Sigma, A3157) for 18 hours. After that, stain was poured off and sections were 
counterstained with aqueous neutral red (Sigma, N6634) for 1 min. Sections were 
washed with water, let to dry and then rinsed in absolute alcohol, cleared in xylene and 
mounted in DPX.  
 
2.5. Immunolocalisation of type I and type II collagens 
 
Immunolocalisation of type I and type II collagens was performed in fixed sections. 
Sections were pre-treated in 10 mg/ml hyaluronidase (Sigma, H4272) for 30 minutes at 
37ºC and in 2 mg/ml pronase (Sigma, P6911), for 30 minutes, at 37ºC. Sections were 
washed in PBS and endogenous peroxidase activity was quenched with 3% hydrogen 
peroxide in 50% methanol (BDH, 101586 6B) for 5 minutes. Sections were washed in 
Tri-buffered saline (TBS) and blocked with 3% BSA (Sigma, A2153) in TBS/ Tween 
20 (Sigma, P7949) for 1 hour to avoid non-specific staining. Sections were further 
incubated with primary antibodies (collagen type I and collagen type II) (Goat anti-type 
I collagen UNLB 1310-01 and Goat anti-type II collagen UNLB 1320-01) overnight at 
4ºC, in a humidified atmosphere. Then, sections were washed once with high salt wash 
solution and twice in TBS/Tween 20, 10 minutes each and then incubated with 
secondary antibody from the kit during 1 hour at room temperature, again in a 
humidified atmosphere. The remaining protocol is as described in the Vectastain Elite 
ABC Kit PK-6105 (Vector Laboratories Ltd, UK) and in the Vector DAB Kit (Vector 
Laboratories Ltd, UK). Slides were washed in water for 5 minutes and then 
counterstained with hematoxylin for nuclei visualization. Finally, slides were mounted 
in DPX. Controls were performed using normal goat serum instead of primary 
antibodies, which was also included in the kit. 
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2.6. Dimethylmethylene blue (DMB) assay for glycosaminoglycans quantification 
 
Samples were collected at 4 weeks of culture, freeze/dried overnight and then 
digested. Digestion solution was prepared by adding papain (Sigma, P4762) and N-
acetyl cysteine (Sigma, A8199) at the concentrations of 0.05% and 0.096%, 
respectively, to 50 ml of digestion buffer (200 mM of phosphate buffer containing 1 
mM EDTA (Sigma, E5134), pH 6.8). Samples were incubated with 600 μl of the 
referred solution, overnight at 60ºC. Afterwards, they were centrifuged at 13000 rpm for 
10 minutes. Supernatant was collected and stored at -20ºC until the assay was 
performed. Dimethymethylene Blue (DMB) stock solution was prepared dissolving 16 
mg of DMB powder in 900 ml of distilled water containing 3.04 g of glycine and 2.73 g 
of NaCl. pH was adjusted to 3.0 with HCl and volume adjusted to 1L. The solution was 
stored at room temperature covered by alumin foil. Chondroitin sulphate (Sigma, 
C8529) solution was prepared in water, in a 5 mg/ml stock solution and kept 
refrigerated. Dilutions of this solution were performed in order to make a standard 
curve. Samples were also diluted as appropriated, with distilled water. Optical density 
was measured in a microplate reader, at 530 nm. Unseeded nanofiber meshes were used 
as controls. They were treated in the same way than the seeded ones for the GAG assay 
procedure. We used three per each GAG assay. 
 
2.7. Statistical analysis 
 
Data from triplicates of GAG quantification are present as averages ± standard errors. 
One-way analysis of variance in conjunction with Turkey’s test was also performed. 
 
 
3. Results 
 
3.1. Electrospun nanofiber meshes 
 
SEM observations of produced nanofiber meshes evidence a random distribution of 
nanofibers, as expected. This is the typical result of electrospining process, caused by 
the electric filed generated in the equipment (Figure 3.1). PCL nanofiber meshes were 
composed by nanofibers with diameters in the submicron range, from 0.4-1.4 µm 
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(Figure 3.1A). The average pore sizes of PCL nanofiber meshes were 72.67±31.48 µm. 
Conversely, the SPCL nanofiber meshes presented a larger dispersion of nanofiber 
diameters (the thinner had diameters around 0.3-20 µm), probably due to the 
insolubility of the starch phase in the organic solvent mixture used. Indeed, a PCL 
solution containing a suspension of colloidal starch particles is obtained, and this has 
important implications in fibers diameter and in meshes morphology. The average pore 
sizes of SPCL, evaluated from SEM micrographs of the nanofiber meshes, were 
65.21±22.07 µm. 
 
 
 
Figure 3.1 – Electron micrographs of (A) poly(ε-caprolactone) (PCL) and (B) starch-
poly(ε -caprolactone) (SPCL) nanofiber meshes processed by electrospinning. 
 
3.2. SEM analysis 
 
SEM micrographs (Figure 3.2) show that cells colonize both types of nanofiber 
meshes, in both culture conditions, covering their surface extensively and 
homogeneously. PCL nanofiber meshes keep their membrane like shape (Figures 3.2A-
C; 3.2G-I), while SPCL nanofiber meshes tend to curl in a tubular structure (Figures 
3.2D-F; 3.2J-L). This structure trapped a considerable number of cells inside. 
Chondrocytes kept their round morphology throughout the experiment, either in PCL 
(Figures 3.2A, B, G-I) or SPCL (Figures 3.2E, F, K) nanofiber meshes, for both culture 
conditions. 
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Figure 3.2 – BAC growth morphology in PCL and SPCL nanofiber meshes, in 
different time points of the experiment, either in static (A-F) or dynamic (G-L) culture 
conditions. Different magnifications were used to highlight cell morphology. Cell 
growth was identical in static culture conditions either for PCL (A-C) or SPCL (D-F) 
nanofiber meshes. The same was observed in dynamic culture conditions, both for PCL 
(G-I) and SPCL (J-L). 
 
3.3. Histological staining 
 
BAC attached and spread not only to the nanofiber meshes surface, but also in the 
inner regions of the mesh structure, as it can be observed with the H&E staining 
(Figures 3.3A, D, G, J). Both PCL and SPCL nanofiber meshes showed similar cell 
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distribution, as well as proteoglycans presence, as shown by toluidine blue (Figure 
3.3B, E, H, K) and alcian blue stainings (Figures 3.3C, F, I, L). Darker staining of alcian 
blue is observed in static culture conditions histological sections (Figure 3.3C, F) than 
in dynamic conditions (Figures 3.3I, L). This result indicates the presence of more 
sulphated proteoglycans in static conditions. SPCL nanofiber meshes curled and formed 
tubes, entrapping considerable amounts of cells inside. 
 
Figure 3.3 – Production of extracellular matrix in PCL and SPCL nanofiber meshes, 
at 4 weeks of culture, either in static (A-F) or dynamic (G-L) culture conditions. Cells 
were able to attach to the nanofibers structure, as showed in hematoxylin-eosin staining, 
for PCL (A, G) and SPCL (D, J). Cells penetrated in this structure and produced 
proteoglycans, detected by toluidine blue staining, either in PCL (B, H) or SPCL (E, K) 
nanofiber meshes. Sulphated proteoglycans were detected by alcian blue staining, again 
for both PCL (C, I) and SPCL (F, L) nanofiber meshes. Two magnifications (10x and 
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20x) were used at each staining for microscopic observation. Scale bar = 100 μm. 
Arrows highlight nanofiber mesh structure. 
 
3.4. Immunolocalisation of type I and type II collagens 
 
There was a larger amount of proteoglycans in these protected inner regions, as well 
as collagen type I and type II (data not shown). Both collagens types were also detected 
either in static (Figure 3.4A-F) or dynamic culture conditions (Figure 3.4G-L). 
Interestingly, collagen type I was more evident on sections prepared from SPCL 
nanofiber meshes (both culture conditions) (Figures 3.4E, K) than on sections from PCL 
nanofiber meshes (Figure 3.4B, H), indicating a predominance of fibrocartilage being 
generated by this combination of structure and material. 
 
Figure 3.4 – Immunolocalisation of collagens in PCL and SPCL nanofiber meshes, at 
4 weeks of culture, either in static (A-F) or dynamic (G-L) culture conditions. Controls 
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(A, D, G, J) were performed with normal goat serum. In static conditions, collagen type 
I was only detected for SPCL (E) nanofiber meshes. Collagen type II, on the other hand, 
was detected for both PCL (C) and SPCL (F) nanofiber meshes. In dynamic conditions, 
collagen type I and type II were detected in PCL (H, I) and SPCL (K, L) nanofiber 
meshes. Two magnifications (10x and 20x) were used at each staining for microscopic 
observation. Scale bar = 100 μm. Arrows highlight nanofiber mesh structure. 
 
3.5. GAGs quantification 
 
Quantification of GAGs present in PCL nanofiber meshes revealed the presence of 
approximately 2.0% of total GAGs in the ECM in static culture conditions, versus 0.8% 
of total GAGs found in dynamic conditions (Figure 3.5). No statistically significant 
difference was found between these results (P>0.05). As for the SPCL nanofiber 
meshes, results revealed 2.4% of total GAGs for the static cultures versus 1.1% for the 
dynamic ones. Again, there was not a statistically significant difference between static 
and dynamic cultures (P>0.05). The same lack of statistical significance was found on 
differences between results obtained with two types of materials (P>0.05).   
 
 
 
 
Figure 3.5 –GAGs quantification for PCL and SPCL nanofiber meshes, at 4 weeks of 
culture. Static culture conditions are represented in white, dynamic culture conditions in 
grey. 
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4. Discussion 
 
The main goal of designing and producing a new scaffold is to provide enhanced 
microenvironment for cells, in an attempt to substitute the natural ECM milieu while 
they expand and repair the tissue. Many materials were already proposed for scaffolds 
production. Among those, natural polymers such as starch [14, 16-23, 30-38] or 
biodegradable polyesters, for example, PCL [11, 13, 17, 39-41] have been developed. In 
this case, electrospinning technique was used to explored those materials and 
consequently obtain a new SPCL fibrous structure. Electrospinning was used to produce 
meshes that were intended to provide good conditions for BAC to produce ECM. 
Recent applications of polymer nanofibers include fields of biotechnology and 
biomedicine [42]. Several tissue engineering approaches, aiming bone [11, 37, 38] and 
cartilage [40, 41] regeneration have also been explored. SEM micrographs confirmed 
that cells were able to colonize both nanofiber meshes, reinforcing the idea that PCL 
and SPCL are suitable polymers for the aimed purpose [17]. BAC attached and spread 
not only at the surface of the nanofiber meshes, but also in the inner regions of the mesh 
structure, as it can be observed with the H&E staining. Our present results indicate that 
BAC penetrates the structure, colonizing it and using it as a support for cell activity. 
This is, to our best knowledge a very encouraging result since most of the studies with 
nanofiber meshes obtained by electrospinning do not show a so clear penetration of 
cells into the mesh structure [25]. Cells were able to produced ECM, as showed by 
toluidine and alcian blue stainings, detecting GAGs accumulation. Both collagen type I 
and II were detected, expression of collagen type I being larger in SPCL meshes. 
Collagen type I is associated with fibrocartilage tissue [43], being undesirable when 
articular cartilage is the goal of a regeneration strategy. PCL electrospun nanofiber 
meshes have been proposed as novel scaffolds for tissue engineering [44], and specially 
for cartilage repair. Li et al., (2003) showed the production of cartilaginous matrix with 
fetal bovine chondrocytes seeded onto PCL nanofibrous scaffolds, highlighting the 
importance of these materials for proliferation and maintenance of the chondrocyte 
phenotype [41]. Recent work from the same authors also show the versatility of these 
nanofibrous scaffolds, in sustaining chondrogenic differentiation of human MSCs [40, 
45]. 
GAG production was not statistically different, comparing both types of materials. 
There was a slightly difference between them, being higher in SPCL than in PCL (2.4% 
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versus 2.0%). SPCL is a blend composed by corn starch and polycaprolactone, that has 
been extensively studied as biomaterial for different biomedical applications [17, 27, 
37, 46]. It was recently reported to support BAC adhesion, proliferation and 
differentiation, in SPCL fiber based scaffolds [46].  It was unexpected to find more 
GAGs in static cultures than in dynamic ones, because chondrocytes are naturally 
subjected to a fluid flow microenvironment, and therefore, could be stimulated by these 
culture conditions [47]. The use of a mechanical force can be employed in their 
culturing process to produce a phenotypically correct tissue [48]. However, it needs to 
replicate relevant physiologic conditions. The intention of using agitation during culture 
was to produce a phenotipically adequate tissue. However, it may be concluded that 
these conditions were not sufficient. We can hypothesize that the higher GAG content 
in static cultures observed in this study was due to some GAGs release to the culture 
medium during the experiment, originated by mixing of culture medium. Furthermore, 
seeding in spinner flasks may have somehow caused some cell damage, due to the 
turbulent flow, generated by the magnetic stirring [49]. Similar results were obtained 
with bovine calf chondrocytes seeded onto fibrous polyglycolic acid meshes, where 
constructs exposed to similar mixing synthesised and released more GAGs into the 
culture medium, and resulted in lower fractions of GAGs [50]. Another study points out 
that mixing may increase the loss of GAGs from the construct, decreasing pericellular 
GAG concentration [51]. 
Data did not allow us to substantiate clearly which one of the materials is best for the 
approach used in this work. It is known that a suitable scaffold for tissue engineering is 
due to have good surface properties, which will allow cell attachment and efficient 
transport of nutrients to growing cells. In that sense, a highly hydrophilic material 
would allow a higher water uptake and consequently, more nutrient supply to cells [52, 
53]. PCL has a more hydrophobic character, whereas SPCL is more hydrophilic, being 
more advantageous, in this perspective, for cell growth comparing to PCL. PCL is a 
homopolymer with very slow degradation kinetics. It is in clinical use for many 
applications, and could be the biodegradable material of choice. However, a wide range 
of options for development of PCL have been already explored in the past. One 
additional alternative to develop its performance being proposed herein is to compound 
it with other biodegradable materials, those compounds offering a new range of tunable 
properties. If we accept that there are advantages of working with a natural-based 
polymer, the combination of starch with PCL may lead to an attractive combination of 
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properties that may be tailored for specific applications, including cartilage tissue 
engineering. This material has been extensively studied for biomedical applications 
because of its biocompatibility and biodegradability [14, 16, 18, 27, 31, 54] and 
potential of inducing low levels of inflammatory response [21]. Its degradation kinetics 
can be controlled by material composition, having a more hydrophilic character and 
enabling designing controlled release systems for growth factors [55]. Results indicate 
that SPCL may be slightly more effective in sustaining ECM production, but it was also 
shown that higher levels of expression of collagen type I may be detrimental in 
obtaining hyaline cartilage by BAC cultured in these meshes. Further optimization of 
this material will be addressed in order to overcome this limitation. 
 
 
5. Conclusions 
 
The aim of this work was to assess if a blend of starch with polycaprolactone (SPCL) 
would have similar performance in sustaining BAC growth and ECM production when 
comparing with PCL. Both PCL and SPCL electrospun nanofiber meshes revealed to be 
interesting structures for cartilage tissue engineering strategies. PCL and SPCL 
nanofiber meshes seeded dynamically in spinner flasks evidenced a good response for 
this purpose. A very interesting result was the evidence that chondrocytes proliferated in 
external regions, and showed some capacity of migrating into inner regions of both 
types of fiber meshes. BAC were able to produce ECM, either in static or dynamic 
culture conditions. Static culture conditions lead to enhanced ECM production. These 
observations were confirmed by staining of proteoglycans, immunolocalisation of 
collagens type I and type II, and GAGs detection.  
In this work we confirmed evidences from the literature that sustain the claim that 
PCL nanofiber meshes are suitable for tissue engineering approaches, and also propose 
a new scaffold for cartilage tissue engineering (SPCL nanofiber meshes). Data did not 
show obvious qualitative nor quantitative differences between the two materials, 
nevertheless, we consider advantageous to use SPCL, not only because of their natural-
based composition, but also because it allows a greater control of the degradation 
kinetics and further functionalization of its structure. It is our understanding that both 
materials have a role to play in cartilage regeneration strategies, and that in particular 
SPCL nanofiber meshes can be further enhanced, not only in terms of degradability but 
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also providing opportunities for local release of growth factors for articular cartilage 
tissue engineering strategies. 
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Abstract 
 
Natural-based polymers have been extensively used in scaffolds production for 
cartilage tissue engineering. The present work aims at evaluating and characterizing 
extracellular matrix (ECM) formation in two types of chitosan-based scaffolds, using 
bovine articular chondrocytes (BAC). The influence of these scaffolds porosity, as well 
as pore size and geometry in cartilagineous tissue formation was studied. The effect of 
stirred conditions on ECM formation was also assessed. Chitosan-Poly (Butylene 
Succinate) (PBS) scaffolds where produced by compression moulding and salt leaching, 
using a blend of 50% of each material. Different porosities and pore sizes structures 
were obtained. BAC were seeded onto CPBS scaffolds using spinner flasks. After that 
period, constructs were transferred to the incubator, where half were cultured under 
stirred conditions, and the other half under static conditions, during 4 weeks. Constructs 
were characterized by scanning electron microscopy, histology procedures, 
immunolocalisation of collagen type I and collagen type II and dimethylmethylene blue 
(DMB) assay for glycosaminoglycans (GAG) quantification. Both materials showed 
good affinity for cell attachment. Cells colonized the entire scaffolds and were able to 
produce ECM. Large pores with random geometry improved proteoglycans and 
collagen type II production. However, that structure has the opposite effect on GAG 
production. Stirred culture conditions indicate to enhance GAG production, in both 
types of scaffolds. 
 
 
1. Introduction 
 
There are four major types of cartilage, which can be distinguished by their specific 
constitutive components: hyaline cartilage, fibrocartilage, elastic cartilage and 
costochondral cartilage [1]. Hyaline articular cartilage is the most abundant type in the 
body, composed of one cell type (the chondrocyte) dispersed in an abundant 
extracellular matrix (ECM). ECM is composed mainly of collagen type II and a large 
proteoglycan, aggrecan [1, 2]. The ECM provides most of the functional properties 
associated with hyaline cartilage, including resistance to compression and provision of 
low friction articulating surfaces in the joints. Injuries to cartilage are often painful and 
may severely affect movement. Unfortunately, articular cartilage has a relatively poor 
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capacity for self-repair (related with the lack of a direct blood supply), and cartilage 
injury is frequently associated with the onset of chronic problems including 
osteoarthritis [1, 3].  
Currently, there is no agreed method to restore fully damaged cartilage [4]. Current 
therapies include abrasion arthroplasty, subchondral drilling, prosthetic joint 
replacement, and ultimately transplantation of autologous chondrocytes or tissues [4, 5]. 
However, these treatments do not constitute a complete recovery for the patient, and in 
most of the cases persistent problems of donor site morbidity, limitations of patient 
mobility and consequent disability, loss of implants and limited durability of the 
prosthetics [2, 4-6] are observed. 
Tissue Engineering represents a promising approach for the repair of articular 
cartilage, but there is still no ideal scaffold for this approach. Chitosan/polyesters appear 
to offer several advantages in this field. 
In recent years, natural based polymers have been extensively studied, as for example, 
chitosan [7-11]. Chitosan is a derivative of chitin, obtained by deacetylation of this 
biopolymer [12]. Chitin is the second most abundant polysaccharide in nature, being 
found usually in crustaceans’ shells. Chitosan is a linear polysaccharide with a structure 
similar to glycosaminoglycans present in  native cartilage ECM [13]. This property is 
extremely important for cartilage tissue engineering, since it allows the development of 
several types of scaffolds. Another interesting property of chitosan is that it can be 
moulded into various shapes [14] and allows for the formation of different pore sizes 
structures [12]. It has an intrinsic antibacterial activity and high biocompatibility [13]. 
Chitosan has been used in several blends to produce many types of scaffolds, for 
example hydrogels [15, 16], porous scaffolds [11], amino acid immobilization [9] or 
drug delivery [17]. Our group has developed innovative blends of synthetic polymers 
with chitosan [7, 8, 18, 19], which have been developed for biomedical applications, 
such as bone [20-22] or cartilage [23, 24]. Studies have been conducted preparing 
chitosan based scaffolds aimed at cartilage regeneration, which  showed evidence of 
favourable responses in vitro [20, 21, 24-26]. As for in vivo studies, a high degree of 
biocompatibility of chitosan scaffolds has been shown in mice [13]. Another study, 
conducted in rabbits, observed  hyaline-like tissue after 24 weeks of implantation [15]. 
Recently, the basis for a cartilage engineering model in a large animal has been 
established, using Merino Sheep and chitosan-based scaffolds [27]. Using ovine MSCs 
combined with chitosan and TGF-β3, histological analysis revealed chondrocyte-like 
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cells surrounded by a hyaline-like cartilaginous matrix that was well integrated with the 
host cartilage [27]. The bio functionality of chitosan scaffolds produced by particle 
aggregation was tested in rats in vivo, which showed promising results in terms of 
connective tissues ingrowth and neo-vascularization [28]. 
In the current study, a bovine chondrocyte model was used to establish primary 
cultures and the formation of ECM in chitosan/ polyester based scaffolds was evaluated. 
Two types of scaffolds with different pore sizes and pore geometries were studied, and 
ECM deposition on both types of scaffolds was evaluated. In addition, different culture 
conditions were used, namely static versus dynamic, in order to establish the most 
suitable method to obtain hyaline cartilage tissue in vitro. 
 
 
2. Materials and Methods 
 
2.1. Scaffolds production 
 
A chitosan-poly(butylene succinate) (50/50% wt) blend was produced and processed 
into scaffolds using a methodology based on compression moulding followed by salt 
leaching, as previously described [8, 18]. Common salt (NaCl) was used as the porogen 
agent. Two different groups of scaffolds were produced: one using 80% weight (wt) of 
salt with particles size between 63-125 µm (80 CPBS). The second group of scaffolds 
was produced using 60% wt of salt with particle size between 250-500 µm (60 CPBS). 
In both cases salt and blend were loaded into a mould, heated and compression-moulded 
into large discs. Discs were sliced to obtain cubes of 5 mm. These cubes were immersed 
in distilled water to leach out the salt, over 6 days. Water was changed every day to 
facilitate the complete dissolution of the porogen agent. By the end of the procedure, 
cubes were dried until a constant weight was obtained. The resulting scaffolds were 
characterized, and will be further referred as 80% porosity or 60% porosity. 
 
2.2. Isolation of bovine articular chondrocytes 
 
Isolation of bovine articular chondrocytes was performed according to a method 
previously reported [29]. Full thickness hyaline cartilage was harvested from bovine 
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metacarpophalangeal joint. The skin was removed and the joint was transferred to a 
laminar air hood.  Cartilage was dissected in small full-depth pieces and washed twice 
with PBS buffer (Sigma, D8537). Then, it was digested with 0.25% (w/v) of tripsin 
solution (Sigma, E5134) for 30 minutes at 37ºC on a rotator. The solution was removed, 
cartilage was washed again in PBS buffer and then incubated in a collagenase type I 
solution (2 mg/ml) (Sigma, E0130) overnight at 37ºC on a rotator (Stuart mini orbital 
shaker SSM1). The following day, cells were washed twice with PBS, counted and 
platted at a density of 2 x 106 cells per Petri dish. Cells were cultivated with expansion 
medium: Dulbecco’s modified Eagle’s medium (Sigma, D5671), containing 10 mM 
Hepes buffer (Sigma, H0887), L-alanyl-L-glutamine (Sigma, G8541), Non Essential 
Aminoacids (Sigma, M7145) 10000 units/ml penicillin, 10000 μg/ml streptomycin 
(Sigma, P0781), 10% foetal calf serum (Biosera, S1810) and 10 ng/ml of basic 
Fibroblast Growth Factor (bFGF) (PeproTech, 100-18B). Culture medium was changed 
twice a week, and cells were expanded until passage 2.  
 
2.3. BAC culture on chitosan-based scaffolds 
 
BAC seeding was performed dynamically, in spinner flasks. Cells were harvested, 
counted and resuspended in expansion medium. Twenty scaffolds were used in each 
experiment, for each type of scaffold. Materials were seeded with a cell suspension 
containing 6,5x106 cells per scaffold. Seeding was performed in spinner flasks, using a 
magnetic stirrer placed inside an incubator, at 37ºC, in order to allow cells penetration 
into the material’s porous structure. After cell seeding was complete, constructs were 
removed from spinner flasks. Two experimental conditions were set: dynamic and 
static. For dynamic culture conditions, half of the constructs were incubated at 37ºC on 
a rotator at 60 rpm. For static conditions, constructs were left to culture statically inside 
the incubator. Culture medium was changed every 3 days. At this stage, the culture 
medium used was differentiation medium (expansion medium without bFGF and with 1 
mg/ml of insulin (Sigma, I5500) and 1 mg/ml of ascorbic acid) (Sigma, A4544). 
Samples were taken at different time points: 1, 2, 3 and 4 weeks of culture.  
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2.4. Microcomputed tomography (µCT) 
  
Microcomputed tomography (µCT) equipment (SkyScan, Belgium) was used as a 
nondestructive technique for a very detailed analysis of the morphology of the 
developed scaffolds. Four scaffolds of each condition were scanned in high-resolution 
mode of 8,7 µm x/y/z and an exposure time of 1792 ms. The energy parameters defined 
in the scanner were 63 keV with a current of 157 µA. Isotropic slice data were obtained 
by the system and reconstructed into 2D images. These slice images were compiled and 
analyzed to render 3D images and obtain quantitative architecture parameters. A µCT 
analyser and a µCT Volume Realistic 3D Visualization, both from SkyScan, were used 
as image processing tools for both µCT reconstruction and to create/visualize the 3D 
representation. Regions of interest (square of 4,5 x 4,5 mm2) were selected in each slice 
image and a threshold was set to eliminate background noise. This threshold (to 
distinguish polymer material from pore voids) was chosen and maintained constant for 
all the scanned specimens and samples. The threshold was also inverted to obtain pore 
volume and to analyze both the pore morphology. 
 
2.5. Scanning Electron Microscopy (SEM) 
 
For scanning electron microscopy analysis, constructs were collected at every time 
point. They were washed in sterile PBS and immersed in 3% glutaraldehyde (Sigma, 
G5882) with 0.1 M cacodylate buffer pH 7.4 (AGAR, R1103) at room temperature for 
30 minutes. Afterwards, they were washed in PBS buffer three times to remove all 
gluteraldehyde from the surface. Then constructs were submerged in osmium tetra oxide 
and left for 2 hours. Finally, they were dehydrated in alcohols and left to air dry. The 
samples were splutter coated with gold and analysed by scanning electron microscopy. 
For this work we used two different scanning electron microscopes: a Philips XL-20 
and a Leica Cambridge S360, Leica Cambridge, Cambridge, UK. 
 
2.6. Histological analysis (H&E, Toluidine Blue, Alcian Blue) 
 
Samples were collected at the end of the experiment (4 weeks of culture) and 
embedded in O.C.T. (OCT compound BDH, Gurr®), in order to make them suitable for  
cryosectioning, and stored at -20ºC. Sections were cut at 8 µm and placed on 
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microscopy slides. A fresh 4% paraformaldehyde (Sigma, P6148) solution in PBS 
buffer was prepared, filtered and cooled down for fixation of the slides. Slides were 
fixed for 30 minutes at 4ºC, washed twice in distilled water and left to air-dry overnight. 
Slides were subsequently stored at 4ºC until used for staining procedures. Hematoxylin-
eosin staining was conducted in an automatic machine, Fume Cupboard; 
X219/E11/LEV1. In this procedure, sections were washed in running tap water for 5 
minutes, and then dipped in 1% acid alcohol for 5-10 seconds. Sections were washed 
again in tap water and stained in eosin for 10 minutes. Another wash with tap water was 
performed for 5 minutes and sections were afterwards dehydrated through alcohols. 
They were cleared in xylene and mounted in DPX (BDH, 36029 2F). Toluidine blue 
stain was performed on a selection of the sections. The staining solution was prepared 
by dissolving 1% of toluidine blue (Sigma, T0394) in distilled water containing 0.5g of 
sodium borate, followed by filtering. One drop of this solution was added to each 
section for 2-3 seconds. Then, sections were rinsed with distilled water and let to air dry 
overnight. Sections were cleared and mounted as described previously. Alcian Blue 
stain was performed by rinsing the sections in 3% acetic acid and incubating them in 
1% alcian blue solution (Sigma, A3157) for 18 hours. After that stage, stain was poured 
off and sections were counterstained with aqueous neutral red (Sigma, N6634) for 1 
min. Sections were washed with water, left to air dry and then rinsed in absolute 
alcohol, cleared and mounted as described previously.  
 
2.7 Immunolocalisation of type I and type II collagens 
 
Immunolocalisation of type I and type II collagens was performed in fixed sections. 
Sections were washed in PBS and pre-treated with 10 mg/ml hyaluronidase (Sigma, 
H4272) in PBS for 30 minutes at 37ºC and with 2 mg/ml pronase (Sigma, P6911) again 
for 30 minutes at 37ºC. Then, sections were washed in PBS and endogenous peroxidase 
activity was quenched with 3% hydrogen peroxide in 50% methanol (BDH, 101586 6B) 
for 5 minutes. Sections were washed in Tri-buffered saline (TBS) solution and blocked 
with 3% BSA (Sigma, A2153) in TBS/ Tween 20 (Sigma, P7949) for 1 hour to avoid 
non-specific staining. Sections were then incubated with primary antibodies (collagen 
type I and collagen type II) (Goat anti-type I collagen UNLB 1310-01 and Goat anti-
type II collagen UNLB 1320-01) overnight at 4ºC, in a humidified atmosphere. The 
next day, sections were washed once with high salt wash solution and twice in 
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TBS/Tween 20 for 10 minutes each and then incubated with secondary antibody from 
the kit during 1 hour at room temperature, again in a humidified atmosphere. The 
remaining protocol is as described in the Vectastain Elite ABC Kit PK-6105 (Vector 
Laboratories Ltd, UK) and in the Vector DAB Kit (Vector Laboratories Ltd, UK). 
Slides were washed in water for 5 minutes and then counterstained with hematoxilyn for 
nuclei visualization. Then slides were mounted in DPX. Controls were performed using 
normal goat serum instead of primary antibodies, which was also included in the kit. 
 
2.8. Dimethylmethylene blue (DMB) assay for glycosaminoglycans quantification 
 
For this assay samples were collected at 4 weeks of culture, freeze/dried overnight and 
then digested. This digestion allowed the separation of the formed extracelular matrix 
from the scaffold. Digestion solution was prepared by adding papain (Sigma, P4762) 
and N-acetyl cysteíne (Sigma, A8199), to obtain the final concentrations of 0.05% and 
0.096%, respectively, to 50 ml of digestion buffer (200 mM of phosphate buffer 
containing 1 mM EDTA (Sigma, E5134), pH 6.8). Samples were placed in 1.5 ml tubes 
and incubated with 600 μl of the referred solution, overnight at 60ºC. Afterwards, 
samples were centrifuged in a bench centrifuge at 13000 rpm for 10 minutes. 
Supernatant was collected and stored at -20ºC until the GAG assay was performed. 
Solutions for this assay were prepared as follows. Dimethymethylene Blue (DMB) 
stock solution was prepared dissolving 16 mg of DMB powder in 900 ml of distilled 
water containing 3.04 g of glycine and 2.73 g of NaCl. This was mixed for 2 hours, 
covered with aluminium foil. pH was adjusted to 3.0 with HCl and volume to 1L. The 
solution was stored at room temperature covered with aluminium foil. Chondroitin 
sulphate (Sigma, C8529) solution was prepared in water, in a 5 mg/ml stock solution 
and kept refrigerated. This solution was diluted with water resulting in 5 unit increments 
from 0 μg/ml to 50 μg/ml, in order to make a standard curve. Samples were also diluted 
as appropriate with distilled water. To a 96 well plate, 20 μl of water was added as a 
blank. The same quantity of chondroitin sulphate diluted solutions was added, in 
duplicate, and the same was performed with all the samples. DMB solution was added, 
250 μl of the solution to each well, in a multichannel pipette, and the optical density was 
measured in a microplate reader, at 530 nm. We used scaffolds without seeded cells as 
controls. 
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2.9. Reproducibility of the experiments 
 
Each scaffold seeding was performed 3 times with cells isolated from a different 
animal. 
 
2.10. Statistical analysis 
 
Data from triplicates of glycosaminoglycans quantification are present as averages ± 
standard errors. One-way analysis of variance in conjunction with Turkey’s test was 
performed on the glycosaminoglycans assays results. 
 
 
3. Results 
 
3.1. Microcomputed tomography 
 
Bi-dimensional and tri-dimensional µCT images from both groups of scaffolds show 
differences between their morphology (Figure 4.1 and 4.2). 60 CPBS scaffolds (4.1A) 
show less pores than 80 CPBS scaffolds (4.1B), as expected. 60 CPBS scaffolds present 
smaller pores. Correlo et al., (2008) recently produced and characterized these two 
types of scaffolds in terms of porosity, pore size and mechanical properties [18]. 80 
CPBS scaffolds were shown to have 78.6±2.5% porosity, and a pore size of 
276.8±52.5µm. 60 CPBS scaffolds, on the other hand, were shown to have a lower 
porosity (57.7±6.6%), as well as a smaller pore size (199.3±5.3 µm) [18]. 
 
Figure 4.1 – Bi-dimensional microCT images of CPBS scaffolds, 60 CPBS scaffolds 
(A) 80 CPBS scaffolds (B), obtained by compression moulding and salt leaching. The 
images highlight the geometry of the obtained pores. 
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Pore geometry was also different in both compositions. As can be observed in the bi-
dimensional images of µCT, pores of the 60 CPBS scaffolds have a geometrically 
defined shape (similar to the salt structure), and seem to be homogeneously distributed 
throughout the scaffolds. On the other hand, the pores of the 80 CPBS scaffolds are 
randomly distributed and do not present a specific shape. 
 
 
Figure 4.2 – Tri-dimensional microCT images of CPBS scaffolds, 80 CPBS scaffolds 
(A) 60 CPBS scaffolds (B), obtained by compression moulding and salt leaching. The 
images highlight the porosity of both scaffolds. 
 
3.2. SEM analysis 
 
The scanning electron microscopy micrographs presented in Figure 4.3 show the 
distribution of cells in the seeded scaffolds throughout the period of the experiment. It 
can be observed that the chondrocytes colonized the entire scaffold, in both types of 
materials. Cells kept their round shaped morphology, typical of chondrocytes, either in 
static culture (Figure 4.3A-4.3D; 4.3I-4.3L), or in stirred culture conditions (Figure 
4.3E-4.3H; 4.3M-4.3P). Nevertheless, it was observed that the colonization of 60 CPBS 
scaffolds appeared slower than in 80 CPBS scaffolds, in both culture conditions. 
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Figure 4.3 – BAC growth morphology in CPBS scaffolds, throughout the time course 
of the experiment. A-H shows results for static (A-D) and dynamic (E-H) cultures in 
60% porosity scaffolds. I-P shows results for static (I-L) and dynamic (M-P) cultures in 
80% porosity scaffolds.  Different magnifications were used to highlight cell 
morphology. 
 
3.3. Histological staining 
 
The colonization of the scaffolds by cells was shown by H&E staining (Figure 4.4A, 
D, G, J). Concerning the 80 CPBS scaffolds, H&E staining shows more cells covering 
the surface of the scaffold than in the 60 CPBS ones. Consequently, more proteoglycans 
are observed, as stated by results of toluidine blue (Figures 4.4H and 4K) and alcian 
blue (Figures 4.4I and 4.4L) stainings. This observation applies for both culture 
conditions (static and dynamic). It is important to highlight the alcian blue staining 
results. The staining in the 80 CPBS scaffolds seems to be stronger and again covering 
more surface area than the obtained for 60 CPBS scaffolds, in both culture conditions. 
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Those results indicate a higher concentration of sulphated proteoglycans in these 
samples. 
 
Figure 4.4 – Production of extracellular matrix in CPBS scaffolds at 4 weeks of 
culture. A-F shows results for static (A-C) and dynamic (D-F) cultures in 60% porosity 
scaffolds. G-L shows results for static (G-I) and dynamic (J-L) cultures in 80% porosity 
scaffolds. Cells were able to attach to scaffolds as showed in hematoxylin-eosin staining 
for 60% porosity (A, D) and 80% porosity scaffolds (G, J). Cells produced 
proteoglycans, detected by toluidine blue staining, either in 60% porosity (B, E) or 80% 
porosity (H, K) scaffolds. Sulphated proteoglycans were detected by alcian blue 
staining, again for both 60% porosity (C, F) and 80% porosity scaffolds (I, L). Two 
magnifications (10x and 20x) were used at each staining for microscopic observation. 
Scale bar = 100 μm. 
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3.4. Immunolocalisation of type I and type II collagens 
 
Results of immunolocalisation of collagens type I and type II in both groups of 
scaffolds are presented in Figure 4.5. Cells seeded into 60 CPBS scaffolds produced 
both collagen type I and type II (Figure 4.5A-F), either in static (Figure 4.5B and 4.5C) 
or in stirred culture conditions (Figure 4.5D and 4.5F). Contrarily, collagen type I was 
discrete in the section of 80 CPBS scaffolds (Figures 4.5H and 4.5K), whereas collagen 
type II synthesis was revealed in all samples (Figures 4.5I and 4.5L). 
 
 
Figure 4.5 – Immunolocalisation of collagens in CPBS scaffolds, at 4 weeks of 
culture. A-F shows results for static (A-C) and dynamic (D-F) cultures in 60% porosity 
scaffolds. G-L shows results for static (G-I) and dynamic (J-L) cultures in 80% porosity 
scaffolds. Controls (A, D, G, J) were performed with normal goat serum. Collagen type 
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I (B-K) and collagen type II (C-L) were detected. Two magnifications (10x and 20x) 
were used at each staining for microscopic observation. Scale bar = 100 μm.  
 
3.5. GAGs quantification 
 
Glycosaminoglycans presented in both types of scaffolds were quantified by the DMB 
assay, and results are presented in Figure 4.6. A significant higher glycosaminoglycans 
production in 60 CPBS scaffolds was detected in comparison with 80 CPBS scaffolds. 
Stirred culture conditions significantly (P<0.05) enhance glycosaminoglycans 
production in both types of scaffolds when compared to static culture conditions. There 
was a statistical difference in glycosaminoglycans production in 60 CPBS scaffolds 
when cultured in stirred conditions compared to the data obtained for static culture 
conditions. For 80 CPBS scaffolds, glycosaminoglycans production in stirred culture 
conditions is higher, but not statistically different. 
 
 
Figure 4.6 –GAGs quantification for CPBS scaffolds, at 4 weeks of culture. Static 
culture conditions are represented in white, dynamic culture conditions in grey. 
 
 
4. Discussion 
 
Structure of pores is one important factor in tissue regeneration. The growth of some 
specific cell types in injured sites is dependent on optimal pore size and geometry [30]. 
Pore size affects cells response in terms of attachment, growth and proliferation [31]. 
Variation in pore size also affects the mechanical stability of constructs, and this is an 
important factor when implanting them in load bearing areas, as well as to evaluate the 
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construct response to mechanical stimuli in bioreactors [32]. In particular, permeability 
affects the shear stresses inside the construct [33], which is a stimulus for cellular 
differentiation or functional adaptation of the construct during the implant. Furthermore, 
mechanical environment in the tissue has a controlling influence on tissue 
differentiation [33]. For in vivo implantation, cells need to be expanded in vitro to a 
sufficient number in order to generate a construct with certain mechanical stability [34]. 
Furthermore, upon implantation the scaffolds and cells will be subjected to the action of 
synovial fluid flow in the joint. The fluid flow is believed to facilitate cell migration and 
promote positive signals by mechanotransduction to the cells.  Therefore, the dynamic 
culture conditions may support high seeding densities and help cells to grow, proliferate 
and produce ECM. Those conditions are also believed to lead to more stable constructs, 
and therefore, may enhance the construct integration within the tissue at the implant 
site. In a work by Gotterbarm et al., (2006), two layered biomaterials were implanted in 
osteochondral defects created in the trochlear groove of Göttinger Minipigs. They 
observed cellular migration and cell attachment, as well as matrix production. These 
authors claim that this cellular filling and attachment was fostered by the porous 
character of the biomaterials, and led to an increased amount of repaired tissue [35].  
In a previous work, Correlo et al., (2008) produced and characterized several 
scaffolds produced from different blends of chitosan and synthetic polyesters, including 
the CPBS scaffolds studied in the present work [18]. A higher range of different types 
of scaffolds were produced by compression moulding and salt leaching, using different 
salt sizes to induce small and large pores. Curiously, small salt sizes originated larger 
pores, due to the aggregation of the salt particles [18]. We choose the scaffolds from the 
blend CPBS (50/50) based on cytotoxicity and direct contact tests previously performed 
(data not shown). We intended to determine the effect of the pore size and shape on the 
production of ECM by bovine articular chondrocytes.  
In a work by Spiteri et al. (2006) it has been shown that substrate porosity enhanced 
bovine articular chondrocytes attachment, growth and formation of cartilage in vitro 
[31]. In our present work, scaffold pore morphology seems to equally affect BAC 
attachment and colonization. Globally, we can observe that cells attached and colonized 
both scaffolds. This observation is similar to the one obtained when rabbit chondrocytes 
were seeded onto chitosan-based hyaluronic acid hybrid polymer fibers. In the referred 
study, cell proliferation had no significant difference between 3 groups of scaffolds with 
different pore sizes [26].  
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Some studies have focused on the effect of pore size on chondrocytes performance. 
Cartilaginous tissue obtained on porous titanium alloy discs with the smaller pore size 
was thicker and had greater amount of proteoglycans, in comparison to tissue obtained 
form discs with larger pore sizes [36]. Another study by Nehrer et al., (1997) showed 
that biosynthetic activity and chondrocyte phenotype were improved in collagen 
matrices with smaller pores [37]. It has been suggested that cell-cell interactions are 
enhanced in scaffolds with small pore sizes, thus resulting in improved chondrocyte 
proliferation [37]. These studies lead to the conclusion that small pores improve 
chondogenesis. However, several other studies point to the opposite direction. Griffon 
et al., (2006) determined that large interconnective pores improve the cellularity and 
matrix content within chitosan scaffolds [38]. In a recent work, Lien et al. (2009) also 
showed that articular chondrocytes of Wistar rats performed better in the group of 
scaffolds with pore size between 250-500 µm in terms of proliferation and ECM 
production [39]. In fact, our findings support these observations. Cells seeded into 60 
CPBS produced both collagen type I and type II (Figure 5A-F), indicative of a fibrous 
cartilage tissue, either in static (Figures 5B and 5C), or stirred culture conditions 
(Figures 5C and 5F). Fibrocartilage is aa mixed matrix consisting of fibrous tissue and 
hyaline cartilage. It contains type I and type II collagen and aggrecan [40]. On the other 
hand, hyaline cartilage contains type II collagens and proteoglycans, being the major 
one aggrecan molecule [40]. Cartilage-like tissue formed in 80 CPBS scaffolds did not 
presented significant staining of collagen type I (5H and 5K) yet showed a marked 
staining for collagen type II, indicating that these tissue properties are more similar to 
hyaline-like cartilage tissue, than those obtained with 60 CPBS scaffolds. However, 
glycosaminoglycans content present in 80 CPBS scaffolds were lower compared with 
obtained for 60 CBPS scaffolds (Figure 6). This result seems to contradict the previous 
ones, going in the direction of the first series of results that were referred, where smaller 
pores enhance the proteoglycans deposition [36, 37]. In fact, the opposite effects of pore 
size in this work, was observed. On one hand, large pores induced cell proliferation, 
production of proteoglycans and collagens. On the other hand, glycosaminoglycans 
production was significantly lower in scaffolds with large pore sizes. Additionally, 
stirred culture conditions seem to also affect glycosaminoglycans production, for both 
types of scaffolds. In general, we observed that stirred conditions enhance 
glycosaminoglycans production. A similar observation was reported by Freyria et al. 
(2004), when using 3D collagen scaffolds seeded with BAC and cultured under static or 
Assessment of ECM formation in chitosan-based scaffolds using bovine articular chondrocytes 
129 
stirred conditions. Thus, authors state that these conditions allow obtaining a 
homogeneous distribution of cells and ECM within scaffolds structure [41]. It is 
described in the literature that substrate geometry and porosity may both influence 
chondrocyte behaviour [36, 37, 42].  Understanding the impact of the biomaterial 
geometry is very important to enhance the in vivo ECM formation. Many factors may 
act in concert, such as fluid flow to enhance the nutrition and waste product removal, as 
well as number of attached cells and their ability to produce ECM [31]. Therefore, the 
optimal conditions for each scaffold must be determined, because each scaffold 
characteristics determine the cell attachment, growth, maintenance of phenotype and 
ECM production [34]. The referred characteristics include the scaffolds texture, porosity 
(size, structure, distribution) and surface free energy [34]. In summary, every parameter 
by itself is important and should be regarded, but the overall of the referred parameters 
makes the scaffold be functional and suitable for cartilage tissue engineering. 
 
 
5. Conclusions 
 
Chitosan-PBS scaffolds were produced by compression moulding followed by salt 
leaching. Two different types of NaCl salt particles were used as porogens, and two 
types of scaffolds with different porosities, pore geometry and size were produced. 80 
CPBS scaffolds presented larger, randomly structured pores opposite to 60 CPBS 
scaffolds that showed smaller pores with a cubic structure. By our observations, we can 
state that 80 CPBS scaffolds seem more effective in inducing ECM production by BAC. 
Pore size and geometry of the pore had an effect on cell proliferation and ECM 
production. Proteoglycans and collagen type II were detected in larger quantities in 80 
CPBS scaffolds (large pores, random structure), when compared with 60 CPBS 
scaffolds (small pores, cubic structure). Nevertheless, glycosaminoglycan amount was 
lower in the 80 CPBS scaffolds. Large pores affected GAG production, either in static 
or dynamic culture conditions. Concerning culture conditions, stirred conditions 
improved ECM production in both types of scaffolds, thus being preferable than static 
culture conditions. 
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Abstract 
 
Mesenchymal Stem Cells (MSCs) have been recognized for their ability to 
differentiate into cells of different tissues such as bone, cartilage or adipose tissue, and 
therefore are of great interest for potential therapeutic strategies. Adherent, colony-
forming, fibroblastic-cells were isolated from human bone marrow aspirates, from 
patients undergoing knee arthroplasties, and the MSCs phenotype characterized by flow 
cytometry. Afterwards, cells were seeded onto electrospun polycaprolactone nanofiber 
meshes and cultured in a multichamber flow perfusion bioreactor, in order to determine 
their ability to produce cartilagineous extracellular matrix. Results indicate that the flow 
perfusion bioreactor increased the chondrogenic differentiation of hBM-MSCs, as 
confirmed either by morphological and RT-PCR analysis. Cartilage-related genes such 
as aggrecan, collagen type II and Sox9 were expressed. ECM deposition was also 
detected by histological procedures. Collagen type II was present in the samples, as well 
as collagen type I. Despite no statistically significant values were obtained for gene 
expression, the other results support the choice of the bioreactor for this type of culture. 
 
 
1. Introduction 
 
Due to the epidemiological importance and the high social costs of joint diseases, 
cartilage engineering holds remarkable potential in orthopedic surgery as an alternative 
to current surgical methods. Traditional implantable materials frequently fail its 
biofunction, due to implant loosening, inflammation, infection, rejection, wear debris 
and tissue inflammation or infection [1]. Tissue Engineering can provide the answers to 
many of these problems. One of the challenges of TE is to mimic the natural 
extracellular matrix (ECM) of connective tissues, including cartilage. Nanoscale is very 
important in this approach, as the ECM substratum that interacts with cells includes 
fibrils at submicron level [2]. Electrospinning process has been used to produce 
nanofibrous scaffolds that can mimic tissues’ ECM by imitating its fibrils morphology 
and distribution [3]. These nanofibrous structures present many advantages, such as 
high specific surface area for cell attachment, higher micro-porous structure and a 3D 
microenvironment for cell-cell and cell-biomaterial contact [1, 4]. In the last few years, 
nanomaterials and nanofibers have been explored as new functional structures for tissue 
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regeneration, in bone [5], cartilage [6],  veins or nerves [7]. Some materials intended for 
cartilage tissue engineering have been produced using electrospinning of several 
synthetic and natural materials, such as PCL [8], PLGA [9], chitosan-based materials 
[10] or starch based materials [11]. 
Cartilage is an avascular tissue composed by chondrocytes entrapped in an ECM rich 
in proteoglycans and collagens [12]. The low self-regeneration potential of cartilage is 
due to the absence of vascular networks and progenitor cells in the tissue, as well as the 
non-mobility of chondrocytes in the dense ECM [13]. Chondrocytes have been used to 
generate engineered cartilage tissue [11, 14], and are usually isolated from articular 
cartilage tissues. Stem cells are also commonly proposed for cartilage tissue 
engineering. Chondrocytes are developmentally derived from stem cells [15]. Compared 
with adult chondrocytes, stem cells are easier to obtain and manipulate, as they can 
undergo several passages before loosening their differentiation potential [16]. 
Mesenchymal stem cells (MSCs) can be isolated from several tissues, including bone 
marrow [17], fat tissue [18] or synovium [19]. Selecting the ideal source of cells for a 
cartilage tissue engineering approach is a demanding and challenging task, as there are 
numerous options. Additionally, the choice of the scaffold is very important. In a recent 
study it was shown dissimilar chondrogenic differentiation behaviour of MSCs derived 
from different tissues, namely human embryonic stem cells, bone marrow and adipose 
tissue. Additionally, their behaviour also differ among the tested silk and chitosan 
scaffolds [16]. 
Dynamic culture systems or bioreactors have been widely studied for cartilage tissue 
engineering approaches [20-22]. Results often show that they enhance ECM formation 
when compared with static cultures. In some bioreactor studies for cartilage tissue 
engineering approaches low levels of shear stress were used successfully, as they 
promoted good mass transfer properties [23]. As chondrocytes are surrounded by an 
environment influenced by mechanical forces, it is logical that the formation of 
cartilagineous tissue is also heavily influenced by the environment. Therefore, if cells 
are surrounded by an appropriated environment, and they have access to the correct 
levels of nutrients, it is believed that they will act like native chondrocytes and secrete 
ECM [23]. 
In a recent work using a bovine articular chondrocytes model, we showed that 
polycaprolactone (PCL) and SPCL (starch-compounded PCL) nanofiber meshes are 
suitable for cartilage tissue engineering [11]. In that study, we used a high initial 
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concentration of bovine articular chondrocytes, and cultured the nanofiber meshes in a 
lab rotator bioreactor. The results were encouraging, but from that work several other 
questions were raised, namely the aspects involved in the future application of this 
model in human therapies. In that study it was used a high number of cells, which most 
of the times are not readily available for clinical application. The dynamic culture 
system used in that previous study did not allow create a controlled environment for the 
culture of the constructs, and it is important to obtain a pre-implant with similar 
characteristics to the native cartilage. Finally, when going to clinic, the access to 
articular chondrocytes is more limited than it is for MSCs. Having all these issues in 
mind, we designed this study to validate if, starting from low seeding densities of 
human bone marrow-derived MSCs in PCL nanofiber meshes cultured in an in-house 
developed multichamber flow perfusion bioreactor (PT patent nº 104155; European 
patent pending [24]), we could induce chondrogenic differentiation of the MSCs and 
consequent ECM deposition. Also, we aimed to determine whether the ECM deposition 
would result in cartilage-like tissue, whose characteristics would resemble native 
articular cartilage. 
 
 
2. Materials and Methods 
 
2.1. Nanofiber meshes processing 
 
A polymeric solution of PCL (PCL 787, TONE polymer, Union Carbide Chemical 
and Plastics Division, Bound Brook, NJ, with 80 kDa), at the concentration of 17% 
(w/v), was prepared by dissolving the polymer into an organic solvent mixture of 
chloroform/ dimethylformamide (70:30) (Sigma-Aldrich, USA). The polymeric solution 
was placed into a syringe, which is coupled to a syringe pump (model KDS100, KD 
Scientific, USA) for flow rate control. A blunted metallic needle with an internal 
diameter of 0.8 mm was attached to the syringe. A grounded aluminium foil was used as 
the fiber mesh collector. A high voltage of 9kV was applied to the needle tip to generate 
the electric field; a needle tip-to-collector distance of 20 cm and the flow rate of 1.0 
ml/h were established. The applied voltage was maintained at 9 kV. All the experiments 
were performed at room temperature and the conditions were optimized for the 
production of PCL nanofiber meshes. The produced PCL nanofiber meshes presented a 
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thickness between 40-60 µm, 70-80% of porosity, determined by nCT (data not shown) 
and an average pore size of 2.7 µm. For more details on the PCL nanofiber meshes, 
please refer to Guimarães et al., 2010 [25]. After collection, nanofiber meshes were cut 
into 1 cm2 squares. 
A clamping system to fixate the produced nanofiber meshes in the multichamber flow 
perfusion bioreactor (PT patent nº 104155; European patent pending [24]) had to be 
assembled. The meshes were fixated in between two silicon rings, which were then 
clamped with nylon stitches [25]. Using this clamping system, the available surface of 
the nanofiber meshes to be cultured in the bioreactor was a circle of 5 mm in diameter. 
For the static cultures, the referred 1 cm2 squares were used. The membranes were then 
sterilized under UV light for 1hour in each side. 
 
2.2. Isolation of hBM-MSCs 
 
HBM-MSCs were isolated from bone-marrow aspirates collected under informed 
consent from patients undergoing knee arthroplasties in Hospital de S. Marcos, Braga, 
Portugal. Samples were collected from a 55 years old female donor, isolated, expanded 
and frozen in several passages. Briefly, during the surgery, bone marrow was collected 
to a container with α-MEM medium (Invitrogen, 12000-063), supplemented with 
antibiotic/ antimycotic solution (Gibco, 15240062) and 5000 units of heparin (Sigma, 
H3393) and maintained in ice until the isolation procedure. Aspirates were 
homogenised, diluted in PBS (Sigma, P4417) (1:1) and incubated for 5 minutes at room 
temperature. Then, bone marrow was diluted in lyses buffer (1:10) and left under 
agitation for 10 minutes. Lyses buffer was prepared with 10 mM of Tris-HCl (Sigma, 
T3253), 1.21g of Tris Base (Sigma, T1503) and 8.3g of NH4Cl (Merck, 1011455000), 
in 1L of distilled water.  Afterwards, the suspension was centrifuged at 1200 rpm, for 15 
minutes at room temperature. Cells were ressuspended in α-MEM medium, 
supplemented with antibiotic/ antimycotic solution and 20% FBS (Biochrom, 
BSC0115/0943k). Cell suspension was filtered for disposal of debris, using 100µm and 
70µm Cell Strainer (BD Falcon™, 352360 and BD Falcon™, 352350). Cells were 
counted and plated at the density of 4.7x103 cells/cm2. Cells were expanded in the 
referred culture medium until passage 5, and then used for seed the nanofiber meshes. 
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2.3. Flow-cytometry analysis 
 
To evaluate cell-surface marker expression, cultured cells were incubated for 20 min 
at 4ºC with fluorescein isothiocyanate (FITC)- or phycoerythrin (PE)-conjugated 
monoclonal antibodies specific for human markers associated with mesenchymal and 
haematopoietic lineages. The antibodies used were: CD29, CD34, CD45, CD73, CD90, 
CD105, CD116. All the antibodies were purchased from BD Pharmingen. The samples 
were analysed on a FACS Calibur (BD Biosciences). 
 
2.4. hBM-MSCs culture on the multichamber flow perfusion bioreactor 
 
hBM-MSCs were detached from the culture flasks by treatment with Trypsin/EDTA 
solution (Invitrogen, 25300-062). Cells were counted and a cell suspension of 200.000 
cells/nanofiber mesh was prepared to seed each of the nanofiber meshes. Cell seeding 
was performed using the “drop” method. The seeding method has been described 
previously in more detail by our group, in Guimarães et al., 2010 [25]. Briefly, each 
scaffold was seeded with a 10 µL drop of α-MEM culture medium containing 200.000 
cells, in 24 well plates. Afterwards, the constructs were maintained at 37ºC and 5% 
CO2, during 4 hours in an incubator to allow cell attachment to the scaffolds. After this 
time period, culture medium was added to each culture well and left in the incubator for 
24 hours. The constructs were then transferred to the bioreactor.  
This is the first work reporting the use of the multichamber bioreactor designed by our 
group. The bioreactor has currently a PT patent and the European patent is under 
submission. For detailed information please refer to Costa et al., 2010 [24]. Briefly, the 
bioreactor apparatus is composed of a central part with 20 individual culture chambers, 
with the diameter of 8 mm each, and two lids attached to the central part. These lids 
form a common inlet and outlet of medium.  These chambers were designed in a way 
which allows the circulation of the culture medium through them, and assures the 
evenly distribution of it between the several flow chambers. For bioreactor cultures, 20 
constructs were transferred for the apparatus and placed one in each chamber. A flow 
velocity of 70 µl/min/nanofiber mesh was established. The bioreactor apparatus herein 
used can be observed in Figure 1. The clamping system has been previously reported 
also by a work in our group by Guimarães et al., 2010 [25].  
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Another set of 20 constructs was transferred to new culture plates and maintained in 
static conditions to be used as control. Chondrogenic differentiation medium consisting 
of α-MEM supplemented with antibiotic/antimycotic solution, ITS liquid media 
supplement (Sigma, I2521), dexamethasone 1mM (Sigma, D1756), Sodium Pyruvate 
0,1M (Sigma, P4562), Ascorbate-2-phosphate 17 mM (Sigma, A4544),  L-Proline 35 
mM (Sigma, P5607) and 1 ng/ml of human recombinant TGF-β3 (PeproTech, 100-36) 
was used for the 28 days of the experiment. Culture medium in the bioreactor was 
completely changed every week (100 mL each time). Control samples were cultured in 
24 well plates, and were fed every other day with 1 mL of culture medium. 
 
 
Figure 5.1 – Multichamber flow perfusion bioreactor (PT Patent nº 104155; European 
patent pending [24]) assembled and the culture system inside the incubator. 
 
Samples were collected at every time point, both from the bioreactor and from static 
controls. For DNA analysis, 2 samples were collected at 14, 21 and 28 days of the 
experiment. For SEM analysis, 1 sample was collected on every time point. Three 
samples at 14, 21 and 28 days were collected for PCR analysis. For histological 
procedures, 1 sample was collected at the end of the experiment. Experiments were 
repeated 3 times. 
 
2.5. Proliferation assay (DNA quantification) 
 
Evaluation of cell proliferation was performed using the PicoGreen dsDNA 
quantification Kit (Molecular Probes, P7589), according to the manufacturer 
instructions. Samples from the flow perfusion bioreactor and from the static control 
were collected at 14, 21 and 28 days. Triplicates of every time point were used. A 
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standard curve ranging from 0.0 to 1.5 µg/ml was established. Fluorescence of both 
samples and standard curve was read with an excitation of 485/20 nm and an emission 
of 528/20 nm. DNA concentration was extrapolated from the standard curve. 
 
2.6. Scanning Electron Microscopy (SEM) 
 
For SEM analysis, one hMSCS-nanofiber meshes construct was collected at each time 
point: 1, 2, 3 and 4 weeks, for each culture condition. They were washed in sterile PBS 
and immersed in 3% glutaraldehyde (Sigma, G-5882) at room temperature for one hour. 
Samples were washed in PBS, dehydrated in increasing ethanol concentrations and let 
to dry at room temperature. Samples were sputter coated with gold and analysed in a 
scanning electron microscope (model S360, Leica Cambridge,UK). 
 
2.7. RNA isolation 
 
Three samples were collected from the flow perfusion bioreactor and from the static 
control. Samples were washed in PBS, immersed in TRIzol reagent (Invitrogen, 15596-
018) and kept at -80ºC for posterior RNA extraction. To perform the RNA extraction, 
samples were taken from the freezer, and kept in ice until complete thawing. 
Chloroform (Sigma, C-2432) was added; samples were vigorously agitated for 15 
seconds and then incubated in ice for 15 minutes. After that incubation, samples were 
centrifuged at 13000 rpm, for 15 minutes, at 4ºC. Afterwards, the supernatant was 
collected for a sterile 1.5 mL tube, and an equivalent volume of isopropanol (Sigma, I-
9516) was added. Samples were incubated at -20ºC overnight, to precipitate the RNA. 
In the next day, samples were centrifuged at 13000 rpm, for 15 minutes, at 4ºC. Then, 
the supernatant was removed and 800 μl of ethanol 70% was added, in order to wash 
away the isopropanol. The ethanol 70% solution was prepared from absolute ethanol 
(Merck, 1.00983.2511) and ultra pure water. The 1.5 mL tubes were agitated vigorously 
and centrifuged again, at 9000 rpm for 5 minutes, at 4ºC. The supernatant was again 
removed, and the pellet was left to air dry. Finally, the pellet was ressuspended in 50 μl 
of DNase, RNase free water (Gibco, 10977-015). The concentration and purity of the 
extracted RNA was evaluated using the NanoDrop ND-1000 Spectrophotometer 
(NanoDrop Technologies Inc, USA). 
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2.8. Real-Time PCR 
 
The Real-Time PCR procedure used in the present work consisted of a two step 
fluorogenic assay using the SyberGreen system (Bio-Rad). All the reagents used in this 
procedure were from Bio-Rad, following the instructions of the manufacturer. 
Thermocycler reaction conditions used were also the mentioned in the kits. In the first 
step, RNA was reversed transcribed into cDNA, using the iScript cDNA synthesis kit 
(1708891). A MiniOpticon real-time PCR detection system (BioRad Laboratories, 
USA) was used to perform the reaction. Afterwards, the cDNA obtained was used as 
template for the amplification of the target genes (aggrecan, collagen type I, II and X, 
Sox9 and Runx2), with the Syber Green Kit (1708884). The number of amplification 
cycles used for every reaction was of 45. GAPDH was used as reference gene, and the 
expression of all the target genes was normalized to the GAPDH expression of that 
sample. All the primer sequences were generated using Primer3 software [26] and 
acquired from MWG Biotech AG, Germany. Primers sequences used are shown in 
Table 5.1. Obtained results were analyzed with CFX Manager Software – version 1.5 
(BioRad Laboratories, USA). 
 
Table 5.1 – Primer sequences used for RT-PCR procedures a. 
Gene Forward (5´-3´) Reverse (5´-3´) 
AGC TGAGTCCTCAAGCCTCCTGT TGGTCTGCAGCAGTTGATTC 
COL II CGGTGAGAAGGGAGAAGTTG GACCGGTCACTCCAGTAGGA
COL I AGCCAGCAGATCGAGAACAT ACACAGGTCTCACCGGTTTC 
COL X CCAGGTCTCGATGGTCCTAA GTCCTCCAACTCCAGGATCA 
Runx2 TTCCAGACCAGCAGCACTC CAGCGTCAACACCATCATTC 
Sox9 TTCATGAAGATGACCGACGC GTCCAGTCGTAGCCCTTGAG 
GAPDH ACAGTCAGCCGCATCTTCTT ACGACCAAATCCGTTGACTC 
 
aAGC = Agreccan; COL II = Collagen type II; COL I = Collagen type I; COL X = Collagen type X; 
Runx2 = Runt-related transcription factor 2; Sox9 = Sry-type high mobility group box 9; GAPDH = 
Glyceraldehyde 3-phosphate dehydrogenase 
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2.9. Histological analysis 
 
Samples were collected at the end of the experiment, included in O.C.T. (Gurr® OCT 
compound, BDH) and stored at -20ºC. Sections with 8 µm thickness were placed in 
microscopy slides, fixed in a fresh 4% paraformaldehyde (PF) (Sigma, P-6148) solution 
in PBS buffer, during 30 minutes at 4ºC, washed twice in distilled water and let 
overnight to air-dry. Slides were stored at 4ºC until they were further used for staining 
procedures. Toluidine blue staining was performed. Staining solution was prepared by 
adding 1% of toluidine blue (Sigma, T0394) dissolved in distilled water containing 0.5 
g of sodium borate, followed by filtering. One drop of this solution was added to each 
section for 2-3 seconds. Then, the sections were rinsed with distilled water and let to air 
dry overnight. Sections were cleared in xylene substitute (Sigma, A5597) and mounted 
in Histo clear (Frilabo, HS200). Safranin O staining was performed by washing slides in 
tap water, then immersed in 0.02% fast green (Fluka, 44715) for 3 minutes. Then, 
samples were immersed in 1% acetic acid (Panreac, 131008) solution for 30 seconds. 
After, slides were immersed in 0.1% safranin O (Fluka, 84120) solution for 5 minutes. 
By the end, slides were washed in tap water and let to air dry. Sections were cleared in 
xylene and mounted as previously described. 
 
2.10. Immunolocalisation of type I and type II collagens 
 
Immunolocalisation of type I and type II collagens was performed in fixed sections. 
Endogenous peroxidase activity was quenched with 0.3% hydrogen peroxide solution 
for 30 minutes. Sections were rinsed in PBS for 5 minutes. R.T.U. Vectastain® 
Universal Elite ABC Kit (Vector, VCPK-7200) was used for antibody incubation, 
according to the instructions of the manufacturer. Shortly, sections were incubated with 
primary antibodies (collagen type I and collagen type II) (UNLB, Goat anti-type I 
collagen 1310-01 and UNLB, Goat anti-type II collagen 1320-01) overnight at 4ºC, in a 
humidified atmosphere. Incubation was revealed by using the Peroxidase Substrate Kit 
DAB (Vector, VCSK-4100). Slides were washed in water for 5 minutes and then 
counterstained with haematoxylin for nuclei visualization. Finally, slides were mounted 
in Histo clear. Controls were performed using normal goat serum instead of primary 
antibodies, which was also included in the kit. 
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2.11. Statistical analysis 
 
Statistical analysis was performed using the SPSS statistic software (Release 15.0.0 
for Windows). Firstly, a Shapiro-Wilk test was used to ascertain about the data 
normality and variance equality. The normality is strongly rejected and, consequently, 
nonparametric tests were used in further comparisons between static and dynamic 
culture conditions. A Mann-Whitney U-test was applied to compare the two 
independent groups of samples for each variable (i.e. DNA quantification and real-time 
PCR). P values lower than 0.01 were considered statistically significant in the analysis 
of the results. A Kruskal-Wallis test was applied to compare differences in between the 
days in each group. P values lower than 0.01 were considered statistically significant in 
the analysis of the results. 
 
 
3. Results 
 
3.1. Electrospun PCL nanofiber meshes  
 
SEM observations of the produced nanofiber meshes show a random distribution as 
expected. This is the most typical morphology obtained in the electrospinning process, 
caused by the electric field generated in the equipment (Figure 5.2). PCL nanofiber 
meshes were composed by nanofibers with diameters in the submicron range, from 0.4 - 
1.4 µm. 
 
Figure 5.2 – SEM micrografs of poly(ε-caprolactone) (PCL) nanofiber meshes 
processed by electrospinning. Scale bars: 50.0 µm= 5 cm; 5.0 µm= 2 cm. 
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3.2. FCM analysis of the isolated cells 
 
Isolated bone marrow cells were expanded and characterized for specific surface 
antigen expression by flow cytometry analysis. hBM-MSCs were analysed for 
hematopoietic marker expression (CD34 and CD45): isolated cells were negative for 
these two markers (not detected, less than 5%). Cells were positive for CD29 (95%), 
CD73 (98.3%), CD90 (97.9%), CD105 (85%) and CD166 (85%) surface markers, 
which are characteristic of mesenchymal stem cells. Based in this data we are very 
confident that the cell fraction isolated from bone marrow contains mostly MSCs. 
 
3.3. DNA quantification 
 
Results show a higher DNA content in samples collected from the flow perfusion 
bioreactor, compared to the static control conditions, in terms of DNA concentration 
(Figure 5.3). In this condition, DNA contents decreased a little at 21 days, but then 
increased by 28 days. In static conditions samples, there is a continuous decrease of the 
DNA contents along the time. In order to find significant differences in DNA contents 
between static and bioreactor culture conditions, the Mann–Whitney U-test was 
performed. No significant differences between both culture conditions were found at 14 
(p=0.18) or 21 days of experiment (p=1.00). However, bioreactor samples displayed a 
significantly higher DNA quantification than the static ones at 28 days of experiment 
(p=0.002). 
Concerning statistic differences between the days of culture, we found none either in 
static (Kruskal-Wallis test, p=0.149), either in the bioreactor (Kruskal-Wallis test, 
p=0.261). 
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Figure 5.3 - Box plot of the DNA quantification in static and bioreactor cultures after 
14, 21 and 28 days of culture. Data were analyzed by nonparametric way of a Mann–
Whitney U-test (* p<0.01, vs Static). 
 
3.4. SEM analysis 
 
SEM observations of the cultured hBM-MSC in electrospun PCL nanofiber meshes 
shows some differences in their morphology along the experiment (Figure 5.4). At 7 
days of culture, samples from the bioreactor showed a round-shaped morphology, 
whereas the cells from the static culture samples presented a fibroblast-like morphology, 
very stretched. The round-shaped morphology of cells in the bioreactor samples is 
maintained throughout the time course of the experiment (Figure 5.4A, C, E, G). In the 
two last time points, the cells morphology is not that evident. In figures 5.4E and 5.4G, 
referring to the bioreactor cultures at 21st and 28th days, respectively, we can observe 
that cells form a sheet that covers the entire meshes surface. Our interpretation of these 
two figures is that the production of ECM component and consequent deposition led to 
a thin film of cells entrapped in this matrix. Therefore, there are less “visible” cells, as 
they are now part of the matrix. On the other hand, in static cultures we can observe 
individual cells, as the matrix production here seems to be delayed, in comparison to the 
bioreactor cultures. Cells in static samples seem to be acquiring the round shaped 
morphology along the time, but by the 28th day of culture they are still not as round-
shaped as the bioreactor (Figure 5.4G and 5.4H). 
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Figure 5.4 – Morphology of hBM-MSCs cultured in electrospun PCL nanofiber 
meshes, in the flow perfusion bioreactor (A, C, E, G) and in static control conditions (B, 
D, F, H) along the time course of the experiment: A, B-7 days; C, D-14 days; E, F- 21 
days; G, H- 28 days. Different magnifications were used to highlight cell morphology. 
Scale bars: 100 µm= 2 cm; 20 µm= 0.5 cm. 
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3.5. Real-time PCR 
 
Samples were collected for real-time PCR at 14, 21 and 28 days of experiment, both 
from the bioreactor and static control culture conditions. The aim was to determine the 
expression of several cartilage-related genes. All the tested genes were being expressed. 
The expression of the Aggrecan transcript was detected for both culture conditions, in 
all time points. The statistical analysis performed, using a Mann–Whitney U-test, 
confirmed the absence of significant difference between culture conditions at 14 
(p=1.000), 21 (p=0.762) and at 28 days of experiment (p=0.800). The Collagen type II 
expression was detected, but no significant difference was found between static and 
bioreactor culture conditions in the 14th day (p=0.233), in the 21st day (p=0.413) or in 
the 28th day of experiment (p=0.400). The Sox9 transcript is observed in both culture 
conditions, following a similar expression pattern. Statistical analysis of the results for 
14 days of culture (p=1.000), 21 (p=0.800) and 28 days (p=0.333) showed no 
significant difference between both culture conditions. The expression of Collagen type 
I showed no significant difference between bioreactor and static culture conditions was 
found in the 14th day (p=0.563), in the 21st day (p=0.075) or in the 28th day (p=0.071). 
Collagen type X is expressed in slightly equal values for both types of cultures, as well 
as Runx2. Statistical analysis for Collagen type X confirmed that no significant 
difference was found between culture conditions in the 14th day (p=1), 21st day (p=0.4) 
or 28th day (p=1). For Runx2, the same was observed: no significant difference between 
the two tested conditions was found in the 21st day (p=0.400) or in the 28th day of 
experiment (p=1.00). 
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Figure 5.5 – Bar plots of chondrogenic markers of flow perfusion bioreactor samples 
and static control conditions normalized for the reference gene GAPDH, after 14, 21 
and 28 days of culture. Data were analyzed with a Mann–Whitney U-test. 
 
3.6. Histological staining 
 
Histological sections of electrospun PCL nanofiber meshes seeded and cultured with 
hBMSCs, at 28 days of culture in the multichamber bioreactor or in static conditions 
were stained for cartilagineous ECM using toluidine blue and safranin O assays (Figure 
5.6). Toluidine blue staining detected the presence of glycosaminoglycans in those 
sections, and safranin O staining confirmed this observation. It is also possible to 
observe a dense concentration of staining on sections from the bioreactor samples 
(Figure 5.6A and B) compared to the static culture sections, on both toluidine blue and 
safranin O staining. 
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Figure 5.6 – Histological section of hBMSCs seeded onto PCL nanofiber meshes for 
chondrogenic differentiation, at 28 days, from bioreactor constructs (A, B) and static 
control cultures (C, D). A, C – Toluidine blue staining; B, D –Safranin O staining. 
Black arrows show the nuclei of the cells. White arrows show ECM. Scale bars: 100 
µm= 1 cm; 50 µm= 2.5 cm. 
 
3.7. Immunolocalisation of type I and type II collagens 
 
Histological sections of electrospun PCL nanofiber meshes cultured with hBMSCs, at 
28 days of culture in the multichamber bioreactor or in static conditions were stained for 
imunolocalisation of collagens type I and II (Figure 5.7). For the bioreactor cultures, 
both types of collagens were detected. Collagen type I stain (Figure 5.7A) appears to be 
slightly clear than the collagen type II staining (Figure 5.7B). On the other hand, there is 
a heavy unspecific staining on the control sections of both types of cultures (Figures 
5.7A and 5.7D), which may have in part been due to dye trapped in folded regions of 
the sections. In static cultures, a marked staining for collagen type I (Figure 5.7E) can 
be observed, when compared to the collagen type II section (Figure 5.7F). 
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Figure 5.7 – Immunolocalisation of collagen type I (B, E) and type II (C, F) in 
electrospun PCL nanofiber meshes, after 28 days of culture in the bioreactor (A-C) and 
in static cultures (D-F). Controls of the immunohistochemistry assay (A) were 
performed with normal horse serum. Scale bar: 100 µm= 1 cm. 
 
 
4. Discussion 
 
Bioreactors are a powerful tool in several areas of tissue engineering. In cartilage 
tissue engineering, they can provide mechanical stimulus to cells, as well as better 
access of nutrients, enhancing the production of ECM. In the present work, we aimed to 
study the effect of a new multichamber flow perfusion bioreactor in the chondrogenic 
differentiation of hBM-MSCs when seeded onto electrospun PCL nanofiber meshes. 
The present work is one of the first reports that we release concerning the utilization of 
the multichamber bioreactor and the present data is starting point for optimization of the 
culture conditions used, as several new questions were raised from the obtained results. 
It has been demonstrated that the quality of tissue-engineered cartilage can be 
manipulated depending on the type and seeding density of cells and bioreactor culture 
conditions [27]. Several perfusion bioreactors have been developed in recent years, 
aiming to enhance tissue growth in in vitro constructs [27-29], for example for bone 
[30], dermal tissues [31] and cartilage [32]. Dynamic flow conditions are known to 
enhance cartilage development compared to static cultures [32-36]. For detailed review 
please refer to Godara et al., 2008 and Butler et al., 2009 [37, 38]. Fluid flow enhances 
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nutrient and waste exchange in vitro, improving mass transport and delivering shear 
stress within the construct [39]. In perfusion bioreactors, the level of shear stress and of 
nutrient transfer can be easily changed by modifying the medium flow rate, and thus, 
the quality of the tissue engineered construct can be improved, depending on the media 
flow velocity [33]. In the present work, we used a media flow of 70 µl/min/ nanofiber 
mesh. We based our choice of the flow velocity in the literature. However, references 
using nanofiber meshes are scarce, if not inexistent. Reported flow velocity for 3D 
constructs for cartilage tissue engineering range from 0.01 ml/min to 5ml/min [27, 28, 
39, 40]. We decided to choose a low flow velocity as a starting point to allow the 
deposition of the ECM components. As we performed a low density seeding, the chosen 
perfusion velocity would allow, in our perspective, to provide cells the nutrients and 
oxygen needed. We would expect cell proliferation, differentiation and consequent 
enhanced deposition of ECM components along the time. As for cell numbers, the 
amount of cellular DNA varied along the experiment, being observed a high decrease in 
static culture conditions at the 28th day. In this time point, bioreactor samples displayed 
a significantly higher DNA quantification than static (p=0.002). It is the fair to state 
that, in terms of cell proliferation, the chosen fluid flow was beneficial for the constructs 
cultured in the bioreactor, enhancing cell proliferation. The beneficial effect of 
directional fluid flow has been demonstrated by Tarng and co-workers, using periosteal 
explants secured onto PCL scaffolds and cultured in spinner flasks. The authors showed 
that fluid flow enhanced cell proliferation, chondrogenic differentiation and cell 
organization [41]. 
 Morphological observation of cells showed some differences between the two 
conditions. Cells in the bioreactor samples have acquired a round-shaped morphology at 
early stages of culture (i.e. 7th and 14th day), whereas the cells cultured in static 
conditions are stretched and flat until at least the 21st day of culture. These observations 
may be related to the fluid flow in the bioreactor samples. The beneficial effect of the 
perfusion can be observed, as the chondrogenic morphology seems to be highlighted in 
these samples, whereas in the static ones, the morphology change can be observed only 
after 21 days in culture. TGF-β3 is the essential growth factor for promoting 
chondrogenesis both in vivo and in vitro conditions [42]. It has been shown that TGF-β3 
induced hBMSCs having increased Sox9 expression with the presence of collagen type 
II and aggrecan [43]. Although the cartilage obtained in this study showed some signs 
of hypertrophy, induced either by the flow perfusion or by the utilization of TGF-β3, the 
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conjugation of both factors may have contributed for the increased chondrogenesis at 
the early stages of culture, for the bioreactor samples. Chondrogenesis at early stages of 
cultures have been also observed when culturing chitosan-BMP6 loaded scaffolds with 
ATDC5 chondrocytes cell line in RCMW™ reactors [44]. Additionally, cells cultured 
in static cultures showed hypertrophy, contrarily to the observed in the cultures from the 
bioreactor. This is not the case of our results, as the presence of hypertrophy related 
genes was detected in both static and dynamic cultures. Hypertrophy was also observed 
by Jung and co-authors, when they applied continuous compressive deformation for 10 
or 24 days to PLCL scaffolds seeded with chondrocytes. These constructs were then 
implanted subcutaneously in nude mice. The observations showed hypertrophic forms 
in the implants stimulated for 24 days, demonstrating that the proper periodical 
application of dynamic compression can enhance GAGs production [45].  
No statistical differences were found between the expression levels in the bioreactor 
samples and the static control cultures. Cartilage-related genes expression such as 
Aggrecan, Collagen type II and Sox9, was detected for both conditions. Sox9 is highly 
expressed, stimulating the production of these genes. The high values obtained for 
standard deviations may be related to the flow velocity inside the fiber meshes. The 
dissimilar geometry of the scaffolds or of the flow perfusion may lead to different local 
shear stressed in each sample, even for the same input flow velocity [39]. Thus, the 
random morphology of the nanofiber meshes may be influencing the results within the 
same replicates. This fact, along with the common inlet and outlet of the bioreactor, 
could have resulted in non uniform flow velocity, and therefore could have influenced 
the ECM deposition and generate the large standard deviations observed in the 
experiments. 
hBM-MSCs cultured in the bioreactor were able to produce proteoglycans, as showed 
by the toluidine blue and safranin O staining. The presence of proteoglycans was also 
detected in the static samples. However, these sections revealed less amount of staining 
when compared to the bioreactor sections. These staining, together with the results of 
RT-PCR for the expression of Aggrecan, indicate the deposition of ECM. Furthermore, 
collagen type I and type II presence in both types of samples at 28 days was also 
detected by immunolocalisation, which is consistent with the RT-PCR results. A 
different result was obtained by Li et al., 2008, using PLLA nanofibrous scaffolds 
cultured in a rotating wall vessel bioreactor for cartilage tissue engineering. Compared 
to the constructs obtained in static cultures, the bioreactor grown constructs produced 
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more total collagen and GAGs, and expressed higher levels of cartilage related genes 
[46]. 
The flow perfusion bioreactor used in this work provides a continuous flow of media 
through the construct, enhancing the mass transfer and the nutrients availability. 
However, the mechanical forces can have a detrimental effect in terms of damaging the 
neo-tissue formation [40]. In the present work, the bioreactor allowed the proliferation 
and chondrogenic differentiation of hBM-MSCs, but no significant differences were 
observed compared to the static cultures. Similar results were obtained for the 
chondrogenic differentiation of human adipose stem cells when cultured in PGA 
scaffolds using a recirculating bioreactor [40]. The authors showed that the 
chondrogenic differentiation, as well as the ECM formation, was not detrimentally 
affected by the bioreactor culture. The obtained results do not allow us to draw any 
conclusion concerning the enhanced effect of the bioreactor over chondrogenic 
differentiation of hBM-MSCs when seeded onto PCL nanofiber meshes. Some of the 
parameters of the experiment here reported have to be modified, as for example the 
number of initial cell seeding, nanofiber meshes structure or even the fluid flow. We do 
sustain that this bioreactor is suitable for this type of culture, and further optimizations 
will be performed. The concept of nanofiber meshes cultured in bioreactors for cartilage 
tissue engineering has been proved to be applicable to this field, combined with 
efficient cell loading and bioreactor technology [46]. 
 
 
5. Conclusions 
 
In the overall, we would like to highlight that the new flow perfusion bioreactor is 
suitable for culturing hBM-MSCs and electropun PCL nanofiber meshes. The culture in 
a flow perfusion bioreactor supported the attachment, proliferation and chondrogenic 
differentiation of hBM-MSCs. The MSCs were able to produce ECM on the electrospun 
PCL nanofiber meshes, as stated by the staining and imunolocalisation results. The 
media fluid flow may be influencing these results, as well as the nanofiber meshes 
random morphology. Therefore, some modifications in the experimental design should 
be considered in future works. The fluid flow should be extensively studied, as there are 
scarce literature references using nanofiber meshes in perfusion bioreactors. In doing 
this, we will try to improve the ECM deposition. Additionally, as one of the factors that 
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may also be influencing the results is the random morphology of the nanofiber meshes, 
different production techniques may be studied in order to obtain fully controlled 
morphologies. 
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Abstract 
 
Native articular cartilage is subjected to synovial fluid flow during normal joint 
function. Thus, it is believed that the morphogenesis of articular cartilage may be 
positively regulated by the application of similar stimulation in vitro. 
In the present work, the effect of fluid flow over the chondrogenic differentiation of 
human bone marrow derived mesenchymal stem cells (hBM-MSCs) was studied. We 
intended to find out if the shear stress caused by the medium perfusion trough the 
constructs was capable of augmenting the differentiation process. Human BMSCs were 
isolated from bone marrow aspirates and were characterized by flow cytometry. After 
expansion, hBM-MSCs were seeded statically onto fiber meshes scaffolds, consisting of 
a blend of 50/50 chitosan and Poly(Butylene Terephtalate Adipate) – CPBTA. 
Constructs were cultured in a flow perfusion bioreactor for 28 days, using complete 
medium for chondrogenesis supplemented with TGF-β3. An enhanced ECM deposition 
and collagen type II production was observed in the bioreactor samples, when compared 
to the static controls. Moreover, it was observed that hBM-MSCs, in static cultures, take 
longer to differentiate. ECM accumulation in these samples is lower than in the 
bioreactor sections, and there is a significant difference in the expression of collagen 
type I. We found that the flow induced shear stress has a beneficial effect on the 
chondrogenic differentiation of hMSCs. 
 
 
1. Introduction 
 
Mesenchymal Stem Cells (MSCs) have been recognized for their ability to 
differentiate into cells of different tissues such as bone, cartilage or adipose tissue, and 
therefore might be of interest for therapeutic strategies. These cells may be induced to 
differentiate in vitro by growth factors supplementation in the culture medium to trigger 
the differentiation into the desired cell type. Particularly, several studies showed that 
MSCs derived from different tissues behave in different ways when induced to 
differentiate in the chondrogenic lineage [1-3]. The chondrogenic potential of adipose 
tissue-derived MSCs over bone marrow-derived MSCs has been compared in various 
works, using different animals. These studies seem to indicate a higher chondrogenic 
Chondrogenic differentiation using a flow perfusion bioreactor 
165 
potential of bone marrow-derived MSCs over adipose tissue-derived MSCS [1-3], 
isolated from different animals. 
Materials and fabrication technologies are critically important in designing temporary, 
artificial extracellular matrices (scaffolds) for tissue engineering. There is still a quest 
for the ideal scaffold for cartilage regeneration, either using synthetic or natural origin 
materials. In recent years, natural based polymers have been extensively studied, 
including hyaluronic acid, collagen or chitosan [4-8]. Chitosan is a derivative of chitin, 
obtained by the deacetylation of this biopolymer [9]. It is a linear polysaccharide with a 
structure similar to the glycosaminoglycans (GAGs) present in the extracellular matrix 
(ECM) of native cartilage [10]. This property is extremely important for cartilage tissue 
engineering, since it allows the development of several types of scaffolds. Another 
interesting property of chitosan is that it can be moulded into various shapes [11] and 
allows different pore sizes structures formation [9]. Chitosan has been used in several 
blends for matrices or scaffolds production, such as hydrogels [12, 13], porous scaffolds 
[8], amino acid immobilization in scaffolds [6] or drug delivery system [14]. In recent 
years, chitosan-based scaffolds were found to be a remarkable tool for tissue 
engineering of various tissues [4, 15-18]. Chitosan has also proved to be suitable for 
improving the in vivo performances of natural-based scaffolds, in particular of soy-
based biomaterials [19]. Chitosan scaffolds have been developed in blends with 
synthetic materials for cartilage tissue engineering, for example chitosan/polybutylene 
succinate (PBS) [20] or chitosan/polycaprolactone [21]. Particularly, the chitosan/ PBS 
blend has proved to be suitable for cartilage tissue engineering, either using cell lines or 
primary cells [20, 22, 23]. Chitosan is frequently referred as a positive influence in 
promoting ECM formation by cells. In a study comparing chitosan and PGA scaffolds, 
it was found that matrix production by chondrocytes was improved in chitosan 
constructs, mainly on the ones with smaller fibers [24]. The beneficial effect of 
microfibers structure in chitosan scaffolds was demonstrated more recently by the same 
authors. They compared the effect of chitosan scaffolds structure (macroporous sponges 
and microfibers) in the chondrogenesis of MSCs, and concluded that it is superior in the 
microfibers [24], indicating the effect of the morphology in cell activity. 
Chondrocytes are responsible for the maintenance and turnover of cartilage ECM, by 
producing collagen type II and aggrecan. The combination of these two proteins 
provides the tensile, shear and compressive stiffness of cartilage. It is very difficult to 
determine a detailed causal relationship between the type of mechanical stimulation 
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used in the cell culture and the resulting ECM structure and mechanical properties of the 
tissue. It was reported, however, that detailed stress limits exist in the application of 
mechanical stimuli, leading to pathological changes in cartilage explants or tissue 
engineering constructs [25]. Flow-induced shear stress has been found to produce a 
significant stimulatory effect [26]. Dynamic shear increases the transcription of matrix 
proteins and, at the same time, augments matrix biosynthesis, preferentially collagen 
synthesis [27, 28].  
At early stages of skeletogenesis, mesenchymal condensation occurs, which is a key 
event to determine cell shape and cell fate. This will be determined by the balance of 
forces in the cell during condensation. The role of shape-changing deviatory shear 
stresses and developmental context in the modulation of gene transcription prior to cell 
commitment was recently studied [29]. It was found that the magnitude and duration of 
multipotent embryonic stem cells to shear stress affects significantly the genes activity 
of key genes to musculoskeletal development, at mesenchymal condensation [29]. 
Therefore, mechanical stimuli must be studied as one of the key elements for a tissue 
engineering strategy, in the sense that it can affect the structure and quality of the neo-
formed tissue.  
In the present work, our aim was to determine the outcome of an in-house developed 
flow perfusion bioreactor (PT patent nº 104155; European patent pending [30]) in the 
chondrogenic differentiation of hBM-MSCs. We intended to find out if the shear stress 
caused by the medium perfusion through the constructs was capable of augmenting the 
differentiation process. 
 
 
2. Materials and Methods 
 
2.1. CPBTA fiber meshes  
 
The chitosan-poly(butylene terephthalate adipate) (CPBTA) (50/50 wt%) fiber mesh 
scaffolds were compounded as described elsewhere [31]. Briefly, the CPBTA fibers 
were obtained using a prototype single screw micro-extruder coupled to a capillary die. 
The extruded fibers were chopped and then were loaded into a mould. The mould was 
heated above the melting temperature (Tm) of the thermoplastic blend during 10 min. 
Finally, immediately after removing the moulds from the oven, the fibers are slightly 
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compressed by a Teflon cylinder to pack and bond the fibers. Finally, standardized 
scaffolds of 2 mm thick discs, with diameter of 8 mm were obtained by cutting the fiber 
bonded meshes with a circular die (8 mm in diameter). 
 
2.2. Isolation of hBM-MSCs 
 
HBM-MSCs were isolated from bone marrow aspirates collected under informed 
consent from patients undergoing knee arthroplasties in the Hospital de São Marcos, in 
Braga, Portugal. During the surgeries, bone marrow is collected to a container with α-
MEM medium (Invitrogen, 12000-063), supplemented with an antibiotic/antimycotic 
solution (Gibco, 15240062) and 5000 units of heparin (Sigma, H3393) and maintained 
in ice until the isolation procedure. Aspirates were homogenised, diluted in PBS 
(Sigma, P4417) (1:1) and incubated for 5 minutes at room temperature. Then, bone 
marrow was diluted in lyses buffer (1:10) and left under agitation for 10 minutes. Lyses 
buffer was prepared with 10 mM of Tris-HCl (Sigma, T3253), 1.21 g of Tris Base 
(Sigma, T1503), 8.3 g of NH4Cl (Merck, 1011455000), in 1L of distilled water.  
Afterwards, cells suspension was centrifuged at 1200 rpm, for 15 minutes at room 
temperature. Cells were ressuspended in α-MEM medium, supplemented with 
antibiotic/antimycotic solution and 20% of foetal bovine serum - FBS (Biochrom, 
Berlin, Germany; Heat Inactivated). Cell suspension was filtered for disposal of debris, 
using 100 µm and 70 µm Cell Strainer (BD Falcon™, 352360 and BD Falcon™, 
352350). Cells were counted and plated at the density of 4.7x103 cells/cm2. Cells were 
expanded in the referred culture medium until the numbers needed for this study. 
 
2.3. Flow-cytometry (FCM) analysis 
 
To evaluate cell-surface marker expression, cultured cells were incubated for 20 min 
at 4ºC with fluorescein isothiocyanate (FITC)- or phycoerythrin (PE)-conjugated 
monoclonal antibodies specific for human markers associated with mesenchymal or 
haematopoietic lineages. The antibodies used were: CD29, CD34, CD44, CD45, CD73, 
CD90, CD105, CD106. All the antibodies were purchased from BD Pharmingen. The 
samples were analysed using a BD FACSCalibur flow cytometer (Enzifarma, Portugal). 
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2.4. hBM-MSCs culture on the bidirectional flow perfusion bioreactor 
 
hBM-MSCs were detached from the culture flasks by treatment with Trypsin/EDTA 
solution (Invitrogen, 25300-062). Cells were counted and a cell suspension of 1x106 
cells/ fiber mesh was prepared to seed each scaffold. Cell seeding was performed in 
static conditions, inside the incubator, at 37ºC, during 24 hours. On the next day, the 
bidirectional flow perfusion bioreactor was fully sterilized in the autoclave. Then, it was 
assembled inside the hood and the constructs to be cultured within were transferred. The 
bidirectional flow perfusion bioreactor (PT patent nº 104155; European patent pending 
[30]) has a maximum of 20 individual culture chambers; according to the study plan, 20 
constructs were transferred for each chamber. The bioreactor was closed and the flow 
rate was set to 100 µl/min/fiber mesh. The bioreactor was transferred into an incubator 
and kept in those conditions during the whole experiment.  
Similar numbers of species was transferred for new 24 wells culture plates and were 
maintained in static conditions as a control, inside the same incubator. Chondrogenic 
differentiation medium consisting of α-MEM supplemented with antibiotic/antimycotic 
solution, ITS liquid media supplement (Sigma, I2521), dexamethasone 1Mm (Sigma, 
D1756), Sodium Pyruvate 0.1 M (Sigma, P4562), Ascorbic acid-2-phosphate 17 mM 
(Sigma, A4544),  L-Proline 35 mM (Sigma, P5607) and 1 ng/ml of human recombinant 
TGF-β3 (PeproTech, 100-36) was used for the 28 days duration of the experiment. 
Culture medium in the bioreactor was completely changed every week (100 mL each 
time). Control samples were cultured in 24 well plates, and were fed every other day 
with 1 mL of culture medium. 
 
2.5. Proliferation assay (DNA quantification) 
 
Evaluation of cell proliferation was performed using the PicoGreen dsDNA 
quantification Kit (Molecular Probes, P-7589), according to the instructions. Samples 
from the flow perfusion bioreactor and from the static control were collected in every 
time point. Triplicates of every time point were produced. A standard curve was 
established. Fluorescence of both samples and standard curve was read with an 
excitation of 485/20 nm and an emission of 528/20 nm. DNA concentration was 
extrapolated from the standard curve. 
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2.6. Scanning Electron Microscopy (SEM) 
 
For SEM analysis, fiber meshes were collected at each time point: 1, 2, 3 and 4 weeks. 
They were washed in sterile PBS and immersed in 3% glutaraldehyde (Sigma, G-5882) 
at room temperature for one hour. Samples were washed in PBS, dehydrated in 
increasing alcohol concentrations and let to dry. Samples were sputter coated with gold 
and analysed. A scanning electron microscope (Cambridge S360, Leica Cambridge, 
Cambridge, UK) was used to observe cells distribution and morphologies. 
 
2.7. RNA isolation 
 
Samples were collected from the flow perfusion bioreactor and from the static control, 
by the end of the experiment. Samples were washed in PBS, immersed in TRIzol 
reagent (Invitrogen, 15596-018) and kept at -80ºC for posterior RNA extraction. When 
the extraction was performed, samples were taken from the freezer and thawed. 
Chloroform (Sigma, C2432) was added and samples were vigorously agitated for 15 
seconds and further incubated in ice for 15 minutes. After that incubation, samples were 
centrifuged at 13000 rpm, during 15 minutes, at 4ºC. Afterwards, the supernatant was 
collected into a sterile 1.5 mL tube, and an equivalent volume of isopropanol (Sigma, 
I9516) was added. Samples were incubated at -20ºC overnight, to precipitate the RNA. 
The next day, samples were centrifuged at 13000 rpm, during 15 minutes, at 4ºC. The 
supernatant was taken and 800 μl of ethanol 70% was added, to wash away the 
isopropanol. The ethanol 70% solution was prepared from absolute ethanol (Merck, 
1.00983.2511) and ultra pure water. Tubes were agitated vigorously and centrifuged 
again, at 9000 rpm during 5 minutes, at 4ºC. The supernatant was again removed, and 
the pellet was left to air dry. Finally, the pellet was ressuspended in 50 μl of distilled 
water DNase, RNase free (Gibco, 10977-015). The concentration and purity of the 
extracted RNA was evaluated using the NanoDrop ND-1000 Spectrophotometer 
(NanoDrop Technologies Inc, USA). 
 
2.8. Real-Time PCR 
 
The Real-Time PCR procedure used in the present work consisted of a two step 
fluorogenic assay using the SyberGreen system (Bio-Rad). All the reagents used in this 
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procedure were from Bio-Rad, following the instructions of the manufacturer. 
Thermocycler reaction conditions were also performed according with those referred in 
the kits. In the first step, RNA was reversed transcribed into cDNA, using the iScript 
cDNA synthesis kit (1708891). A BioRad CFX96 real-time PCR detection system 
(BioRad Laboratories, USA) was used to perform the reaction. Afterwards, the cDNA 
obtained was used as template for the amplification of the target genes (Table 6.1), with 
the Syber Green Kit (1708884). GAPDH was used as the house-keeping gene, and the 
expression of all the target genes was normalized to the GAPDH of that sample. All the 
primer sequences were generated using Primer3 software (http://frodo.wi.mit.edu/) and 
acquired from MWG Biotech AG, Germany. Table I shows the primers sequences used 
in the analysis. The obtained results were analyzed with CFX Manager Software – 
version 1.5 (BioRad Laboratories, USA). 
 
Table 6.1 – Primer sequences used for RT-PCR procedures *. 
Gene Forward (5´-3´) Reverse (5´-3´) 
AGC TGAGTCCTCAAGCCTCCTGT TGGTCTGCAGCAGTTGATTC 
COL II CGGTGAGAAGGGAGAAGTTG GACCGGTCACTCCAGTAGGA
COL I AGCCAGCAGATCGAGAACAT ACACAGGTCTCACCGGTTTC 
COL X CCAGGTCTCGATGGTCCTAA GTCCTCCAACTCCAGGATCA 
Runx2 TTCCAGACCAGCAGCACTC CAGCGTCAACACCATCATTC 
Sox9 TTCATGAAGATGACCGACGC GTCCAGTCGTAGCCCTTGAG 
GAPDH ACAGTCAGCCGCATCTTCTT ACGACCAAATCCGTTGACTC 
*AGC = Agreccan; COL II = Collagen type II; COL I = Collagen type I; COL X = Collagen type X; 
Runx2 = Runt-related transcription factor 2; Sox9 = Sry-type high mobility group box 9; GAPDH = 
Glyceraldehyde 3-phosphate dehydrogenase 
 
2.9. Histological analysis 
 
Samples were collected at the end of the experiment and processed for histology. 
Samples were fixed in 10% neutral buffered formalin and then dehydrated through 
increasing concentrations of ethanol, immersed in infiltration solutions, embedded in 
Technovit glycol methacrylate (kit 8100, Heraeus Kulzer, EBSciences, CO, USA) and 
then polymerized. Specimens were cut to obtain longitudinal 7 µm thick sections, using 
a modified microtome equipped with a tungsten blade (Leica RM 2155). Hematoxylin-
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eosin staining was performed to evaluate the cells distribution within the scaffolds. 
Toluidine blue stain was also performed to detect the presence of proteoglycans. 
Staining solution was prepared by adding 1% of toluidine blue (Sigma, T-0394) 
dissolved in distilled water containing 0.5g of sodium borate, followed by filtering. One 
drop of this solution was added to each section during 1 minute. The sections were 
further rinsed with distilled water and let to air dry overnight. Sections were cleared in 
xylene substitute (Sigma, A5597) and mounted in Histo clear (Frilabo, HS200). 
Safranin O staining was performed by washing slides in tap water, then immersed in 
0.02% fast green (Fluka, 44715) during 6 minutes. Then, they were immersed in 1% 
acetic acid (Panreac, 131008) solution during 1 minute. After, slides were immersed in 
0.1% safranin O (Fluka, 84120) solution for 10 minutes. By the end, slides were washed 
in tap water and let to air dry. Sections were cleared in xylene and mounted as 
previously described for further analysis. 
 
2.10. Immunolocalisation of type I and type II collagens 
 
Immunolocalisation of type I and type II collagens was performed. Endogenous 
peroxidase activity was quenched with 0.3% hydrogen peroxide solution during 30 
minutes. Sections were rinsed in PBS during 5 minutes. R.T.U. Vectastain® Universal 
Elite ABC Kit (Vector, VCPK-7200) was used for antibody incubation, according to the 
instructions of the manufacturer. Shortly, sections were incubated with primary 
antibodies (collagen type I and collagen type II) (UNLB, Goat anti-type I collagen 
1310-01 and UNLB, Goat anti-type II collagen 1320-01) overnight at 4ºC, in a 
humidified atmosphere. Incubation was revealed by using the Peroxidase Substrate Kit 
DAB (Vector, VCSK-4100), according to the instructions of the manufacturer. Slides 
were washed in water during 5 minutes and counterstained with hematoxilin for nuclei 
visualization. Finally, slides were mounted in Histo clear. Controls were performed 
using normal goat serum instead of primary antibodies, which was also included in the 
kit. 
 
2.11. Statistical analysis 
 
Statistical analysis was performed using the SPSS statistic software (Release 15.0.0 
for Windows). Firstly, a Shapiro-Wilk test was used to ascertain about the data 
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normality and variance equality. The result of the normality was negative and, 
consequently, nonparametric tests were used in further comparisons between static and 
dynamic culture conditions. A Mann-Whitney U-test was applied to compare the two 
independent groups of samples for each variable (i.e. DNA quantification and real-time 
PCR). P values lower than 0.01 were considered statistically significant in the analysis 
of the results. 
 
 
3. Results 
 
3.1. FCM analysis of the isolated cells 
 
Isolated bone marrow cells were expanded and characterized for specific surface 
antigen expression by flow cytometry analysis. hBM-MSCs were analysed for 
hemopoietic marker expression (CD34 and CD45): isolated cells were negative for 
these two markers. Cells were positive for CD29, CD44, CD73, CD90, CD105 and 
CD106 surface markers typically detected in mesenchymal stem cells. Based on this 
data we are confident that the bone marrow isolated cells are effectively MSCs. 
 
3.2. DNA quantification 
 
Samples were collected in different time points of the experiment from both culture 
conditions, and processed for DNA quantification. Results are shown in Figure 6.1. 
Concerning the bioreactor samples, DNA contents increased at 21 days of culture, 
decreasing in the last time point. In static culture conditions, DNA content increased 
continuously during the whole period of the experiment. In order to find significant 
differences in DNA quantification among static and bioreactor conditions, the Mann–
Whitney U-test was performed. In terms of DNA quantification, no significant 
difference between static and bioreactor cultures was found at 14 days (p=0.18), but 
static cultures displayed a significantly higher DNA quantification than the bioreactor 
ones at 21 and 28 days of culture (p=0.002). 
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Figure 6.1 - Box plot of the DNA quantification in static and bioreactor cultures after 
14, 21 and 28 days of culture. Data were analyzed by nonparametric way of a Mann–
Whitney U-test (* p<0.01, vs Static). 
 
3.3. SEM analysis 
 
SEM analysis of the cultured hBM-MSC in CPBTA fiber meshes show differences in 
their morphology during the time course of the experiment (Figure 6.2). Micrographs of 
the bioreactor samples show that cells were located at the center of the scaffold, and that 
they proliferated. Cells show a round-shaped morphology at early stages of culture (e.g. 
Figures 6.2A and 6.2C), which remains unchanged until the end of the experiment. On 
the other hand, cells in static culture samples maintained their stretched morphology 
until the 21st day of experiment (Figures 6.2B, 6.2D and 6.2F). At 21 days, cells begin 
to acquire a round-shaped morphology (Figures 6.2F and 6.2H), but not as evident as in 
the bioreactor samples (Figures 6.2A, 6.2C, 6.2E, 6.2G).  By the observation of the 
micrographs, it seems that cells cultured under static conditions proliferated more than 
the ones cultured in the bioreactor. 
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Figure 6.2 – Morphology of hBM-MSCs cultured in CPBTA fiber meshes, in the 
flow perfusion bioreactor (A, C, E, G) and in static control conditions (B, D, F, H) 
during the time course of the experiment: A, B-7 days; C, D-14 days; E, F- 21 days; G, 
H- 28 days. Different magnifications were used to highlight for cell distribution within 
the scaffolds and the cells morphology. 
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3.4. Real-Time PCR 
 
Gene expression during the experiment was assessed by Real - Time PCR. Results 
were normalized against the reference gene expression, GAPDH (Figure 6.3). 
Expression of cartilage related genes was detected in the bioreactor and also in static 
culture conditions samples. The gene expression patterns were considerably different in 
both conditions. In the bioreactor samples, cartilage related genes were expressed, 
indicating the hBM-MSCs were differentiating into chondrocytes. Aggrecan expression 
is maintained along the experiment, as well as Sox9 expression. Collagen type II 
expression increases at 28 days. Collagen type I is expressed in low levels, and shows a 
decreasing trend of expression until the last time point. Hypertrophy related genes – 
Collagen type X and Runx2 – have low expression and also decrease with time. These 
results point towards chondrogenic differentiation of the cells and the production of 
proteins present in the ECM of cartilage, as expected. 
A different pattern of expression was observed in static control conditions. Although 
Aggrecan expression is slightly higher than in bioreactor samples, cartilage related 
genes showed a lower expression for all time points. On the other hand, Collagen type I 
had a large increase from the 21st to the 28th day of experiment. Moreover, hypertrophy 
related genes showed an increase along the time, as well as a higher expression than the 
one found for bioreactor samples. In Aggrecan expression no significant differences 
between both conditions was found at 14 (p=0.548), 21 (p=0.905) or 28 days (p=0.038) 
of experiment. The same was observed for Collagen type II expression at 14 (p=0.038), 
21 (p=0.114) or 28th days (p=1). Collagen type I expression showed no significant 
difference at 14 (p=0.114) and 21 days (p=0.139). However, at 28 days, static control 
conditions displayed a significantly higher expression of Collagen type I than the 
bioreactor samples (p<0.01). Sox9 did not show significant differences, either at 14 
(p=0.277), 21 (p=0.190) or 28 days (p=0.222). The same was found for Collagen type X 
at 14 (p=0.100), 21 (p=0.200) or 28 days (p=0.100), and Runx2 at 14 (p=0.100), 21 
(p=0.100) or 28 days (p=0.100).  
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Figure 6.3 – Bar plots of chondrogenic markers of flow perfusion bioreactor samples 
and static control conditions normalized for the reference gene, GAPDH, after 14, 21 
and 28 days of culture. Data were analyzed with a Mann–Whitney U test. In the bar plot 
for Collagen type I, data were analyzed with a Mann–Whitney U test (* p<0.01, vs 
static culture conditions). 
 
3.5. Histological staining 
 
Samples of CPBTA fiber meshes seeded with hBMSCs from both studied culture 
conditions were collected at the end of the experiment. Histological longitudinal 
sections were stained for cell localisation with hematoxylin-eosin. Toluidine blue and 
safranin O stain were used for detection of ECM proteoglycans (Figure 6.4). Cells from 
the bioreactor sections are more round-shaped (Figure 6.4A) when compared to the 
static cultures sections, that are stretched (Figure 6.4B). ECM production was detected 
in the bioreactor samples, either in the toluidine blue sections (Figure 6.4C) or in the 
safranin O sections (Figure 6.4E). The observation of the static culture sections revealed 
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that cells were able to produce ECM (Figures 6.4D and 6.4F), but in a smaller amount 
than in the bioreactor. 
 
 
 
Figure 6.4 - Histological section of hBMSCs seeded onto CPBTA fiber meshes for 
chondrogenic differentiation, at 28 days of culture, in the flow perfusion bioreactor (A, 
C, E) and in the static control cultures (B, D, F). A, B – Hematoxylin-eosin stain for cell 
localisation; C, D – Safranin O stain for ECM localisation; E, F – Toluidine blue stain 
for proteoglycans. 
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3.6. Immunolocalisation of type I and type II collagens 
 
Histological sections of CPBTA fiber meshes seeded with hBMSCs and of the static 
cultures were stained for imunolocalisation of collagens type I and II (Figure 6.5). In 
both culture conditions there was some level of unspecific staining, as showed in the 
control slides (Figures 6.5A and 6.5B). Collagen type I staining was not so clear in the 
bioreactor sections than in the static culture ones, as shown in Figures 6.5C and 6.5D, 
respectively. The contrary was observed for collagen type II: there is a darker staining 
in the bioreactor sections than in the static culture ones (Figures 6.5E and 6.5F). 
 
 
 
Figure 6.5 – Immunolocalisation of collagen type I (C, D) and type II (E, F) in 
CPBTA fiber meshes, after 28 days of culture in the bioreactor (A, C, E) and in static 
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cultures (B, D, F). Controls of the immunolocalisation assay (A, B) were performed 
with normal horse serum. Red arrows show areas with positive stain and cells nuclei. 
Blue arrows show CPBTA fiber meshes. 
 
 
4. Discussion 
 
Perfusion and shear stress can affect in a positive way the chondrogenic 
differentiation and ECM deposition [25, 27, 28, 32]. In the present work, our aim was to 
determine the outcome of a flow perfusion bioreactor strategy in the chondrogenic 
differentiation of hBM-MSCs. We intended to find out if the shear stress caused by the 
medium perfusion trough the constructs was capable of improving the differentiation 
process. 
DNA quantification revealed a decrease of this nucleic acid in the bioreactor samples 
from the 21st day of culture. On the other hand, static cultures DNA increased along the 
time, indicating that cells are driven for proliferation rather than towards differentiation. 
No significant differences were found between both culture conditions at 14 days of 
experiment. However, static cultures displayed a significantly higher DNA 
quantification than the bioreactor, at 21 and 28 days. SEM observations are consistent 
with the DNA results. In the bioreactor samples, hBM-MSCs show evidence of early 
differentiation, as they present a round-shaped morphology in all time points. On the 
contrary, for static samples, SEM observations show that the morphology of the cells is 
fibroblastic, until the 21st day of experiment, evidencing low differentiation rate and 
high proliferation. These observations can also be sustained by the DNA concentration, 
which is higher in static cultures than in the bioreactor, for all time points. 
Expression analysis of several cartilage related genes indicates a significant difference 
between the Collagen type I expression in the static cultures when compared to the 
bioreactor. This significant difference suggests the formation of fibrotic cartilage. 
Imunolocalisation results are consistent with this observation, as there is positive 
staining for collagen type I in the static culture samples, whereas there is a very weak 
staining in the bioreactor sections. Moreover, collagen type II was stained positive for 
both cultures and the expression of Collagen type II was detected. Histological stain 
results indicated the production of ECM in both bioreactor and static cultures. However, 
the stain is stronger in the bioreactor sections. Proteoglycans accumulation and the 
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expression of cartilage-related genes (AGC, Col II, Sox9) show that cells cultured in the 
bioreactor were able to differentiate into cartilagineous tissue. The cartilage-like tissue 
formed in the static cultures is more fibrotic, as there is an increased collagen type I 
production. ECM detection by histological methods revealed regions of deposit matrix, 
leading to the conclusion that, when hBM-MSCs are cultured statically, their 
chondrogenic differentiation ability decreases. There is a weaker tissue staining than the 
one formed when cells are cultured under flow perfusion. A similar result was found 
when bovine articular chondrocytes were seeded onto chitosan/PBS scaffolds and 
cultured under stirred conditions; ECM deposition was enhanced in scaffolds subjected 
to stirring, compared to static cultures [20].  This result suggests that not only the ECM 
components are produced in larger amounts in shear conditions, but also the GAGs are 
produced in a greater extent. Another work using ovine chondrocytes cultures on PGA 
scaffolds demonstrated the beneficial effect of perfusion on GAGs synthesis [33].  
ECM stain is in agreement with the expression of Aggrecan and Sox9. At 28 days of 
culture, an expression decrease of both Aggrecan and Sox9 in the bioreactor samples 
may suggest that cells are undergoing hypertrophy, since at the same time there is 
expression of Collagen type X and Runx2. The same behaviour was not observed for the 
static cultures. Mechanical stress is known to be necessary to produce and maintain 
healthy and fully functional articular cartilage. Some regulatory systems are believed to 
exist in the tissue, which influence GAGs and collagens metabolism [25, 27, 28, 32]. 
The size, concentration or linkage form of the tissues can be influenced by the 
mechanical culture conditions, being all these factors pivotal for the tissues functional 
behaviour. Therefore, it is difficult to state rules for the biochemistry of proteoglycans. 
In any case, it has been shown that GAGs content can be influenced by shear stress, 
whereas in its absence the GAGs concentration decreases [25, 32, 34]. Fitzgerald and 
colleagues (2006) showed that compressive and shear stress differently regulates 
chondrocyte transcription. Furthermore, they found that dynamic shear, in the absence 
of hydrostatic pressure gradients, induced matrix proteins transcription [27]. These 
findings are consistent with other works that also found that dynamic shear increased 
the transcription of matrix proteins to a greater extent than dynamic compression, and at 
the same time augmented matrix biosynthesis, preferentially collagen synthesis [28]. 
Our results are consistent with these observations. We found enhanced ECM deposition 
and collagen type II production in the bioreactor samples. Furthermore, it is possible to 
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observe that hBM-MSCs, in static cultures, take longer to differentiate, and that ECM 
accumulation in the sections is lower than in the bioreactor sections. 
 
 
5. Conclusions 
 
Herein our aim was to determine if the perfusion shear stress produced by a home-
made flow perfusion bioreactor was able to enhance the chondrogenic differentiation of 
hBM-MSCs. Our observations showed improved ECM deposition and collagen type II 
production in the bioreactor samples, when compared to the static controls. Moreover, it 
was observed that hBM-MSCs chondrogenic differentiation in static cultures begins at 
later time points than in the bioreactor samples. ECM accumulation is likewise lower 
than in the bioreactor sections, and there is a significant difference in the expression of 
collagen type I. In the present work, we found evidences that confirm our hypothesis 
that shear stress has a beneficial effect on the chondrogenic differentiation of hBM-
MSCs. 
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Abstract 
 
Chondrocytes are mainly responsible for maintaining the integrity of the extracellular 
matrix of articular cartilage and for the protection of the underlying subchondral bone. 
Mesenchymal Stem Cells (MSCs) are also believed to contribute to the maintenance of 
cartilage. Moreover, these cells have been recognized for their ability to differentiate 
into cells of different tissues such as bone, cartilage or adipose tissue, and therefore 
might be of great interest for developing cartilage therapeutic strategies. These cells are 
typically induced to differentiate by growth factors supplementation in the culture 
medium that will trigger differentiation into the desired cell phenotype.  
One frequent problem that occurs in cartilage tissue engineering is that expanded 
chondrocytes undergo dedifferentiation when in 2D culture. This process leads 
frequently to the undesired production of fibrocartilage, and is associated with the loss 
of their phenotype in vitro. The use of an additional cell source to enhance cell numbers, 
not loosing the differentiation potential upon expansion in vitro may be an original 
choice. Moreover, soluble factors released by chondrocytes have been shown to 
influence stem cells differentiation onto the chondrogenic lineage. The use of 
conditioned medium obtained from chondrocytes for stimulating stem cells 
chondrogenic differentiation may be a very interesting alternative for moving into the 
clinical application of these cells.  
In the present work, direct contact co-cultures and indirect co-cultures (using 
conditioned medium obtained from a culture of human articular chondrocytes) of 
human bone marrow-derived MSCs (hBMSCs) and human Wharton´s jelly MSCs 
(hWJSCs) were established. Cells were isolated from human samples collected at a 
local hospital, under donors’ informed consent. The co-cultures were performed in 
previously produced 3D scaffolds, composed by a blend of 50/50 chitosan and poly 
(butylene succinate) – CPBS. Co-cultures were maintained during 28 days. Both types 
of stem cells were able to undergo chondrogenic differentiation, either in direct or 
indirect co-cultures. By the end of the experiment, the indirect co-cultures (using 
conditioned medium) showed significantly higher values in terms of DNA content, 
glycosaminoglycans (GAGs) accumulation and specific cartilage-related genes 
expression, when compared to direct co-cultures, for both types of adult MSCs tested. 
Human BMSCs resulted in fibrous cartilage, as it can be concluded by the significantly 
higher expression of Collagen type I. The hWJSCs showed higher chondrogenic 
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differentiation ability when compared to hBMSCs, as denoted by the higher values for 
GAGs accumulation and cartilage related genes expression.  
Therefore, we were able to demonstrate the high chondrogenic potential of hWJSCs, 
and proved that co-cultures of articular chondrocytes with these cells are able to 
produce more cartilaginous ECM, when compared to co-cultures with hBMSCs. The 
use of conditioned medium obtained from articular chondrocytes induced MSCs 
chondrogenic differentiation and ECM formation. The obtained results showed that this 
new strategy is very interesting and should be further explored for clinical applications. 
 
 
1. Introduction 
 
Research concerning cartilage regeneration is of special importance, since this tissue 
lacks self-repairing capacity and causes a huge social and economic impact. Several cell 
types have been proposed for cartilage tissue engineering, as for example the direct use 
of autologous chondrocytes. However, this method is not very convenient, since it 
involves a biopsy used as cell source for primary chondrocytes that is always limited in 
size and consequently in cell numbers obtained [1]. Also, chondrocytes tend to 
dedifferentiate when expanded in 2D culture, in vitro [1]. The use of stem cells can be 
very useful to overcome these issues, as they can be expanded into clinically relevant 
numbers and further differentiate into the chondrogenic lineage. Applying a 3D milieu 
is pivotal when designing a cartilage TE strategy, because chondrocytes 
dedifferentiation is reversible, and when these cells are further cultured in a 3D 
environment, they may regain their phenotype [2-5]. 
The most widespread tissue source of adult mesenchymal stem cells (MSCs) is the 
bone marrow [6, 7]. Bone marrow MSCs (BMSCs) have been proposed and applied for 
various tissue engineering applications, including for cartilage repair [6, 8-11]. Yet, the 
number of available MSCs in bone marrow [12], and the possibility of donor site 
morbidity in the procedure to obtain bone marrow aspirates, leads to the need to identify 
other MSCs sources. Human umbilical cord Wharton´s jelly has been reported as a 
potential alternative tissue source [13, 14], since human umbilical cord MSCs share 
many properties with bone marrow mesenchymal stem cells, thus supporting their 
applicability for cell-based therapies [15]. Human WJSCs (hWJSCs) have a higher 
frequency of colony forming units (CFUs-F) than hBMSCs, thus a larger number of 
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MSCs may be obtained in the initial isolation from Wharton´s jelly [13]. Further details 
on Wharton´s jelly cells as a primitive stromal cell population can be found elsewhere 
[16, 17]. Human WJSCs have also shown a higher proliferative potential than hBMSCs 
[15], being able to undergo osteogenic, chondrogenic and adipogenic differentiation 
[14]. Thus, those cells are prospective candidates for cartilage tissue engineering, as 
they display a distinct chondrogenic potential. Moreover, the improved chondrogenic 
potential of cells derived from the umbilical cord was confirmed in a study comparing 
the differentiation potential of human BMSCs and human umbilical cord stem cells 
(UCSCs) in 2D cultures [18]. 
Several strategies have been proposed to direct chondrogenesis of stem cells, which 
can be applied either alone or in conjunction. The referred two strategies comprise the 
use of specific growth factors, employing 3D structures to act as supports for cell 
growth and differentiation, or to co-culture progenitor cells with conditioned medium 
obtained from cartilage explants [19]. Cartilage is a paracrine organ, which secretes 
humoral factors that influence the proliferation and differentiation of cells present in the 
surrounding tissues [20]. Chondrogenesis and osteogenesis of MSCs during in vitro 
micromass culture was affected by the use of conditioned medium obtained from 
cultures of chondrocytes [21]. It was observed that  chondrocytes secrete factors that 
may affect the differentiation status of stem cells, and can promote chondrogenesis and 
osteogenesis  [21]. In indirect co-cultures with chondrocytes and embryonic stem cells 
the interaction of paracrine factors secreted by chondrocytes with the referred cells was 
observed [22]. This interaction led to the enhancement of the embryonic stem cells 
chondrogenic commitment [22]. 
The use of a porous biodegradable scaffold to support cell growth is frequently 
proposed for tissue engineering approaches [23-26]. Chondrocytes tend to switch into a 
fibroblast-like phenotype when cultured in monolayer, in tissue culture flasks. The 
presence of a porous structure providing a 3D environment for their culture is pivotal 
for the phenotype development and stability in vitro [27]. In the case of adult stem cells, 
the influence of 3D porous structures is relevant when considering its chondrogenic 
differentiation. Both the proliferation and differentiation of MSCs can be positively 
influenced by the culture in 3D scaffolds. It was demonstrated in the literature that 
mesenchymal stem cells can be attracted into a cartilage defect by the guidance of a 
collagenous matrix after drilling a channel in the cartilage structure until reaching the 
subchondral bone [28]. 
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Our group has been investigating scaffolds produced with several of chitosan/ 
poly(butylene succinate) (CPBS) for cartilage tissue engineering. Those scaffolds 
showed good performance in supporting cell proliferation and ECM deposition [29-31]. 
CPBS scaffolds were reported to sustain the chondrogenic differentiation of a mouse 
mesenchymal progenitor cell line [30] and to promote cartilaginous ECM deposition 
when cultured with bovine articular chondrocytes [29, 31]. Moreover, CPBS fiber 
meshes were also proposed for bone-related strategies using MSCs, with positive results 
[23, 32]. These fiber meshes present a highly connected 3D porous structure, as well as 
a large surface area for cell attachment and proliferation [33]. The versatility of these 
scaffolds makes them very promising candidates for future osteochondral applications. 
Nevertheless, their suitability for cartilage TE using MSCs has not been assessed 
previously. We herein hypothesize that CPBS scaffolds can also support and promote 
human MSCs chondrogenic differentiation. This is the main reason for the selection of 
these scaffolds for the present work.  
Co-cultures aiming the regeneration of cartilage are the subject of recent scientific 
interest. Several studies in the literature propose their applicability for cartilage tissue 
engineering, either using articular chondrocytes from different sources [34] or passages 
[35], stem cells and articular chondrocytes [36], or embryonic stem cells and articular 
chondrocytes [37]. The co-culture of sheep BMSCs with synovial cells showed the 
expression of chondrocytic markers [38], while the use of rat BMSCs with allogenic 
cartilage explants revealed a sustained expression of Sox9 in an early stage of 
chondrogenesis and collagen type X at a later stage, which is an undesired outcome 
since it indicates hypertrophy [39]. Co-culture of synovial-derived stem cells with TGF-
β3 transfected articular chondrocytes resulted in significantly improved chondrogenesis 
of the progenitor cells [40]. The chondrogenic effect of co-culturing chondrocytes with 
MSCs may be influenced by the tissue of origin of stem cells [41, 42]. For instance, in a 
study with human adipose-derived MSCs (ASCs) co-cultures with human articular 
chondrocytes [41], it was demonstrated that co-cultured ASCs and chondrocytes clearly 
differ in their chondrogenic potential, when compared to articular chondrocytes cultured 
alone. The co-culture of ASCs with chondrocytes resulted in decreased chondrogenesis 
[41]. Conversely, in a work comparing chondrogenesis of ASCs and BMSCs seeded 
onto hyaluronic acid scaffolds, it was shown that chondrogenesis was more efficient 
using BMSCs than ASCs or chondrocytes alone [42]. In the case of WJSCs, to our best 
knowledge, only one report can be found in the literature referring to co-cultures of 
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hWJSCs with articular chondrocytes for chondrogenic differentiation [43]. Thus, we 
herein aimed at determining whether their previously reported enhanced chondrogenic 
potential when compared to BMSCs would be maintained, of even improved, in co-
cultures with articular chondrocytes using a 3D scaffold. Additionally, we aimed to 
verify if using conditioned medium from a separate articular chondrocyte culture would 
improve the induction of chondrogenic differentiation of stem cells when compared 
with direct contact between these cells in co-culture. The possibility of using 
conditioned medium opens interesting possibilities for obtaining larger numbers of 
differentiated cells prior to implantation, in the context of its clinical application. 
 
 
2. Materials and Methods 
 
2.1. CPBS fiber meshes  
 
The porous fiber meshes used as 3D scaffolds in the present work have been produced 
and successfully tested earlier by our group for bone related applications using human 
BMSCs [44]. A detailed description of the production methods can be found elsewhere 
[45]. The chitosan used for scaffolds production was supplied by France Chitin 
(Orange, France), with a degree of deacetylation of 85%. Bionolle™ 1050, a 
polybutylene succinate copolymer (MFI~50) was obtained from Showa Highpolymer 
Co. Ltd., Tokyo, Japan. Briefly, the CPBS fibers were obtained using a prototype single 
screw micro-extruder coupled to a capillary die. The extruded fibers were chopped and 
further loaded into a mould, which was heated above the melting temperature of the 
thermoplastic blend during 10 minutes. Immediately after removing the moulds from 
the oven, the fibers were slightly compressed by a Teflon cylinder to pack and bond the 
fibers. Finally, standardized scaffolds in the form of 2 mm thick discs, and with a 
diameter of 8 mm were obtained by cutting the fiber bonded meshes with a circular 
punch tool. 
 
2.2. Isolation and expansion of hBMSCs  
 
Human BMSCs were isolated from bone-marrow aspirates collected after obtaining 
informed consent from patients undergoing knee arthroplasties. Those samples were 
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obtained under the scope of the cooperation agreement established between the 3B´s 
Research Group of the University of Minho and the Orthopaedics Department of the 
Hospital de São Marcos, Braga, Portugal. During the surgeries, bone marrow was 
collected into a container with α-MEM medium, supplemented with antibiotic/ 
antimycotic solution and 5000 units of heparin (Sigma, H3393) and maintained in ice 
until the isolation procedure. Aspirates were homogenised, diluted in phosphate saline 
buffer – PBS (Sigma, D8537) (1:1) and incubated for 5 minutes at room temperature. 
Then, bone marrow was diluted in lyses buffer (1:10) and left under agitation for 10 
minutes. Lyses buffer was prepared with 10 mM of Tris-HCl (Sigma, T3253), 1.21 g of 
Tris Base (Sigma, T1503) and 8.3 g of NH4Cl (Merck, 1011455000), in 1L of distilled 
water.  Afterwards, the suspension was centrifuged at 1200 rpm, for 15 minutes at room 
temperature. Cells were ressuspended in α-MEM medium, supplemented with 
antibiotic/ antimycotic solution and 20 % FBS. Cell suspension was filtered for disposal 
of debris, using 100 µm and 70 µm Cell Strainer (BD Falcon™, 352360 and BD 
Falcon™, 352350). Cells were counted and plated at the density of 4.7x103 cells/cm2. 
Cells were expanded in the referred culture medium until obtaining the cell numbers 
needed for this study. The stemness character of the isolated hBMSCs was analysed 
previously by flow cytometry, (CD34 and CD45 –negative; CD29, CD44, CD73, CD90, 
CD105 and CD106 - positive), using a flow cytometer, and differentiation studies into 
osteogenic, chondrogenic, and adipogenic lineage [32]. 
 
2.3. Isolation and expansion of hWJSCs  
 
Human umbilical cords were obtained after obtaining informed consent from full-term 
caesarian sections donors, under the scope of the cooperation agreement of the 3B´s 
Research Group of the University of Minho and the Obstetrics Department of the 
Hospital de São Marcos, Braga, Portugal. Human WJSCs were isolated according to the 
procedure originally described by Sarugaser et al. [13]. Briefly, umbilical cords (UC) 
were cut into 3–5 cm segments. These segments were then dissected by separation of 
the UC section epithelium along its length, exposing the underlying Wharton’s jelly. 
Each vessel, with its surrounding Wharton’s jelly matrix, was pulled away, and the ends 
of each dissected vessel were tied together with a suture creating “loops”. Following, 
the loops were digested using a 1 mg/ml collagenase type I solution (Sigma, C0130) 
prepared with PBS. After 18–24 hours, the loops were removed. The remaining 
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suspension was diluted with PBS to reduce its viscosity, followed by a centrifugation at 
1200 rpm for 5 minutes. Cells were ressuspended in 10 ml culture medium consisting of 
α-MEM medium (Invitrogen, 12000-063), supplemented with antibiotic/ antimycotic 
solution (Gibco, 15240062), 10% fetal bovine serum (Baptista Marques, 
BSC0115/0943k) and counted in a hemocytometer. Finally, cells were plated and 
expanded until reaching 80–90% confluence. The stemness character of these cells was 
previously studied by flow cytometry for MSCs markers (CD34, CD45-negative and 
CD29, CD73, CD90, CD105, CD166-positive cells), using a flow cytometer (FACS 
Calibur (BD Biosciences)), and differentiation studies into osteogenic, chondrogenic, 
and adipogenic lineage [46]. 
 
2.4. Isolation and expansion of human articular chondrocytes 
 
The isolation of human articular chondrocytes (hACs) was performed according to a 
method previously reported in the literature [47]. HACs were isolated from human 
cartilage samples collected under informed consent from patients undergoing knee 
arthroplasties in the Orthopaedics Department of the Hospital de São Marcos, Braga, 
Portugal, under the scope of the previously referred agreement. During surgeries, the 
knee was collected into a container with PBS and maintained in ice until the isolation 
procedure.  Cartilage was dissected in small full-depth pieces and washed twice with 
PBS buffer. Then, it was digested with 0.25% (w/v) of trypsin solution (Sigma, E5134) 
for 30 minutes at 37ºC on a rotator. The solution was removed, cartilage was washed 
again in PBS buffer and then incubated in a 2 mg/ml collagenase type II solution 
(Sigma, E0130) overnight at 37ºC on a rotator. The following day, cells were washed 
twice with PBS, counted and platted at a density of 2x106 cells per Petri dish. Cells 
were cultivated with expansion medium: Dulbecco’s modified Eagle’s medium (Sigma, 
D5671), containing 10 mM Hepes buffer (Sigma, H0887), L-alanyl-L-glutamine 
(Sigma, G8541), Non Essential Aminoacids (Sigma, M7145), antibiotic/ antimycotic 
solution, 10% fetal bovine serum and 10 ng/ml of basic Fibroblast Growth Factor 
(bFGF) (PeproTech, 100-18B).  
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2.5. Co-cultures 
 
Cells were expanded until they reached the needed number. They were then split, 
counted and then seeded onto the CPBS fiber meshes. Two study groups were 
established: direct co-culture using one source of hMSCs (either hBMSCs or hWJSCs) 
and hACs; indirect co-culture using conditioned medium obtained from hACs cultures. 
The indirect co-culture method herein described is a variation of the transwell inserts 
technique [22, 48]. Instead of separating the two cultures with a transwell, we cultured 
separately the chondrocytes and the stem cells. As explained in the introduction, it is 
known that the 3D structure of the scaffolds can positively influence the chondrogenic 
commitment of MSCs. We hypothesised that by providing the microenvironment and 
the soluble factors present in the chondrocytes medium we would be able to influence 
the chondrogenic differentiation of both types of MSCs used in the present work. Thus, 
as the medium provided was previously consumed by the chondrocytes, we used 
conditioned medium mixed (50/50 in volume) with fresh medium. By means of diluting 
the factors secreted by the chondrocytes in fresh medium, it was our intention to provide 
the required nutrients to the MSCs indirect co-cultures, avoiding the risk of nutrient 
deprivation. 
 
2.5.1. Direct co-cultures 
A suspension of 1x106 cells (5x105 hBMSCs and 5x105 hACs) per scaffold was used 
for seeding the fiber meshes, in a rotator inside the incubator at 37ºC and 5% CO2, 
during 24 hours. Basic medium was used: Dulbecco’s modified Eagle’s Medium 
containing 10 mM Hepes solution, L–alanyl–L–glutamine, Non Essential Aminoacids, 
antibiotic/ antimicotic and 10% fetal bovine serum. Afterwards, constructs were 
transferred to new culture plates containing differentiation medium. This medium is a 
modification of the expansion medium: instead of adding bFGF, 1mg/ml of L-ascorbic 
acid (Sigma, A8960) and 50 mg/ml of insulin (Sigma, I5500) were added. Constructs 
were placed inside the incubator under the same conditions and cultured for 28 days. 
Medium was changed every other day. The same procedure was used for the direct co-
cultures of hWJSCs. 
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2.5.2. Indirect co-cultures 
Indirect co-cultures were performed using conditioned medium obtained from the 
chondrocytes in culture. First, a cell suspension containing 1x106 cells per scaffold was 
prepared for each type of cell (hBMSCs or hACs). Each cell type was seeded onto 
different CPBS scaffolds, in different culture plates. The seeding procedure was similar 
to the one described above for the direct co-cultures. Afterwards, cells were placed in 
new culture plates containing differentiation medium. After two days, the medium was 
changed. Human BMSCs medium was completely removed, and replaced by the 
mixture of conditioned and fresh medium. It consisted of a mixture of the medium 
which was removed from the chondrocytes culture, plus fresh differentiation medium 
(50/50). Medium of these cultures (hBMSCs) was changed every other day, using the 
referred mixture of conditioned medium. For the hACs cultures, fresh differentiation 
medium was used, and changed every other day. The two types of cultures were 
maintained for 28 days, in an incubator, at 37ºC and 5% CO2. The same procedure was 
used for the indirect co-cultures of hWJSCs. 
 
2.6. Proliferation assay (DNA quantification) 
 
Evaluation of cells proliferation was performed using the PicoGreen dsDNA 
quantification Kit (Molecular Probes, P7589, Invitrogen), according to the manufacturer 
protocol. Samples from every culture were collected at each time point. Triplicates of 
each time point were produced. A standard curve was established. Fluorescence of both 
samples and standard curve was read with an excitation of 485 nm and an emission of 
528 nm, in a microplate reader (Synergie HT). The DNA concentration was 
extrapolated directly from the standard curve. 
 
2.7. Dimethylmethylene blue (DMB) assay for glycosaminoglycans quantification 
 
Dimethylmethylene blue assay was performed according to the method described by 
Kafienah and Sims, 2004 [49]. Briefly, samples were collected at 1 and 4 weeks of 
culture, frozen overnight and then digested. This digestion allowed separating the 
formed ECM from the scaffold. The digestion solution was prepared by adding 1 
mg/mL of proteinase K (Sigma, P8044) diluted in 50 mM Tris-HCl, at pH of 7.6. Tris-
HCl solution was prepared using the appropriate amount of Tris-HCl, adding sodium 
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azide (Sigma, 13412) to a final concentration of 0.05% (w/v). The pH was corrected to 
obtain the final value of 7.6. Samples were placed in 1.5 mL tubes and incubated with 1 
mL of the referred solution, overnight at 60ºC. Afterwards, samples were centrifuged in 
a bench centrifuge at 13000 rpm for 10 minutes and the supernatant was collected. 
Solutions for this assay were prepared as follows. Dimethymethylene Blue (DMB) 
stock solution was prepared dissolving 16 mg of DMB powder (Aldrich, 34088) in 900 
ml of distilled water containing 3.04 g of glycine (Sigma, G8898) and 2.73 g of NaCl 
(Sigma, S3014). This was mixed for 2 hours, covered with aluminium foil. pH was 
adjusted to 3.0 with HCl (Panreac, 1310202424) and a final volume of 1L. The solution 
was stored at room temperature covered with aluminium foil. Chondroitin sulphate 
(Sigma, C8529) solution was prepared in water, in a 5 mg/ml stock solution and kept 
refrigerated. This solution was diluted with water resulting in 5 unit increments from 0 
μg/ml to 50 μg/ml, in order to make a standard curve. 20 μl of water were added to a 96 
well plate, as a blank. The same quantity of chondroitin sulphate diluted solutions was 
added, in triplicate, and the same was performed with all the samples. DMB solution 
was added, 250 μl to each well, the plates were incubated for 10 minutes and then the 
optical density was measured in a microplate reader, at 525 nm. 
 
2.8. RNA isolation 
 
Samples were collected from all controls at 7 and 28 days of experiment. Samples 
were washed in PBS, immersed in TRIzol reagent (Invitrogen, 15596-018) and kept at -
80ºC for posterior RNA extraction. When the extraction was performed, samples were 
taken from the freezer, in order to thaw. Chloroform (Sigma, C2432) was added; 
samples were vigorously agitated for 15 seconds and then incubated in ice for 15 
minutes. After that incubation, samples were centrifuged at 13000 rpm, for 15 minutes, 
at 4ºC. Afterwards, the supernatant was collected for a sterile 1.5 mL tube, and an 
equivalent volume of isopropanol (Sigma, I9516) was added. Samples were incubated at 
-20ºC overnight, to precipitate the RNA. The next day, samples were centrifuged at 
13000 rpm, for 15 minutes, at 4ºC. Then, the supernatant was taken and 800 μl of 
ethanol 70% was added, in order to wash away the isopropanol. This ethanol 70% 
solution was prepared from absolute ethanol (Merck, 1.00983.2511) and ultra pure 
water. Tubes were agitated vigorously and centrifuged again, at 9000 rpm for 5 minutes, 
at 4ºC. The supernatant was again removed, and the pellet was left to air dry. Finally, 
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the pellet was ressuspended in 50 μl of distilled water DNase, RNase free (Gibco, 
10977-015). The concentration and purity of the extracted RNA was evaluated using the 
NanoDrop ND-1000 Spectrophotometer (NanoDrop Technologies Inc, USA). 
 
2.9. Real-Time PCR 
 
The Real-Time PCR procedure used in the present work consisted of a two step 
fluorogenic assay using the PerfeCta™ SYBR® Green system (Quanta Biosciences, 
95055-100). All reagents used in this procedure were purchased from Quanta 
Biosciences, following the instructions of the manufacturer. Thermocycler reaction 
conditions used were also the ones mentioned in the kits. In the first step, RNA was 
reversed transcribed into cDNA, using the qScript cDNA Synthesis Kit (95047-500). A 
MasterCycler EP Gradient detection system (Eppendorf, USA) was used to perform the 
reaction. Afterwards, the obtained cDNA was used as template for the amplification of 
the targets genes sohwn in Table I, with the PerfeCta™ SYBR® Green FastMix™ kit 
(95072-05K). Tested genes were aggrecan, collagens type I and II and Sox9. GAPDH 
was used as house-keeping gene, and the expression of all target genes was normalized 
against the GAPDH of that sample for each time point of the study. All primer 
sequences were generated using Primer3 software [50] and acquired from MWG 
Biotech AG, Germany. Table I shows the primers sequences used. 
 
Table 7.1 – Primer sequences used for RT-PCR procedures *. 
Gene Forward (5´-3´) Reverse (5´-3´) 
AGC TGAGTCCTCAAGCCTCCTGT TGGTCTGCAGCAGTTGATTC 
COL II CGGTGAGAAGGGAGAAGTTG GACCGGTCACTCCAGTAGGA
COL I AGCCAGCAGATCGAGAACAT ACACAGGTCTCACCGGTTTC 
Sox9 TTCATGAAGATGACCGACGC GTCCAGTCGTAGCCCTTGAG 
GAPDH ACAGTCAGCCGCATCTTCTT ACGACCAAATCCGTTGACTC 
*AGC = Agreccan; COL II = Collagen type II; COL I = Collagen type I; Sox9 = Sry-type high mobility 
group box 9; GAPDH = Glyceraldehyde 3-phosphate dehydrogenase 
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2.10. Histological analysis 
 
Samples were collected at the end of the experiment and processed for histology. 
Samples were then fixed in 10% neutral buffered formalin and then dehydrated through 
crescent concentrations of ethanol, immersed in infiltration solutions, embedded in 
Technovit glycol methacrylate (kit 8100, Heraeus Kulzer, EBSciences, CO, USA) and 
then polymerized. Specimens were cut to obtain longitudinal sections of 7 µm of 
thickness, using a modified microtome equipped with a tungsten blade (Leica RM 
2155). Staining solution for toluidine blue assay was prepared by adding 1% of 
toluidine blue (Sigma, T0394) dissolved in distilled water containing 0.5 g of sodium 
borate, followed by filtering. One drop of this solution was added to each section for 1 
minute. Then, the sections were rinsed with distilled water and let to air dry overnight. 
Sections were cleared in xylene substitute (Sigma, A5597) and mounted in Histo clear 
(Frilabo, HS200). Safranin O staining was performed by washing slides in tap water, 
then immersed in 0.02% fast green solution (Fluka, 44715) for 6 minutes. Then, they 
were immersed in 1% acetic acid (Panreac, 131008) solution for 1 minute. After, slides 
were immersed in 0.1% safranin O (Fluka, 84120) solution for 10 minutes. By the end, 
slides were washed in tap water and let to air dry. Sections were cleared in xylene 
substitute and mounted as previously described. 
 
2.11. Statistical analysis 
 
Statistical analysis was performed using the SPSS statistic software (Release 15.0.0 
for Windows). Firstly, a Shapiro-Wilk test was used to ascertain about the data 
normality and variance equality. The normality condition was rejected and, 
consequently, nonparametric tests were used in further comparisons between direct and 
indirect co-cultures. A Kruskal-Wallis test followed by Tukey’s HSD test was applied 
to compare differences in between the days in culture type. P values lower than 0.001 
were considered statistically significant in the analysis of the results. 
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3. Results 
 
3.1. DNA quantification 
 
The DNA concentration for each type of co-culture was assessed. Samples were 
collected at each time point of the experiment. We determined if there were any 
differences in between the days of culture, for each type of co-culture (direct or 
indirect), and also in the control conditions. 
 
3.1.1. Co-cultures using hBMSCs 
In terms of DNA concentration, both types of co-cultures using hBMSCs seem to 
follow the same trend of proliferation. DNA contents increased with time in both types 
of co-cultures, whereas the positive control shows a decrease at 21 days, increasing 
again towards the end of the experiment (Figure 7.1A). These results indicate that both 
types of co-cultures using hBMSCs were proliferating at a comparable rate, whereas in 
the control conditions (hACs) cell numbers did not increased between 14 and 21 days, 
recovering only in the last time point. Figure 7.1B shows the table of results for the 
statistical analysis concerning the differences between the various time points of the 
experiment, for each type of co-culture using hBMSCs. We found no significant 
differences between the various time points either in direct co-cultures (p=0.172) or 
indirect co-cultures (p=0.062), showing that the proliferation was not very strong during 
the experiment. The control conditions show a significant increase from the 7th to the 
28th day of experiment, as observed in the statistical analysis results in Figure 7.1C. It is 
noteworthy that both the direct and indirect co-cultures show the highest levels of DNA 
concentration when compared to the controls in the last time point. 
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Figure 7.1 - Box plot of the DNA concentration in co-cultures using human bone 
marrow MSCs. A - Box plot of DNA concentration for direct and indirect co-cultures 
with hBMSCs and control conditions (hACs alone). B – Table with the statistical 
analysis results for the between days of culture differences (Kruskal-Wallis test, 
presented as median ± interquartile range (IQR)). C – Table with the statistical analysis 
results for between days differences in the control conditions (Kruskal-Wallis test 
followed by Tukey’s HSD test.). 
 
3.1.2. Co-cultures using hWJSCs 
The trend of DNA concentration of hWJSCs co-cultures is rather different than the 
DNA concentration found for the co-cultures using hBMSCs. Both direct and indirect 
co-cultures show a decreasing tendency in the first days of culture. Then, the DNA 
concentration in direct co-cultures continues decreasing until the 21st day, increasing 
afterwards until the end of the experiment (Figure 7.2A). This result might indicate that 
the proliferation of the direct co-cultures with hWJSCs slowed down up to the 21st day. 
Conversely, indirect co-cultures with hWJSCs show an increase in DNA concentration 
after 14 days of culture, showing a marked decrease towards the last time point. 
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Comparing the various time points, we found no significant differences between the 
days in direct co-cultures (p=0.04) using hWJSCs (Figure 7.2B). At 21 days, indirect 
co-cultures using hWJSCs displayed a significantly higher DNA concentration than in 
the other time points (p<0.001). On the contrary, at 28 days these cultures displayed a 
significantly lower DNA concentration than all the other time points (p<0.001). This 
result seems to indicate that the proliferation is slowing down towards the end of the 
experiment. On the contrary, the control conditions showed a significant increase 
comparing the 7th and 28th day of the experiment (Figure 7.2C). The highest DNA 
concentration after 28 days of culture was obtained by direct co-cultures. 
 
Figure 7.2 - Box plot of the DNA concentration in co-cultures using human WJSCs. 
A - Box plot of DNA concentration for direct and indirect co-cultures with hWJSCs and 
control conditions (hACs alone). B – Table with the statistical analysis results for the 
between days of culture differences (Kruskal-Wallis test, presented as median ± 
interquartile range (IQR)). C – Table with the statistical analysis results for between 
days differences in the indirect co-cultures and in control conditions (Kruskal-Wallis 
test followed by Tukey’s HSD test.). 
 
Co-cultures of hACs and two sources of MSCs for cartilage TE 
 
203 
3.2. Glycosaminoglycans quantification 
 
The GAGs content for each type of co-culture was assessed. Samples were collected 
at 7 and 28 days of the experiment. We compared GAGs content between the types of 
co-cultures (direct vs indirect). We also compared the differences between both types of 
co-cultures and our control condition, hACs to determine if the co-cultures were 
accumulating more GAGs than chondrocytes alone. Afterwards, we determined if any 
differences were observed between the different time points, for each type of co-culture 
(direct or indirect). 
 
3.2.1. Co-cultures with hBMSCs 
Both direct and indirect co-cultures with hBMSCs show a small decrease in the GAG 
content from 7 to 28 days of the experiment, whereas control conditions showed the 
expected significant increase in GAGs deposition over time (Figure 7.3A). 
 
 
 
Figure 7.3 - Box plot of the GAGs concentration in both types of co-cultures, along 
the experiment. A - Box plot of GAGs concentration for direct and indirect co-cultures 
with hBMSCs and control conditions (hACs alone). B - Box plot of the GAGs 
concentration for direct and indirect co-cultures using hWJSCs and control conditions 
(hACs alone). Data were analyzed by nonparametric way of a Kruskal-Wallis test 
followed by Tukey’s HSD test. * denotes significant differences compared to direct co-
cultures. 
 
Co-cultures of hACs and two sources of MSCs for cartilage TE 
 
 
204 
No significant difference between direct and indirect co-cultures using hMSCs was 
found for 7 days of culture (p=0.061). At the end of the experiment, direct co-cultures 
displayed a significantly lower amount of GAGs than indirect co-cultures (p=0.006), as 
well as lower than the values for the control conditions (p=0.002). These results show 
that those co-cultures did not deposit more GAGs than the control condition. No 
significant differences between 7 and 28 days were observed in direct co-cultures 
(p=0.534) and in indirect co-cultures with hBMSCs (p=0.963).  
 
3.2.2. Co-cultures using hWJSCs 
In co-cultures using hWJSCs, a consistent trend was observed for all the conditions. 
Direct and indirect co-cultures, as well as the control conditions, show an increase in 
GAGs content along the time in culture (Figure 7.3B). For co-cultures using hWJSCs no 
significant difference between direct and indirect co-cultures was found after 7 days 
(p=0.138) nor after 28 days (p=0.733). Significant differences were found between 7 
and 28 days of culture for both direct and indirect co-cultures. After 28 days, all the 
conditions displayed a significantly higher GAG concentration compared to 7 days 
(p<0.01), meaning that the GAGs accumulation is very alike to the control conditions, 
with native chondrocytes.  
The GAGs concentration values obtained for all the time points for direct or indirect 
co-cultures with hBMSCs show consistently lower values when comparing to the ones 
obtained for the co-cultures with hWJSCs. 
 
3.3. Real-Time PCR 
 
Samples were collected for Real-Time PCR at 7 and 28 days of experiment. The aim 
was to determine the expression of several cartilage-related genes and to compare the 
differences between the expressions in both types of co-cultures, on both time points. 
 
3.3.1. Co-cultures using hBMSCs 
 In both types of co-cultures using hBMSCs, no significant differences were found 
between the cultures for Aggrecan or Sox9, at 7 days (p=0.072 and p=0.868, 
respectively) or 28 days (p=0.183 and p=0.115, respectively), as shown in Figure 7.4. 
Direct co-cultures using hBMSCs expressed significantly higher values of Collagen 
type I, compared either to indirect co-cultures or to the control conditions (p<0.001), 
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indicating the formation of fibrocartilage in direct co-cultures.  Collagen type II 
expression in indirect co-cultures of hBMSCs, displayed a significantly higher 
expression than direct co-cultures and control conditions (p<0.001) at 7 day of culture. 
After 28 days, direct co-cultures displayed a significantly higher Collagen type II 
expression than indirect co-cultures (p=0.009) and control conditions (p=0.002). 
 
 
Figure 7.4 – Bar plots of chondrogenic markers present in direct and indirect co-
cultures using hBMSCs, normalized for the reference gene GAPDH, after 7 and 28 days 
of culture. Data were analyzed by nonparametric way of a Kruskal-Wallis test for 
Aggrecan and Sox9. Data related with Collagen type I and Collagen type II were 
analyzed by nonparametric way of a Kruskal-Wallis test followed by Tukey’s HSD test. 
* denotes significant differences compared to direct co-cultures, # denotes significant 
differences compared to indirect co-cultures. 
 
3.3.2. Co-cultures using hWJSCs 
Statistic analysis of gene expression in direct and indirect co-cultures using hWJSCs 
showed significant differences for almost all the genes (Figure 7.5). For Aggrecan, there 
was a significantly lower expression on the control conditions, when compared to direct 
and indirect co-cultures (p<0.001), at 7 days of culture. However, at 28 days of culture, 
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both types of co-cultures using hBMSCs showed a significantly higher expression of 
Aggrecan than control conditions (p<0.001). Additionally, indirect co-cultures also 
displayed a significantly higher value for Aggrecan expression when compared to direct 
co-cultures (p=0.007). 
Indirect co-cultures also expressed significantly higher values of Sox9 expression, at 
28 days of culture, when compared to direct co-cultures and control conditions 
(p<0.001). For Collagen type I, no significant difference between cell type was found 
either at 7 (p=0.044) or 28 days of culture (p=0.498). However, the trend was to 
decrease its expression for the longer time periods. 
Direct co-cultures using hWJSCs displayed a significantly higher expression of 
Collagen type II than indirect co-cultures, after 7 days in culture. In contrast, indirect 
co-cultures displayed a significantly higher Collagen type II expression than the control 
conditions (p=0.006), and a significant trend to increase the expression of this important 
gene, in contrast to other culture conditions. 
 
 
 
Figure 7.5 – Bar plots of chondrogenic markers present in direct and indirect co-
cultures using hWJSCs, normalized for the reference gene GAPDH, after 7 and 28 days 
of culture. Data were analyzed by nonparametric way of a Kruskal-Wallis test for 
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Collagen type I. Data related to Aggrecan, Sox9 and Collagen type II expressions were 
analyzed by nonparametric way of a Kruskal-Wallis test followed by Tukey’s HSD test. 
* denotes significant differences compared to direct co-cultures, # denotes significant 
differences compared to indirect co-cultures. 
 
3.4. Histological staining 
 
By the end of the experiment, samples of every co-culture were collected for 
histological sectioning. Sections were stained for cartilagineous ECM using toluidine 
blue and safranin O assays (Figure 7.6). Both types of cells, either in direct or indirect 
co-culture, were able to produce ECM, as shown by the positive stain of toluidine blue 
and safranin O for ECM components. The cells were able to proliferate around the fiber 
meshes, and were able to grow in between the fibers inside the structure of the 
scaffolds. For co-cultures using hBMSCs no evident differences in terms of the quantity 
of cartilage ECM formation are observed in the histological staining results, either for 
direct or indirect co-cultures. Nevertheless, positive staining for proteoglycans can be 
observed either with toluidine blue or with safranin O stain. These observations are 
consistent with the previously obtained results for GAGs accumulation, as well as the 
RT-PCR results that showed the expression of cartilage related genes at the end of the 
experiment. 
In the case of co-cultures using hWJSCs, the same observations were made. It is 
possible to state ECM formation both in direct and indirect co-cultures, stained with 
toluidine blue and safranin O. These observations are also consistent with the previously 
obtained results for GAGs accumulation and cartilage related genes expression at 28 
days of culture. 
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Figure 7.6 – Histological sections of direct and indirect co-cultures using human 
BMSCs and WJSCs, stained for ECM localisation. 
 
 
4. Discussion 
 
The use of biomaterial scaffolds to enhance ECM-cell interactions has been reported 
as a very important factor when using stem cells for TE [7, 42, 51]. For detailed 
overview on this matter, please refer to [52, 53]. The positive effect of 3D scaffolds in 
the chondrogenic differentiation of BMSCs [54-56] and UCSCs [32, 57] has been 
reported elsewhere. In the present work we showed that both hBMSCs and hWJSCs 
were able to undergo chondrogenic differentiation when seeded onto CPBS fiber 
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meshes. Polyglycolic acid (PGA) scaffolds were recently used for comparing the 
potential of hBMSCs and hUCSCs for cartilage tissue engineering. The authors 
observed enhanced chondrogenic differentiation of hUCSCs when compared to 
hBMSCs [7]. The chondrogenic differentiation of MSCs on chitosan fibrous scaffolds 
and chitosan sponges was compared, demonstrating that chondrogenesis on chitosan 
scaffolds is superior on microfibers, when compared to sponges [58]. 
Herein, chondrogenic differentiation of human BMSCs and WJSCs was observed 
both in direct and indirect co-cultures. The soluble signals released by articular 
chondrocytes, either by the direct contact or in the form of soluble factors released in 
the culture medium, did effectively promote chondrogenic differentiation of hBMSCs 
and of hWJSCs. A recent study reported similar conclusions for the chondrogenic 
differentiation of adipose stem cells when co-cultured with chondrocytes [59]. In that 
report, adipose stem cells were cultured in pellets either directly or indirectly with 
chondrocytes, and it was concluded that the chondrocytes secreted signals promoted 
chondrogenic differentiation of adipose stem cells. The co-culture systems used in the 
present work were able to provide MSCs with the signals and the stimulation needed for 
their chondrogenic differentiation. A similar result was found when using conditioned 
medium from chondrocytes in the chondrogenic differentiation of embryonic stem cells 
[48]. The authors could show the coordination of signals between the co-cultures, 
suggesting that chondrogenic differentiation of embryonic stem cells can be achieved by 
co-cultures with chondrocytes, without other exogenous growth factors being required. 
No significant differences between the days in culture, in terms of proliferative ability, 
were found for the co-cultures using hBMSCs. Likewise, no significant differences 
were found for direct co-cultures using hWJSCs. However, when analysing the 
proliferative ability of hWJSCs in indirect co-cultures we observed significantly higher 
differences between the 21st day and all the other time points. Moreover, the values 
obtained for the DNA concentration of hWJSCs are higher than the ones obtained for 
the hBMSCs. The higher proliferative potential of hWJSCs compared to hBMSCs has 
been demonstrated earlier [15], as well as their enhanced chondrogenic potential [14]. 
Both types of co-cultures were able to produce and deposit GAGs. For the cultures with 
hBMSCs, a significantly lower GAG concentration value was found for the direct co-
cultures, comparing to the indirect. For the cultures using hWJSCs, no significant 
differences were found in terms of GAGs concentration between direct and indirect co-
cultures. These results show that indirect co-cultures may be more effective in ECM 
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components production, at least in terms of chondrogenic differentiation of hBMSCs, 
since no differences were found for hWJSCs. Our data with co-cultures of hBMSCs are 
similar to the results obtained in a study using passaged chondrocytes and primary 
bovine chondrocytes [19]. In that study, indirect co-cultures of primary and passaged 
chondrocytes were performed using filter inserts and it was found that the passaged 
cells accumulated ECM, when in contact with the conditioned medium produced by the 
primary chondrocytes. Although indirect co-cultures using hBMSCs seem to have an 
advantage in terms of GAGs accumulation, both types of co-cultures using these cells 
displayed a significantly lower value when compared to the chondrocytes culture 
(control condition). These results show that co-cultures with hBMSCs produced and 
accumulated less GAGs than the native chondrocytes cultures. In terms of GAGs, we 
can say that the hBMSCs co-cultures do not show a clear advantage over chondrocytes. 
Interestingly, both direct and indirect co-cultures using hWJSCs displayed a 
significantly higher concentration of GAGs at 28 days of culture, compared to 7 days. 
The values for GAGs concentration were higher in the cultures using hWJSCs than in 
the cultures using hBMSCs, indicating more formation and accumulation of these 
important components of the cartilaginous ECM.  Our results showed enhanced 
chondrogenesis in hWJSCs, when in indirect or direct co-cultures.  
In the histological sections, it is noticeable that both cultures of hBMSCs and of 
hWJSCs were able to produce ECM components, namely proteoglycans. These 
components were stained both with toludine blue and with safranin O, showing ECM 
deposition. ECM accumulation was also observed in passaged human chondrocytes, 
when in co-cultures with bovine chondrocytes [34]. Co-cultures of equine BMSCs with 
equine articular chondrocytes improved the expression of cartilage related genes, and 
induced the production of a more homogeneous ECM within the neo-cartilage [36].  
In terms of gene expression, for the cultures using hBMSCs, direct co-cultures 
showed significantly higher expression of Collagen type I than indirect co-cultures, at 
the end of the experiment. In terms of Collagen type II expression, direct co-cultures 
displayed a significantly higher expression at 7 days of culture than indirect co-cultures. 
On the other hand, towards the end of the experiment, indirect co-cultures showed a 
higher expression of collagen type II compared to the direct co-cultures. Again, the 
positive effect of using conditioned medium is evidenced by the results. For hWJSCs 
co-cultures, a significantly higher expression of Aggrecan was found for indirect co-
cultures of hWJSCs at 28 days, compared to the direct ones. The same significantly 
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higher expression was observed for Sox9 expression. For Collagen type II, there was a 
decrease in the last day of culture for the direct co-cultures. In this last time point, a 
significantly higher expression was found for the indirect co-cultures, when compared 
to the control conditions. Therefore, this system of co-culturing has a considerable 
clinic potential.  
The use of conditioned medium to promote the differentiation of MSCs for further 
implantation is a valuable concept in terms of regenerative medicine, because it will 
allow obtained conditioned medium of unrelated chondrocytes to promote the 
differentiation of autologous stem cells. In the present work, we propose a new strategy 
for cartilage tissue engineering strategies based on the use of conditioned medium, and 
we were able to demonstrate its effect in MSCs chondrogenesis. The positive effect of 
the conditioned medium in osteogenesis and chondrogenesis has been recently 
demonstrated, using MSCs seeded onto polycaprolactone/hydroxyapatite scaffolds and 
on alginate, respectively [60]. In a different approach, using porcine cells for 
chondrogenic differentiation for intervertebral disc repair, notochordal cell conditioned 
medium promoted MSCs differentiation, induced significantly more collagen type II 
expression and GAGs production in MSCs [61]. In the present work, the soluble factors 
released by hACs in culture were able to induce chondrogenic differentiation of both 
hBMSCs and hWJSCs without the addition of growth factors. This is a very interesting 
result, since in a clinical perspective it is preferable to use conditioned medium for 
chondrogenic differentiation of MSCs than to induce it with growth factors or even with 
direct co-cultures. There are many cost associated with the use of growth factors, so this 
cost could be reduced when using conditioned medium. Indeed, this technique should 
be further explored, as some reports show that the use of conditioned medium is very 
versatile. For example, conditioned medium from a human hepatocarcinoma cell line 
(HepG2) enhanced in vitro chondrogenesis of murine embryonic stem cells [62]. 
Therefore, chondrocyte cell lines could be eventually established for conditioned 
medium production, to further induce chondrogenic differentiation of autologous MSCs 
in 3D scaffolds prior to its implantation. However, it is very important to identify, in the 
first place, the soluble factors that are being release into the hACs culture medium and 
that successfully induced the chondrogenic differentiation of hBMSCs and hWJSCs. 
Indirect co-cultures of human MSCs using conditioned medium from hACs seem to 
be more suitable for engineered cartilage formation. The results of indirect co-cultures 
(either with BMSCs or with WJSCs) towards the end of the experiment were 
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significantly higher for all the tested parameters, namely GAGs accumulation and 
cartilage related-genes expression (Collagen type II, Aggrecan and Sox9). Concerning 
the type of human MSCs tested, we obtained strong evidence that hWJSCs are more 
promising than hBMSCs for cartilage related applications using this strategy. 
Additionally, more GAGs accumulation was measured again for both direct and indirect 
co-cultures using hWJSCs. These cultures also expressed Aggrecan, Sox9 and Collagen 
type II, genes related to articular cartilage. Collagen type I, related to fibrotic cartilage, 
did not have a significant expression in these cultures with hWJSCs. This result may be 
indirectly related to a superior chondrogenic performance of hWJSCs when compared 
to hBMSCs [7]. 
 
 
5. Conclusions 
 
Human adult MSCs were able to differentiate into the chondrogenic lineage, when co-
cultured with hACs in CPBS scaffolds. In terms of type of culture, indirect co-cultures 
(using conditioned medium) seem more effective for chondrogenic differentiation. This 
is a very interesting result to be further explored for clinical translation. In this way, 
conditioned medium without the addition of other supplements or growth factors can be 
employed to enhance MSCs expansion and chondrogenic differentiation, prior to 
implantation. Indirect co-cultures using conditioned medium, using either BMSCs or 
WJSCs, showed significant higher values in terms of GAGs accumulation and cartilage 
related genes expression, when compared to direct co-cultures. In terms of cell source, 
hWJSCs showed higher proliferation rates and higher chondrogenic differentiation 
ability when compared to hBMSCs. Human WJSCs expressed significant higher values 
of DNA concentration, GAGs accumulation and cartilage related genes (Aggrecan, 
Collagen type II and Sox9). Human BMSCs chondrogenic differentiation produced 
fibrous cartilage, as stated by the significantly higher expression of Collagen type I 
when compared to hWJSCs. 
In conclusion, indirect co-cultures of hWJSCs using conditioned medium obtained 
from hACs cultures are a new approach for cartilage tissue engineering that should be 
extensively studied for future clinical applications, as an alternative method for 
expanding autologous cells prior to implantation. 
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Abstract 
 
Chondrocytes are mainly responsible for maintaining the integrity of the extracellular 
matrix of articular cartilage and for the protection of the underlying subchondral bone. 
Mesenchymal Stem Cells (MSCs) are also believed to contribute to the maintenance of 
cartilage. Moreover, these cells have been recognized for their ability to differentiate 
into cells of different tissues such as bone, cartilage or adipose tissue, and therefore 
might be of great interest for developing cartilage therapeutic strategies. These cells are 
typically induced to differentiate by growth factors supplementation in the culture 
medium that will trigger differentiation into the desired cell phenotype.  
One frequent problem that occurs in cartilage tissue engineering is that expanded 
chondrocytes undergo dedifferentiation when in 2D culture. This process leads 
frequently to the undesired production of fibrocartilage, and is associated with the loss 
of their phenotype in vitro. The use of an additional cell source to enhance cell numbers, 
not loosing the differentiation potential upon expansion in vitro may be an original 
choice. Moreover, soluble factors released by chondrocytes have been shown to 
influence stem cells differentiation onto the chondrogenic lineage. The use of 
conditioned medium obtained from chondrocytes for stimulating stem cells 
chondrogenic differentiation may be a very interesting alternative for moving into the 
clinical application of these cells.  
In the present work, direct contact co-cultures and indirect co-cultures (using 
conditioned medium obtained from a culture of human articular chondrocytes) of 
human bone marrow-derived MSCs (hBMSCs) and human Wharton´s jelly MSCs 
(hWJSCs) were established. Cells were isolated from human samples collected at a 
local hospital, under donors’ informed consent. The co-cultures were performed in 
previously produced 3D scaffolds, composed by a blend of 50/50 chitosan and poly 
(butylene succinate) – CPBS. Co-cultures were maintained during 28 days. Both types 
of stem cells were able to undergo chondrogenic differentiation, either in direct or 
indirect co-cultures. By the end of the experiment, the indirect co-cultures (using 
conditioned medium) showed significantly higher values in terms of DNA content, 
glycosaminoglycans (GAGs) accumulation and specific cartilage-related genes 
expression, when compared to direct co-cultures, for both types of adult MSCs tested. 
Human BMSCs resulted in fibrous cartilage, as it can be concluded by the significantly 
higher expression of Collagen type I. The hWJSCs showed higher chondrogenic 
Co-cultures of hACs and two sources of MSCs for cartilage TE 
 
189 
differentiation ability when compared to hBMSCs, as denoted by the higher values for 
GAGs accumulation and cartilage related genes expression.  
Therefore, we were able to demonstrate the high chondrogenic potential of hWJSCs, 
and proved that co-cultures of articular chondrocytes with these cells are able to 
produce more cartilaginous ECM, when compared to co-cultures with hBMSCs. The 
use of conditioned medium obtained from articular chondrocytes induced MSCs 
chondrogenic differentiation and ECM formation. The obtained results showed that this 
new strategy is very interesting and should be further explored for clinical applications. 
 
 
1. Introduction 
 
Research concerning cartilage regeneration is of special importance, since this tissue 
lacks self-repairing capacity and causes a huge social and economic impact. Several cell 
types have been proposed for cartilage tissue engineering, as for example the direct use 
of autologous chondrocytes. However, this method is not very convenient, since it 
involves a biopsy used as cell source for primary chondrocytes that is always limited in 
size and consequently in cell numbers obtained [1]. Also, chondrocytes tend to 
dedifferentiate when expanded in 2D culture, in vitro [1]. The use of stem cells can be 
very useful to overcome these issues, as they can be expanded into clinically relevant 
numbers and further differentiate into the chondrogenic lineage. Applying a 3D milieu 
is pivotal when designing a cartilage TE strategy, because chondrocytes 
dedifferentiation is reversible, and when these cells are further cultured in a 3D 
environment, they may regain their phenotype [2-5]. 
The most widespread tissue source of adult mesenchymal stem cells (MSCs) is the 
bone marrow [6, 7]. Bone marrow MSCs (BMSCs) have been proposed and applied for 
various tissue engineering applications, including for cartilage repair [6, 8-11]. Yet, the 
number of available MSCs in bone marrow [12], and the possibility of donor site 
morbidity in the procedure to obtain bone marrow aspirates, leads to the need to identify 
other MSCs sources. Human umbilical cord Wharton´s jelly has been reported as a 
potential alternative tissue source [13, 14], since human umbilical cord MSCs share 
many properties with bone marrow mesenchymal stem cells, thus supporting their 
applicability for cell-based therapies [15]. Human WJSCs (hWJSCs) have a higher 
frequency of colony forming units (CFUs-F) than hBMSCs, thus a larger number of 
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MSCs may be obtained in the initial isolation from Wharton´s jelly [13]. Further details 
on Wharton´s jelly cells as a primitive stromal cell population can be found elsewhere 
[16, 17]. Human WJSCs have also shown a higher proliferative potential than hBMSCs 
[15], being able to undergo osteogenic, chondrogenic and adipogenic differentiation 
[14]. Thus, those cells are prospective candidates for cartilage tissue engineering, as 
they display a distinct chondrogenic potential. Moreover, the improved chondrogenic 
potential of cells derived from the umbilical cord was confirmed in a study comparing 
the differentiation potential of human BMSCs and human umbilical cord stem cells 
(UCSCs) in 2D cultures [18]. 
Several strategies have been proposed to direct chondrogenesis of stem cells, which 
can be applied either alone or in conjunction. The referred two strategies comprise the 
use of specific growth factors, employing 3D structures to act as supports for cell 
growth and differentiation, or to co-culture progenitor cells with conditioned medium 
obtained from cartilage explants [19]. Cartilage is a paracrine organ, which secretes 
humoral factors that influence the proliferation and differentiation of cells present in the 
surrounding tissues [20]. Chondrogenesis and osteogenesis of MSCs during in vitro 
micromass culture was affected by the use of conditioned medium obtained from 
cultures of chondrocytes [21]. It was observed that  chondrocytes secrete factors that 
may affect the differentiation status of stem cells, and can promote chondrogenesis and 
osteogenesis  [21]. In indirect co-cultures with chondrocytes and embryonic stem cells 
the interaction of paracrine factors secreted by chondrocytes with the referred cells was 
observed [22]. This interaction led to the enhancement of the embryonic stem cells 
chondrogenic commitment [22]. 
The use of a porous biodegradable scaffold to support cell growth is frequently 
proposed for tissue engineering approaches [23-26]. Chondrocytes tend to switch into a 
fibroblast-like phenotype when cultured in monolayer, in tissue culture flasks. The 
presence of a porous structure providing a 3D environment for their culture is pivotal 
for the phenotype development and stability in vitro [27]. In the case of adult stem cells, 
the influence of 3D porous structures is relevant when considering its chondrogenic 
differentiation. Both the proliferation and differentiation of MSCs can be positively 
influenced by the culture in 3D scaffolds. It was demonstrated in the literature that 
mesenchymal stem cells can be attracted into a cartilage defect by the guidance of a 
collagenous matrix after drilling a channel in the cartilage structure until reaching the 
subchondral bone [28]. 
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Our group has been investigating scaffolds produced with several of chitosan/ 
poly(butylene succinate) (CPBS) for cartilage tissue engineering. Those scaffolds 
showed good performance in supporting cell proliferation and ECM deposition [29-31]. 
CPBS scaffolds were reported to sustain the chondrogenic differentiation of a mouse 
mesenchymal progenitor cell line [30] and to promote cartilaginous ECM deposition 
when cultured with bovine articular chondrocytes [29, 31]. Moreover, CPBS fiber 
meshes were also proposed for bone-related strategies using MSCs, with positive results 
[23, 32]. These fiber meshes present a highly connected 3D porous structure, as well as 
a large surface area for cell attachment and proliferation [33]. The versatility of these 
scaffolds makes them very promising candidates for future osteochondral applications. 
Nevertheless, their suitability for cartilage TE using MSCs has not been assessed 
previously. We herein hypothesize that CPBS scaffolds can also support and promote 
human MSCs chondrogenic differentiation. This is the main reason for the selection of 
these scaffolds for the present work.  
Co-cultures aiming the regeneration of cartilage are the subject of recent scientific 
interest. Several studies in the literature propose their applicability for cartilage tissue 
engineering, either using articular chondrocytes from different sources [34] or passages 
[35], stem cells and articular chondrocytes [36], or embryonic stem cells and articular 
chondrocytes [37]. The co-culture of sheep BMSCs with synovial cells showed the 
expression of chondrocytic markers [38], while the use of rat BMSCs with allogenic 
cartilage explants revealed a sustained expression of Sox9 in an early stage of 
chondrogenesis and collagen type X at a later stage, which is an undesired outcome 
since it indicates hypertrophy [39]. Co-culture of synovial-derived stem cells with TGF-
β3 transfected articular chondrocytes resulted in significantly improved chondrogenesis 
of the progenitor cells [40]. The chondrogenic effect of co-culturing chondrocytes with 
MSCs may be influenced by the tissue of origin of stem cells [41, 42]. For instance, in a 
study with human adipose-derived MSCs (ASCs) co-cultures with human articular 
chondrocytes [41], it was demonstrated that co-cultured ASCs and chondrocytes clearly 
differ in their chondrogenic potential, when compared to articular chondrocytes cultured 
alone. The co-culture of ASCs with chondrocytes resulted in decreased chondrogenesis 
[41]. Conversely, in a work comparing chondrogenesis of ASCs and BMSCs seeded 
onto hyaluronic acid scaffolds, it was shown that chondrogenesis was more efficient 
using BMSCs than ASCs or chondrocytes alone [42]. In the case of WJSCs, to our best 
knowledge, only one report can be found in the literature referring to co-cultures of 
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hWJSCs with articular chondrocytes for chondrogenic differentiation [43]. Thus, we 
herein aimed at determining whether their previously reported enhanced chondrogenic 
potential when compared to BMSCs would be maintained, of even improved, in co-
cultures with articular chondrocytes using a 3D scaffold. Additionally, we aimed to 
verify if using conditioned medium from a separate articular chondrocyte culture would 
improve the induction of chondrogenic differentiation of stem cells when compared 
with direct contact between these cells in co-culture. The possibility of using 
conditioned medium opens interesting possibilities for obtaining larger numbers of 
differentiated cells prior to implantation, in the context of its clinical application. 
 
 
2. Materials and Methods 
 
2.1. CPBS fiber meshes  
 
The porous fiber meshes used as 3D scaffolds in the present work have been produced 
and successfully tested earlier by our group for bone related applications using human 
BMSCs [44]. A detailed description of the production methods can be found elsewhere 
[45]. The chitosan used for scaffolds production was supplied by France Chitin 
(Orange, France), with a degree of deacetylation of 85%. Bionolle™ 1050, a 
polybutylene succinate copolymer (MFI~50) was obtained from Showa Highpolymer 
Co. Ltd., Tokyo, Japan. Briefly, the CPBS fibers were obtained using a prototype single 
screw micro-extruder coupled to a capillary die. The extruded fibers were chopped and 
further loaded into a mould, which was heated above the melting temperature of the 
thermoplastic blend during 10 minutes. Immediately after removing the moulds from 
the oven, the fibers were slightly compressed by a Teflon cylinder to pack and bond the 
fibers. Finally, standardized scaffolds in the form of 2 mm thick discs, and with a 
diameter of 8 mm were obtained by cutting the fiber bonded meshes with a circular 
punch tool. 
 
2.2. Isolation and expansion of hBMSCs  
 
Human BMSCs were isolated from bone-marrow aspirates collected after obtaining 
informed consent from patients undergoing knee arthroplasties. Those samples were 
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obtained under the scope of the cooperation agreement established between the 3B´s 
Research Group of the University of Minho and the Orthopaedics Department of the 
Hospital de São Marcos, Braga, Portugal. During the surgeries, bone marrow was 
collected into a container with α-MEM medium, supplemented with antibiotic/ 
antimycotic solution and 5000 units of heparin (Sigma, H3393) and maintained in ice 
until the isolation procedure. Aspirates were homogenised, diluted in phosphate saline 
buffer – PBS (Sigma, D8537) (1:1) and incubated for 5 minutes at room temperature. 
Then, bone marrow was diluted in lyses buffer (1:10) and left under agitation for 10 
minutes. Lyses buffer was prepared with 10 mM of Tris-HCl (Sigma, T3253), 1.21 g of 
Tris Base (Sigma, T1503) and 8.3 g of NH4Cl (Merck, 1011455000), in 1L of distilled 
water.  Afterwards, the suspension was centrifuged at 1200 rpm, for 15 minutes at room 
temperature. Cells were ressuspended in α-MEM medium, supplemented with 
antibiotic/ antimycotic solution and 20 % FBS. Cell suspension was filtered for disposal 
of debris, using 100 µm and 70 µm Cell Strainer (BD Falcon™, 352360 and BD 
Falcon™, 352350). Cells were counted and plated at the density of 4.7x103 cells/cm2. 
Cells were expanded in the referred culture medium until obtaining the cell numbers 
needed for this study. The stemness character of the isolated hBMSCs was analysed 
previously by flow cytometry, (CD34 and CD45 –negative; CD29, CD44, CD73, CD90, 
CD105 and CD106 - positive), using a flow cytometer, and differentiation studies into 
osteogenic, chondrogenic, and adipogenic lineage [32]. 
 
2.3. Isolation and expansion of hWJSCs  
 
Human umbilical cords were obtained after obtaining informed consent from full-term 
caesarian sections donors, under the scope of the cooperation agreement of the 3B´s 
Research Group of the University of Minho and the Obstetrics Department of the 
Hospital de São Marcos, Braga, Portugal. Human WJSCs were isolated according to the 
procedure originally described by Sarugaser et al. [13]. Briefly, umbilical cords (UC) 
were cut into 3–5 cm segments. These segments were then dissected by separation of 
the UC section epithelium along its length, exposing the underlying Wharton’s jelly. 
Each vessel, with its surrounding Wharton’s jelly matrix, was pulled away, and the ends 
of each dissected vessel were tied together with a suture creating “loops”. Following, 
the loops were digested using a 1 mg/ml collagenase type I solution (Sigma, C0130) 
prepared with PBS. After 18–24 hours, the loops were removed. The remaining 
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suspension was diluted with PBS to reduce its viscosity, followed by a centrifugation at 
1200 rpm for 5 minutes. Cells were ressuspended in 10 ml culture medium consisting of 
α-MEM medium (Invitrogen, 12000-063), supplemented with antibiotic/ antimycotic 
solution (Gibco, 15240062), 10% fetal bovine serum (Baptista Marques, 
BSC0115/0943k) and counted in a hemocytometer. Finally, cells were plated and 
expanded until reaching 80–90% confluence. The stemness character of these cells was 
previously studied by flow cytometry for MSCs markers (CD34, CD45-negative and 
CD29, CD73, CD90, CD105, CD166-positive cells), using a flow cytometer (FACS 
Calibur (BD Biosciences)), and differentiation studies into osteogenic, chondrogenic, 
and adipogenic lineage [46]. 
 
2.4. Isolation and expansion of human articular chondrocytes 
 
The isolation of human articular chondrocytes (hACs) was performed according to a 
method previously reported in the literature [47]. HACs were isolated from human 
cartilage samples collected under informed consent from patients undergoing knee 
arthroplasties in the Orthopaedics Department of the Hospital de São Marcos, Braga, 
Portugal, under the scope of the previously referred agreement. During surgeries, the 
knee was collected into a container with PBS and maintained in ice until the isolation 
procedure.  Cartilage was dissected in small full-depth pieces and washed twice with 
PBS buffer. Then, it was digested with 0.25% (w/v) of trypsin solution (Sigma, E5134) 
for 30 minutes at 37ºC on a rotator. The solution was removed, cartilage was washed 
again in PBS buffer and then incubated in a 2 mg/ml collagenase type II solution 
(Sigma, E0130) overnight at 37ºC on a rotator. The following day, cells were washed 
twice with PBS, counted and platted at a density of 2x106 cells per Petri dish. Cells 
were cultivated with expansion medium: Dulbecco’s modified Eagle’s medium (Sigma, 
D5671), containing 10 mM Hepes buffer (Sigma, H0887), L-alanyl-L-glutamine 
(Sigma, G8541), Non Essential Aminoacids (Sigma, M7145), antibiotic/ antimycotic 
solution, 10% fetal bovine serum and 10 ng/ml of basic Fibroblast Growth Factor 
(bFGF) (PeproTech, 100-18B).  
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2.5. Co-cultures 
 
Cells were expanded until they reached the needed number. They were then split, 
counted and then seeded onto the CPBS fiber meshes. Two study groups were 
established: direct co-culture using one source of hMSCs (either hBMSCs or hWJSCs) 
and hACs; indirect co-culture using conditioned medium obtained from hACs cultures. 
The indirect co-culture method herein described is a variation of the transwell inserts 
technique [22, 48]. Instead of separating the two cultures with a transwell, we cultured 
separately the chondrocytes and the stem cells. As explained in the introduction, it is 
known that the 3D structure of the scaffolds can positively influence the chondrogenic 
commitment of MSCs. We hypothesised that by providing the microenvironment and 
the soluble factors present in the chondrocytes medium we would be able to influence 
the chondrogenic differentiation of both types of MSCs used in the present work. Thus, 
as the medium provided was previously consumed by the chondrocytes, we used 
conditioned medium mixed (50/50 in volume) with fresh medium. By means of diluting 
the factors secreted by the chondrocytes in fresh medium, it was our intention to provide 
the required nutrients to the MSCs indirect co-cultures, avoiding the risk of nutrient 
deprivation. 
 
2.5.1. Direct co-cultures 
A suspension of 1x106 cells (5x105 hBMSCs and 5x105 hACs) per scaffold was used 
for seeding the fiber meshes, in a rotator inside the incubator at 37ºC and 5% CO2, 
during 24 hours. Basic medium was used: Dulbecco’s modified Eagle’s Medium 
containing 10 mM Hepes solution, L–alanyl–L–glutamine, Non Essential Aminoacids, 
antibiotic/ antimicotic and 10% fetal bovine serum. Afterwards, constructs were 
transferred to new culture plates containing differentiation medium. This medium is a 
modification of the expansion medium: instead of adding bFGF, 1mg/ml of L-ascorbic 
acid (Sigma, A8960) and 50 mg/ml of insulin (Sigma, I5500) were added. Constructs 
were placed inside the incubator under the same conditions and cultured for 28 days. 
Medium was changed every other day. The same procedure was used for the direct co-
cultures of hWJSCs. 
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2.5.2. Indirect co-cultures 
Indirect co-cultures were performed using conditioned medium obtained from the 
chondrocytes in culture. First, a cell suspension containing 1x106 cells per scaffold was 
prepared for each type of cell (hBMSCs or hACs). Each cell type was seeded onto 
different CPBS scaffolds, in different culture plates. The seeding procedure was similar 
to the one described above for the direct co-cultures. Afterwards, cells were placed in 
new culture plates containing differentiation medium. After two days, the medium was 
changed. Human BMSCs medium was completely removed, and replaced by the 
mixture of conditioned and fresh medium. It consisted of a mixture of the medium 
which was removed from the chondrocytes culture, plus fresh differentiation medium 
(50/50). Medium of these cultures (hBMSCs) was changed every other day, using the 
referred mixture of conditioned medium. For the hACs cultures, fresh differentiation 
medium was used, and changed every other day. The two types of cultures were 
maintained for 28 days, in an incubator, at 37ºC and 5% CO2. The same procedure was 
used for the indirect co-cultures of hWJSCs. 
 
2.6. Proliferation assay (DNA quantification) 
 
Evaluation of cells proliferation was performed using the PicoGreen dsDNA 
quantification Kit (Molecular Probes, P7589, Invitrogen), according to the manufacturer 
protocol. Samples from every culture were collected at each time point. Triplicates of 
each time point were produced. A standard curve was established. Fluorescence of both 
samples and standard curve was read with an excitation of 485 nm and an emission of 
528 nm, in a microplate reader (Synergie HT). The DNA concentration was 
extrapolated directly from the standard curve. 
 
2.7. Dimethylmethylene blue (DMB) assay for glycosaminoglycans quantification 
 
Dimethylmethylene blue assay was performed according to the method described by 
Kafienah and Sims, 2004 [49]. Briefly, samples were collected at 1 and 4 weeks of 
culture, frozen overnight and then digested. This digestion allowed separating the 
formed ECM from the scaffold. The digestion solution was prepared by adding 1 
mg/mL of proteinase K (Sigma, P8044) diluted in 50 mM Tris-HCl, at pH of 7.6. Tris-
HCl solution was prepared using the appropriate amount of Tris-HCl, adding sodium 
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azide (Sigma, 13412) to a final concentration of 0.05% (w/v). The pH was corrected to 
obtain the final value of 7.6. Samples were placed in 1.5 mL tubes and incubated with 1 
mL of the referred solution, overnight at 60ºC. Afterwards, samples were centrifuged in 
a bench centrifuge at 13000 rpm for 10 minutes and the supernatant was collected. 
Solutions for this assay were prepared as follows. Dimethymethylene Blue (DMB) 
stock solution was prepared dissolving 16 mg of DMB powder (Aldrich, 34088) in 900 
ml of distilled water containing 3.04 g of glycine (Sigma, G8898) and 2.73 g of NaCl 
(Sigma, S3014). This was mixed for 2 hours, covered with aluminium foil. pH was 
adjusted to 3.0 with HCl (Panreac, 1310202424) and a final volume of 1L. The solution 
was stored at room temperature covered with aluminium foil. Chondroitin sulphate 
(Sigma, C8529) solution was prepared in water, in a 5 mg/ml stock solution and kept 
refrigerated. This solution was diluted with water resulting in 5 unit increments from 0 
μg/ml to 50 μg/ml, in order to make a standard curve. 20 μl of water were added to a 96 
well plate, as a blank. The same quantity of chondroitin sulphate diluted solutions was 
added, in triplicate, and the same was performed with all the samples. DMB solution 
was added, 250 μl to each well, the plates were incubated for 10 minutes and then the 
optical density was measured in a microplate reader, at 525 nm. 
 
2.8. RNA isolation 
 
Samples were collected from all controls at 7 and 28 days of experiment. Samples 
were washed in PBS, immersed in TRIzol reagent (Invitrogen, 15596-018) and kept at -
80ºC for posterior RNA extraction. When the extraction was performed, samples were 
taken from the freezer, in order to thaw. Chloroform (Sigma, C2432) was added; 
samples were vigorously agitated for 15 seconds and then incubated in ice for 15 
minutes. After that incubation, samples were centrifuged at 13000 rpm, for 15 minutes, 
at 4ºC. Afterwards, the supernatant was collected for a sterile 1.5 mL tube, and an 
equivalent volume of isopropanol (Sigma, I9516) was added. Samples were incubated at 
-20ºC overnight, to precipitate the RNA. The next day, samples were centrifuged at 
13000 rpm, for 15 minutes, at 4ºC. Then, the supernatant was taken and 800 μl of 
ethanol 70% was added, in order to wash away the isopropanol. This ethanol 70% 
solution was prepared from absolute ethanol (Merck, 1.00983.2511) and ultra pure 
water. Tubes were agitated vigorously and centrifuged again, at 9000 rpm for 5 minutes, 
at 4ºC. The supernatant was again removed, and the pellet was left to air dry. Finally, 
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the pellet was ressuspended in 50 μl of distilled water DNase, RNase free (Gibco, 
10977-015). The concentration and purity of the extracted RNA was evaluated using the 
NanoDrop ND-1000 Spectrophotometer (NanoDrop Technologies Inc, USA). 
 
2.9. Real-Time PCR 
 
The Real-Time PCR procedure used in the present work consisted of a two step 
fluorogenic assay using the PerfeCta™ SYBR® Green system (Quanta Biosciences, 
95055-100). All reagents used in this procedure were purchased from Quanta 
Biosciences, following the instructions of the manufacturer. Thermocycler reaction 
conditions used were also the ones mentioned in the kits. In the first step, RNA was 
reversed transcribed into cDNA, using the qScript cDNA Synthesis Kit (95047-500). A 
MasterCycler EP Gradient detection system (Eppendorf, USA) was used to perform the 
reaction. Afterwards, the obtained cDNA was used as template for the amplification of 
the targets genes sohwn in Table I, with the PerfeCta™ SYBR® Green FastMix™ kit 
(95072-05K). Tested genes were aggrecan, collagens type I and II and Sox9. GAPDH 
was used as house-keeping gene, and the expression of all target genes was normalized 
against the GAPDH of that sample for each time point of the study. All primer 
sequences were generated using Primer3 software [50] and acquired from MWG 
Biotech AG, Germany. Table I shows the primers sequences used. 
 
Table 7.1 – Primer sequences used for RT-PCR procedures *. 
Gene Forward (5´-3´) Reverse (5´-3´) 
AGC TGAGTCCTCAAGCCTCCTGT TGGTCTGCAGCAGTTGATTC 
COL II CGGTGAGAAGGGAGAAGTTG GACCGGTCACTCCAGTAGGA
COL I AGCCAGCAGATCGAGAACAT ACACAGGTCTCACCGGTTTC 
Sox9 TTCATGAAGATGACCGACGC GTCCAGTCGTAGCCCTTGAG 
GAPDH ACAGTCAGCCGCATCTTCTT ACGACCAAATCCGTTGACTC 
*AGC = Agreccan; COL II = Collagen type II; COL I = Collagen type I; Sox9 = Sry-type high mobility 
group box 9; GAPDH = Glyceraldehyde 3-phosphate dehydrogenase 
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2.10. Histological analysis 
 
Samples were collected at the end of the experiment and processed for histology. 
Samples were then fixed in 10% neutral buffered formalin and then dehydrated through 
crescent concentrations of ethanol, immersed in infiltration solutions, embedded in 
Technovit glycol methacrylate (kit 8100, Heraeus Kulzer, EBSciences, CO, USA) and 
then polymerized. Specimens were cut to obtain longitudinal sections of 7 µm of 
thickness, using a modified microtome equipped with a tungsten blade (Leica RM 
2155). Staining solution for toluidine blue assay was prepared by adding 1% of 
toluidine blue (Sigma, T0394) dissolved in distilled water containing 0.5 g of sodium 
borate, followed by filtering. One drop of this solution was added to each section for 1 
minute. Then, the sections were rinsed with distilled water and let to air dry overnight. 
Sections were cleared in xylene substitute (Sigma, A5597) and mounted in Histo clear 
(Frilabo, HS200). Safranin O staining was performed by washing slides in tap water, 
then immersed in 0.02% fast green solution (Fluka, 44715) for 6 minutes. Then, they 
were immersed in 1% acetic acid (Panreac, 131008) solution for 1 minute. After, slides 
were immersed in 0.1% safranin O (Fluka, 84120) solution for 10 minutes. By the end, 
slides were washed in tap water and let to air dry. Sections were cleared in xylene 
substitute and mounted as previously described. 
 
2.11. Statistical analysis 
 
Statistical analysis was performed using the SPSS statistic software (Release 15.0.0 
for Windows). Firstly, a Shapiro-Wilk test was used to ascertain about the data 
normality and variance equality. The normality condition was rejected and, 
consequently, nonparametric tests were used in further comparisons between direct and 
indirect co-cultures. A Kruskal-Wallis test followed by Tukey’s HSD test was applied 
to compare differences in between the days in culture type. P values lower than 0.001 
were considered statistically significant in the analysis of the results. 
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3. Results 
 
3.1. DNA quantification 
 
The DNA concentration for each type of co-culture was assessed. Samples were 
collected at each time point of the experiment. We determined if there were any 
differences in between the days of culture, for each type of co-culture (direct or 
indirect), and also in the control conditions. 
 
3.1.1. Co-cultures using hBMSCs 
In terms of DNA concentration, both types of co-cultures using hBMSCs seem to 
follow the same trend of proliferation. DNA contents increased with time in both types 
of co-cultures, whereas the positive control shows a decrease at 21 days, increasing 
again towards the end of the experiment (Figure 7.1A). These results indicate that both 
types of co-cultures using hBMSCs were proliferating at a comparable rate, whereas in 
the control conditions (hACs) cell numbers did not increased between 14 and 21 days, 
recovering only in the last time point. Figure 7.1B shows the table of results for the 
statistical analysis concerning the differences between the various time points of the 
experiment, for each type of co-culture using hBMSCs. We found no significant 
differences between the various time points either in direct co-cultures (p=0.172) or 
indirect co-cultures (p=0.062), showing that the proliferation was not very strong during 
the experiment. The control conditions show a significant increase from the 7th to the 
28th day of experiment, as observed in the statistical analysis results in Figure 7.1C. It is 
noteworthy that both the direct and indirect co-cultures show the highest levels of DNA 
concentration when compared to the controls in the last time point. 
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Figure 7.1 - Box plot of the DNA concentration in co-cultures using human bone 
marrow MSCs. A - Box plot of DNA concentration for direct and indirect co-cultures 
with hBMSCs and control conditions (hACs alone). B – Table with the statistical 
analysis results for the between days of culture differences (Kruskal-Wallis test, 
presented as median ± interquartile range (IQR)). C – Table with the statistical analysis 
results for between days differences in the control conditions (Kruskal-Wallis test 
followed by Tukey’s HSD test.). 
 
3.1.2. Co-cultures using hWJSCs 
The trend of DNA concentration of hWJSCs co-cultures is rather different than the 
DNA concentration found for the co-cultures using hBMSCs. Both direct and indirect 
co-cultures show a decreasing tendency in the first days of culture. Then, the DNA 
concentration in direct co-cultures continues decreasing until the 21st day, increasing 
afterwards until the end of the experiment (Figure 7.2A). This result might indicate that 
the proliferation of the direct co-cultures with hWJSCs slowed down up to the 21st day. 
Conversely, indirect co-cultures with hWJSCs show an increase in DNA concentration 
after 14 days of culture, showing a marked decrease towards the last time point. 
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Comparing the various time points, we found no significant differences between the 
days in direct co-cultures (p=0.04) using hWJSCs (Figure 7.2B). At 21 days, indirect 
co-cultures using hWJSCs displayed a significantly higher DNA concentration than in 
the other time points (p<0.001). On the contrary, at 28 days these cultures displayed a 
significantly lower DNA concentration than all the other time points (p<0.001). This 
result seems to indicate that the proliferation is slowing down towards the end of the 
experiment. On the contrary, the control conditions showed a significant increase 
comparing the 7th and 28th day of the experiment (Figure 7.2C). The highest DNA 
concentration after 28 days of culture was obtained by direct co-cultures. 
 
Figure 7.2 - Box plot of the DNA concentration in co-cultures using human WJSCs. 
A - Box plot of DNA concentration for direct and indirect co-cultures with hWJSCs and 
control conditions (hACs alone). B – Table with the statistical analysis results for the 
between days of culture differences (Kruskal-Wallis test, presented as median ± 
interquartile range (IQR)). C – Table with the statistical analysis results for between 
days differences in the indirect co-cultures and in control conditions (Kruskal-Wallis 
test followed by Tukey’s HSD test.). 
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3.2. Glycosaminoglycans quantification 
 
The GAGs content for each type of co-culture was assessed. Samples were collected 
at 7 and 28 days of the experiment. We compared GAGs content between the types of 
co-cultures (direct vs indirect). We also compared the differences between both types of 
co-cultures and our control condition, hACs to determine if the co-cultures were 
accumulating more GAGs than chondrocytes alone. Afterwards, we determined if any 
differences were observed between the different time points, for each type of co-culture 
(direct or indirect). 
 
3.2.1. Co-cultures with hBMSCs 
Both direct and indirect co-cultures with hBMSCs show a small decrease in the GAG 
content from 7 to 28 days of the experiment, whereas control conditions showed the 
expected significant increase in GAGs deposition over time (Figure 7.3A). 
 
 
 
Figure 7.3 - Box plot of the GAGs concentration in both types of co-cultures, along 
the experiment. A - Box plot of GAGs concentration for direct and indirect co-cultures 
with hBMSCs and control conditions (hACs alone). B - Box plot of the GAGs 
concentration for direct and indirect co-cultures using hWJSCs and control conditions 
(hACs alone). Data were analyzed by nonparametric way of a Kruskal-Wallis test 
followed by Tukey’s HSD test. * denotes significant differences compared to direct co-
cultures. 
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No significant difference between direct and indirect co-cultures using hMSCs was 
found for 7 days of culture (p=0.061). At the end of the experiment, direct co-cultures 
displayed a significantly lower amount of GAGs than indirect co-cultures (p=0.006), as 
well as lower than the values for the control conditions (p=0.002). These results show 
that those co-cultures did not deposit more GAGs than the control condition. No 
significant differences between 7 and 28 days were observed in direct co-cultures 
(p=0.534) and in indirect co-cultures with hBMSCs (p=0.963).  
 
3.2.2. Co-cultures using hWJSCs 
In co-cultures using hWJSCs, a consistent trend was observed for all the conditions. 
Direct and indirect co-cultures, as well as the control conditions, show an increase in 
GAGs content along the time in culture (Figure 7.3B). For co-cultures using hWJSCs no 
significant difference between direct and indirect co-cultures was found after 7 days 
(p=0.138) nor after 28 days (p=0.733). Significant differences were found between 7 
and 28 days of culture for both direct and indirect co-cultures. After 28 days, all the 
conditions displayed a significantly higher GAG concentration compared to 7 days 
(p<0.01), meaning that the GAGs accumulation is very alike to the control conditions, 
with native chondrocytes.  
The GAGs concentration values obtained for all the time points for direct or indirect 
co-cultures with hBMSCs show consistently lower values when comparing to the ones 
obtained for the co-cultures with hWJSCs. 
 
3.3. Real-Time PCR 
 
Samples were collected for Real-Time PCR at 7 and 28 days of experiment. The aim 
was to determine the expression of several cartilage-related genes and to compare the 
differences between the expressions in both types of co-cultures, on both time points. 
 
3.3.1. Co-cultures using hBMSCs 
 In both types of co-cultures using hBMSCs, no significant differences were found 
between the cultures for Aggrecan or Sox9, at 7 days (p=0.072 and p=0.868, 
respectively) or 28 days (p=0.183 and p=0.115, respectively), as shown in Figure 7.4. 
Direct co-cultures using hBMSCs expressed significantly higher values of Collagen 
type I, compared either to indirect co-cultures or to the control conditions (p<0.001), 
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indicating the formation of fibrocartilage in direct co-cultures.  Collagen type II 
expression in indirect co-cultures of hBMSCs, displayed a significantly higher 
expression than direct co-cultures and control conditions (p<0.001) at 7 day of culture. 
After 28 days, direct co-cultures displayed a significantly higher Collagen type II 
expression than indirect co-cultures (p=0.009) and control conditions (p=0.002). 
 
 
Figure 7.4 – Bar plots of chondrogenic markers present in direct and indirect co-
cultures using hBMSCs, normalized for the reference gene GAPDH, after 7 and 28 days 
of culture. Data were analyzed by nonparametric way of a Kruskal-Wallis test for 
Aggrecan and Sox9. Data related with Collagen type I and Collagen type II were 
analyzed by nonparametric way of a Kruskal-Wallis test followed by Tukey’s HSD test. 
* denotes significant differences compared to direct co-cultures, # denotes significant 
differences compared to indirect co-cultures. 
 
3.3.2. Co-cultures using hWJSCs 
Statistic analysis of gene expression in direct and indirect co-cultures using hWJSCs 
showed significant differences for almost all the genes (Figure 7.5). For Aggrecan, there 
was a significantly lower expression on the control conditions, when compared to direct 
and indirect co-cultures (p<0.001), at 7 days of culture. However, at 28 days of culture, 
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both types of co-cultures using hBMSCs showed a significantly higher expression of 
Aggrecan than control conditions (p<0.001). Additionally, indirect co-cultures also 
displayed a significantly higher value for Aggrecan expression when compared to direct 
co-cultures (p=0.007). 
Indirect co-cultures also expressed significantly higher values of Sox9 expression, at 
28 days of culture, when compared to direct co-cultures and control conditions 
(p<0.001). For Collagen type I, no significant difference between cell type was found 
either at 7 (p=0.044) or 28 days of culture (p=0.498). However, the trend was to 
decrease its expression for the longer time periods. 
Direct co-cultures using hWJSCs displayed a significantly higher expression of 
Collagen type II than indirect co-cultures, after 7 days in culture. In contrast, indirect 
co-cultures displayed a significantly higher Collagen type II expression than the control 
conditions (p=0.006), and a significant trend to increase the expression of this important 
gene, in contrast to other culture conditions. 
 
 
 
Figure 7.5 – Bar plots of chondrogenic markers present in direct and indirect co-
cultures using hWJSCs, normalized for the reference gene GAPDH, after 7 and 28 days 
of culture. Data were analyzed by nonparametric way of a Kruskal-Wallis test for 
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Collagen type I. Data related to Aggrecan, Sox9 and Collagen type II expressions were 
analyzed by nonparametric way of a Kruskal-Wallis test followed by Tukey’s HSD test. 
* denotes significant differences compared to direct co-cultures, # denotes significant 
differences compared to indirect co-cultures. 
 
3.4. Histological staining 
 
By the end of the experiment, samples of every co-culture were collected for 
histological sectioning. Sections were stained for cartilagineous ECM using toluidine 
blue and safranin O assays (Figure 7.6). Both types of cells, either in direct or indirect 
co-culture, were able to produce ECM, as shown by the positive stain of toluidine blue 
and safranin O for ECM components. The cells were able to proliferate around the fiber 
meshes, and were able to grow in between the fibers inside the structure of the 
scaffolds. For co-cultures using hBMSCs no evident differences in terms of the quantity 
of cartilage ECM formation are observed in the histological staining results, either for 
direct or indirect co-cultures. Nevertheless, positive staining for proteoglycans can be 
observed either with toluidine blue or with safranin O stain. These observations are 
consistent with the previously obtained results for GAGs accumulation, as well as the 
RT-PCR results that showed the expression of cartilage related genes at the end of the 
experiment. 
In the case of co-cultures using hWJSCs, the same observations were made. It is 
possible to state ECM formation both in direct and indirect co-cultures, stained with 
toluidine blue and safranin O. These observations are also consistent with the previously 
obtained results for GAGs accumulation and cartilage related genes expression at 28 
days of culture. 
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Figure 7.6 – Histological sections of direct and indirect co-cultures using human 
BMSCs and WJSCs, stained for ECM localisation. 
 
 
4. Discussion 
 
The use of biomaterial scaffolds to enhance ECM-cell interactions has been reported 
as a very important factor when using stem cells for TE [7, 42, 51]. For detailed 
overview on this matter, please refer to [52, 53]. The positive effect of 3D scaffolds in 
the chondrogenic differentiation of BMSCs [54-56] and UCSCs [32, 57] has been 
reported elsewhere. In the present work we showed that both hBMSCs and hWJSCs 
were able to undergo chondrogenic differentiation when seeded onto CPBS fiber 
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meshes. Polyglycolic acid (PGA) scaffolds were recently used for comparing the 
potential of hBMSCs and hUCSCs for cartilage tissue engineering. The authors 
observed enhanced chondrogenic differentiation of hUCSCs when compared to 
hBMSCs [7]. The chondrogenic differentiation of MSCs on chitosan fibrous scaffolds 
and chitosan sponges was compared, demonstrating that chondrogenesis on chitosan 
scaffolds is superior on microfibers, when compared to sponges [58]. 
Herein, chondrogenic differentiation of human BMSCs and WJSCs was observed 
both in direct and indirect co-cultures. The soluble signals released by articular 
chondrocytes, either by the direct contact or in the form of soluble factors released in 
the culture medium, did effectively promote chondrogenic differentiation of hBMSCs 
and of hWJSCs. A recent study reported similar conclusions for the chondrogenic 
differentiation of adipose stem cells when co-cultured with chondrocytes [59]. In that 
report, adipose stem cells were cultured in pellets either directly or indirectly with 
chondrocytes, and it was concluded that the chondrocytes secreted signals promoted 
chondrogenic differentiation of adipose stem cells. The co-culture systems used in the 
present work were able to provide MSCs with the signals and the stimulation needed for 
their chondrogenic differentiation. A similar result was found when using conditioned 
medium from chondrocytes in the chondrogenic differentiation of embryonic stem cells 
[48]. The authors could show the coordination of signals between the co-cultures, 
suggesting that chondrogenic differentiation of embryonic stem cells can be achieved by 
co-cultures with chondrocytes, without other exogenous growth factors being required. 
No significant differences between the days in culture, in terms of proliferative ability, 
were found for the co-cultures using hBMSCs. Likewise, no significant differences 
were found for direct co-cultures using hWJSCs. However, when analysing the 
proliferative ability of hWJSCs in indirect co-cultures we observed significantly higher 
differences between the 21st day and all the other time points. Moreover, the values 
obtained for the DNA concentration of hWJSCs are higher than the ones obtained for 
the hBMSCs. The higher proliferative potential of hWJSCs compared to hBMSCs has 
been demonstrated earlier [15], as well as their enhanced chondrogenic potential [14]. 
Both types of co-cultures were able to produce and deposit GAGs. For the cultures with 
hBMSCs, a significantly lower GAG concentration value was found for the direct co-
cultures, comparing to the indirect. For the cultures using hWJSCs, no significant 
differences were found in terms of GAGs concentration between direct and indirect co-
cultures. These results show that indirect co-cultures may be more effective in ECM 
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components production, at least in terms of chondrogenic differentiation of hBMSCs, 
since no differences were found for hWJSCs. Our data with co-cultures of hBMSCs are 
similar to the results obtained in a study using passaged chondrocytes and primary 
bovine chondrocytes [19]. In that study, indirect co-cultures of primary and passaged 
chondrocytes were performed using filter inserts and it was found that the passaged 
cells accumulated ECM, when in contact with the conditioned medium produced by the 
primary chondrocytes. Although indirect co-cultures using hBMSCs seem to have an 
advantage in terms of GAGs accumulation, both types of co-cultures using these cells 
displayed a significantly lower value when compared to the chondrocytes culture 
(control condition). These results show that co-cultures with hBMSCs produced and 
accumulated less GAGs than the native chondrocytes cultures. In terms of GAGs, we 
can say that the hBMSCs co-cultures do not show a clear advantage over chondrocytes. 
Interestingly, both direct and indirect co-cultures using hWJSCs displayed a 
significantly higher concentration of GAGs at 28 days of culture, compared to 7 days. 
The values for GAGs concentration were higher in the cultures using hWJSCs than in 
the cultures using hBMSCs, indicating more formation and accumulation of these 
important components of the cartilaginous ECM.  Our results showed enhanced 
chondrogenesis in hWJSCs, when in indirect or direct co-cultures.  
In the histological sections, it is noticeable that both cultures of hBMSCs and of 
hWJSCs were able to produce ECM components, namely proteoglycans. These 
components were stained both with toludine blue and with safranin O, showing ECM 
deposition. ECM accumulation was also observed in passaged human chondrocytes, 
when in co-cultures with bovine chondrocytes [34]. Co-cultures of equine BMSCs with 
equine articular chondrocytes improved the expression of cartilage related genes, and 
induced the production of a more homogeneous ECM within the neo-cartilage [36].  
In terms of gene expression, for the cultures using hBMSCs, direct co-cultures 
showed significantly higher expression of Collagen type I than indirect co-cultures, at 
the end of the experiment. In terms of Collagen type II expression, direct co-cultures 
displayed a significantly higher expression at 7 days of culture than indirect co-cultures. 
On the other hand, towards the end of the experiment, indirect co-cultures showed a 
higher expression of collagen type II compared to the direct co-cultures. Again, the 
positive effect of using conditioned medium is evidenced by the results. For hWJSCs 
co-cultures, a significantly higher expression of Aggrecan was found for indirect co-
cultures of hWJSCs at 28 days, compared to the direct ones. The same significantly 
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higher expression was observed for Sox9 expression. For Collagen type II, there was a 
decrease in the last day of culture for the direct co-cultures. In this last time point, a 
significantly higher expression was found for the indirect co-cultures, when compared 
to the control conditions. Therefore, this system of co-culturing has a considerable 
clinic potential.  
The use of conditioned medium to promote the differentiation of MSCs for further 
implantation is a valuable concept in terms of regenerative medicine, because it will 
allow obtained conditioned medium of unrelated chondrocytes to promote the 
differentiation of autologous stem cells. In the present work, we propose a new strategy 
for cartilage tissue engineering strategies based on the use of conditioned medium, and 
we were able to demonstrate its effect in MSCs chondrogenesis. The positive effect of 
the conditioned medium in osteogenesis and chondrogenesis has been recently 
demonstrated, using MSCs seeded onto polycaprolactone/hydroxyapatite scaffolds and 
on alginate, respectively [60]. In a different approach, using porcine cells for 
chondrogenic differentiation for intervertebral disc repair, notochordal cell conditioned 
medium promoted MSCs differentiation, induced significantly more collagen type II 
expression and GAGs production in MSCs [61]. In the present work, the soluble factors 
released by hACs in culture were able to induce chondrogenic differentiation of both 
hBMSCs and hWJSCs without the addition of growth factors. This is a very interesting 
result, since in a clinical perspective it is preferable to use conditioned medium for 
chondrogenic differentiation of MSCs than to induce it with growth factors or even with 
direct co-cultures. There are many cost associated with the use of growth factors, so this 
cost could be reduced when using conditioned medium. Indeed, this technique should 
be further explored, as some reports show that the use of conditioned medium is very 
versatile. For example, conditioned medium from a human hepatocarcinoma cell line 
(HepG2) enhanced in vitro chondrogenesis of murine embryonic stem cells [62]. 
Therefore, chondrocyte cell lines could be eventually established for conditioned 
medium production, to further induce chondrogenic differentiation of autologous MSCs 
in 3D scaffolds prior to its implantation. However, it is very important to identify, in the 
first place, the soluble factors that are being release into the hACs culture medium and 
that successfully induced the chondrogenic differentiation of hBMSCs and hWJSCs. 
Indirect co-cultures of human MSCs using conditioned medium from hACs seem to 
be more suitable for engineered cartilage formation. The results of indirect co-cultures 
(either with BMSCs or with WJSCs) towards the end of the experiment were 
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significantly higher for all the tested parameters, namely GAGs accumulation and 
cartilage related-genes expression (Collagen type II, Aggrecan and Sox9). Concerning 
the type of human MSCs tested, we obtained strong evidence that hWJSCs are more 
promising than hBMSCs for cartilage related applications using this strategy. 
Additionally, more GAGs accumulation was measured again for both direct and indirect 
co-cultures using hWJSCs. These cultures also expressed Aggrecan, Sox9 and Collagen 
type II, genes related to articular cartilage. Collagen type I, related to fibrotic cartilage, 
did not have a significant expression in these cultures with hWJSCs. This result may be 
indirectly related to a superior chondrogenic performance of hWJSCs when compared 
to hBMSCs [7]. 
 
 
5. Conclusions 
 
Human adult MSCs were able to differentiate into the chondrogenic lineage, when co-
cultured with hACs in CPBS scaffolds. In terms of type of culture, indirect co-cultures 
(using conditioned medium) seem more effective for chondrogenic differentiation. This 
is a very interesting result to be further explored for clinical translation. In this way, 
conditioned medium without the addition of other supplements or growth factors can be 
employed to enhance MSCs expansion and chondrogenic differentiation, prior to 
implantation. Indirect co-cultures using conditioned medium, using either BMSCs or 
WJSCs, showed significant higher values in terms of GAGs accumulation and cartilage 
related genes expression, when compared to direct co-cultures. In terms of cell source, 
hWJSCs showed higher proliferation rates and higher chondrogenic differentiation 
ability when compared to hBMSCs. Human WJSCs expressed significant higher values 
of DNA concentration, GAGs accumulation and cartilage related genes (Aggrecan, 
Collagen type II and Sox9). Human BMSCs chondrogenic differentiation produced 
fibrous cartilage, as stated by the significantly higher expression of Collagen type I 
when compared to hWJSCs. 
In conclusion, indirect co-cultures of hWJSCs using conditioned medium obtained 
from hACs cultures are a new approach for cartilage tissue engineering that should be 
extensively studied for future clinical applications, as an alternative method for 
expanding autologous cells prior to implantation. 
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Abstract 
 
Chondrocytes are mainly responsible for maintaining the integrity of the extracellular 
matrix of articular cartilage and for the protection of the underlying subchondral bone. 
Mesenchymal Stem Cells (MSCs) are also believed to contribute to the maintenance of 
cartilage. Moreover, these cells have been recognized for their ability to differentiate 
into cells of different tissues such as bone, cartilage or adipose tissue, and therefore 
might be of great interest for developing cartilage therapeutic strategies. These cells are 
typically induced to differentiate by growth factors supplementation in the culture 
medium that will trigger differentiation into the desired cell phenotype.  
One frequent problem that occurs in cartilage tissue engineering is that expanded 
chondrocytes undergo dedifferentiation when in 2D culture. This process leads 
frequently to the undesired production of fibrocartilage, and is associated with the loss 
of their phenotype in vitro. The use of an additional cell source to enhance cell numbers, 
not loosing the differentiation potential upon expansion in vitro may be an original 
choice. Moreover, soluble factors released by chondrocytes have been shown to 
influence stem cells differentiation onto the chondrogenic lineage. The use of 
conditioned medium obtained from chondrocytes for stimulating stem cells 
chondrogenic differentiation may be a very interesting alternative for moving into the 
clinical application of these cells.  
In the present work, direct contact co-cultures and indirect co-cultures (using 
conditioned medium obtained from a culture of human articular chondrocytes) of 
human bone marrow-derived MSCs (hBMSCs) and human Wharton´s jelly MSCs 
(hWJSCs) were established. Cells were isolated from human samples collected at a 
local hospital, under donors’ informed consent. The co-cultures were performed in 
previously produced 3D scaffolds, composed by a blend of 50/50 chitosan and poly 
(butylene succinate) – CPBS. Co-cultures were maintained during 28 days. Both types 
of stem cells were able to undergo chondrogenic differentiation, either in direct or 
indirect co-cultures. By the end of the experiment, the indirect co-cultures (using 
conditioned medium) showed significantly higher values in terms of DNA content, 
glycosaminoglycans (GAGs) accumulation and specific cartilage-related genes 
expression, when compared to direct co-cultures, for both types of adult MSCs tested. 
Human BMSCs resulted in fibrous cartilage, as it can be concluded by the significantly 
higher expression of Collagen type I. The hWJSCs showed higher chondrogenic 
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differentiation ability when compared to hBMSCs, as denoted by the higher values for 
GAGs accumulation and cartilage related genes expression.  
Therefore, we were able to demonstrate the high chondrogenic potential of hWJSCs, 
and proved that co-cultures of articular chondrocytes with these cells are able to 
produce more cartilaginous ECM, when compared to co-cultures with hBMSCs. The 
use of conditioned medium obtained from articular chondrocytes induced MSCs 
chondrogenic differentiation and ECM formation. The obtained results showed that this 
new strategy is very interesting and should be further explored for clinical applications. 
 
 
1. Introduction 
 
Research concerning cartilage regeneration is of special importance, since this tissue 
lacks self-repairing capacity and causes a huge social and economic impact. Several cell 
types have been proposed for cartilage tissue engineering, as for example the direct use 
of autologous chondrocytes. However, this method is not very convenient, since it 
involves a biopsy used as cell source for primary chondrocytes that is always limited in 
size and consequently in cell numbers obtained [1]. Also, chondrocytes tend to 
dedifferentiate when expanded in 2D culture, in vitro [1]. The use of stem cells can be 
very useful to overcome these issues, as they can be expanded into clinically relevant 
numbers and further differentiate into the chondrogenic lineage. Applying a 3D milieu 
is pivotal when designing a cartilage TE strategy, because chondrocytes 
dedifferentiation is reversible, and when these cells are further cultured in a 3D 
environment, they may regain their phenotype [2-5]. 
The most widespread tissue source of adult mesenchymal stem cells (MSCs) is the 
bone marrow [6, 7]. Bone marrow MSCs (BMSCs) have been proposed and applied for 
various tissue engineering applications, including for cartilage repair [6, 8-11]. Yet, the 
number of available MSCs in bone marrow [12], and the possibility of donor site 
morbidity in the procedure to obtain bone marrow aspirates, leads to the need to identify 
other MSCs sources. Human umbilical cord Wharton´s jelly has been reported as a 
potential alternative tissue source [13, 14], since human umbilical cord MSCs share 
many properties with bone marrow mesenchymal stem cells, thus supporting their 
applicability for cell-based therapies [15]. Human WJSCs (hWJSCs) have a higher 
frequency of colony forming units (CFUs-F) than hBMSCs, thus a larger number of 
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MSCs may be obtained in the initial isolation from Wharton´s jelly [13]. Further details 
on Wharton´s jelly cells as a primitive stromal cell population can be found elsewhere 
[16, 17]. Human WJSCs have also shown a higher proliferative potential than hBMSCs 
[15], being able to undergo osteogenic, chondrogenic and adipogenic differentiation 
[14]. Thus, those cells are prospective candidates for cartilage tissue engineering, as 
they display a distinct chondrogenic potential. Moreover, the improved chondrogenic 
potential of cells derived from the umbilical cord was confirmed in a study comparing 
the differentiation potential of human BMSCs and human umbilical cord stem cells 
(UCSCs) in 2D cultures [18]. 
Several strategies have been proposed to direct chondrogenesis of stem cells, which 
can be applied either alone or in conjunction. The referred two strategies comprise the 
use of specific growth factors, employing 3D structures to act as supports for cell 
growth and differentiation, or to co-culture progenitor cells with conditioned medium 
obtained from cartilage explants [19]. Cartilage is a paracrine organ, which secretes 
humoral factors that influence the proliferation and differentiation of cells present in the 
surrounding tissues [20]. Chondrogenesis and osteogenesis of MSCs during in vitro 
micromass culture was affected by the use of conditioned medium obtained from 
cultures of chondrocytes [21]. It was observed that  chondrocytes secrete factors that 
may affect the differentiation status of stem cells, and can promote chondrogenesis and 
osteogenesis  [21]. In indirect co-cultures with chondrocytes and embryonic stem cells 
the interaction of paracrine factors secreted by chondrocytes with the referred cells was 
observed [22]. This interaction led to the enhancement of the embryonic stem cells 
chondrogenic commitment [22]. 
The use of a porous biodegradable scaffold to support cell growth is frequently 
proposed for tissue engineering approaches [23-26]. Chondrocytes tend to switch into a 
fibroblast-like phenotype when cultured in monolayer, in tissue culture flasks. The 
presence of a porous structure providing a 3D environment for their culture is pivotal 
for the phenotype development and stability in vitro [27]. In the case of adult stem cells, 
the influence of 3D porous structures is relevant when considering its chondrogenic 
differentiation. Both the proliferation and differentiation of MSCs can be positively 
influenced by the culture in 3D scaffolds. It was demonstrated in the literature that 
mesenchymal stem cells can be attracted into a cartilage defect by the guidance of a 
collagenous matrix after drilling a channel in the cartilage structure until reaching the 
subchondral bone [28]. 
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Our group has been investigating scaffolds produced with several of chitosan/ 
poly(butylene succinate) (CPBS) for cartilage tissue engineering. Those scaffolds 
showed good performance in supporting cell proliferation and ECM deposition [29-31]. 
CPBS scaffolds were reported to sustain the chondrogenic differentiation of a mouse 
mesenchymal progenitor cell line [30] and to promote cartilaginous ECM deposition 
when cultured with bovine articular chondrocytes [29, 31]. Moreover, CPBS fiber 
meshes were also proposed for bone-related strategies using MSCs, with positive results 
[23, 32]. These fiber meshes present a highly connected 3D porous structure, as well as 
a large surface area for cell attachment and proliferation [33]. The versatility of these 
scaffolds makes them very promising candidates for future osteochondral applications. 
Nevertheless, their suitability for cartilage TE using MSCs has not been assessed 
previously. We herein hypothesize that CPBS scaffolds can also support and promote 
human MSCs chondrogenic differentiation. This is the main reason for the selection of 
these scaffolds for the present work.  
Co-cultures aiming the regeneration of cartilage are the subject of recent scientific 
interest. Several studies in the literature propose their applicability for cartilage tissue 
engineering, either using articular chondrocytes from different sources [34] or passages 
[35], stem cells and articular chondrocytes [36], or embryonic stem cells and articular 
chondrocytes [37]. The co-culture of sheep BMSCs with synovial cells showed the 
expression of chondrocytic markers [38], while the use of rat BMSCs with allogenic 
cartilage explants revealed a sustained expression of Sox9 in an early stage of 
chondrogenesis and collagen type X at a later stage, which is an undesired outcome 
since it indicates hypertrophy [39]. Co-culture of synovial-derived stem cells with TGF-
β3 transfected articular chondrocytes resulted in significantly improved chondrogenesis 
of the progenitor cells [40]. The chondrogenic effect of co-culturing chondrocytes with 
MSCs may be influenced by the tissue of origin of stem cells [41, 42]. For instance, in a 
study with human adipose-derived MSCs (ASCs) co-cultures with human articular 
chondrocytes [41], it was demonstrated that co-cultured ASCs and chondrocytes clearly 
differ in their chondrogenic potential, when compared to articular chondrocytes cultured 
alone. The co-culture of ASCs with chondrocytes resulted in decreased chondrogenesis 
[41]. Conversely, in a work comparing chondrogenesis of ASCs and BMSCs seeded 
onto hyaluronic acid scaffolds, it was shown that chondrogenesis was more efficient 
using BMSCs than ASCs or chondrocytes alone [42]. In the case of WJSCs, to our best 
knowledge, only one report can be found in the literature referring to co-cultures of 
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hWJSCs with articular chondrocytes for chondrogenic differentiation [43]. Thus, we 
herein aimed at determining whether their previously reported enhanced chondrogenic 
potential when compared to BMSCs would be maintained, of even improved, in co-
cultures with articular chondrocytes using a 3D scaffold. Additionally, we aimed to 
verify if using conditioned medium from a separate articular chondrocyte culture would 
improve the induction of chondrogenic differentiation of stem cells when compared 
with direct contact between these cells in co-culture. The possibility of using 
conditioned medium opens interesting possibilities for obtaining larger numbers of 
differentiated cells prior to implantation, in the context of its clinical application. 
 
 
2. Materials and Methods 
 
2.1. CPBS fiber meshes  
 
The porous fiber meshes used as 3D scaffolds in the present work have been produced 
and successfully tested earlier by our group for bone related applications using human 
BMSCs [44]. A detailed description of the production methods can be found elsewhere 
[45]. The chitosan used for scaffolds production was supplied by France Chitin 
(Orange, France), with a degree of deacetylation of 85%. Bionolle™ 1050, a 
polybutylene succinate copolymer (MFI~50) was obtained from Showa Highpolymer 
Co. Ltd., Tokyo, Japan. Briefly, the CPBS fibers were obtained using a prototype single 
screw micro-extruder coupled to a capillary die. The extruded fibers were chopped and 
further loaded into a mould, which was heated above the melting temperature of the 
thermoplastic blend during 10 minutes. Immediately after removing the moulds from 
the oven, the fibers were slightly compressed by a Teflon cylinder to pack and bond the 
fibers. Finally, standardized scaffolds in the form of 2 mm thick discs, and with a 
diameter of 8 mm were obtained by cutting the fiber bonded meshes with a circular 
punch tool. 
 
2.2. Isolation and expansion of hBMSCs  
 
Human BMSCs were isolated from bone-marrow aspirates collected after obtaining 
informed consent from patients undergoing knee arthroplasties. Those samples were 
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obtained under the scope of the cooperation agreement established between the 3B´s 
Research Group of the University of Minho and the Orthopaedics Department of the 
Hospital de São Marcos, Braga, Portugal. During the surgeries, bone marrow was 
collected into a container with α-MEM medium, supplemented with antibiotic/ 
antimycotic solution and 5000 units of heparin (Sigma, H3393) and maintained in ice 
until the isolation procedure. Aspirates were homogenised, diluted in phosphate saline 
buffer – PBS (Sigma, D8537) (1:1) and incubated for 5 minutes at room temperature. 
Then, bone marrow was diluted in lyses buffer (1:10) and left under agitation for 10 
minutes. Lyses buffer was prepared with 10 mM of Tris-HCl (Sigma, T3253), 1.21 g of 
Tris Base (Sigma, T1503) and 8.3 g of NH4Cl (Merck, 1011455000), in 1L of distilled 
water.  Afterwards, the suspension was centrifuged at 1200 rpm, for 15 minutes at room 
temperature. Cells were ressuspended in α-MEM medium, supplemented with 
antibiotic/ antimycotic solution and 20 % FBS. Cell suspension was filtered for disposal 
of debris, using 100 µm and 70 µm Cell Strainer (BD Falcon™, 352360 and BD 
Falcon™, 352350). Cells were counted and plated at the density of 4.7x103 cells/cm2. 
Cells were expanded in the referred culture medium until obtaining the cell numbers 
needed for this study. The stemness character of the isolated hBMSCs was analysed 
previously by flow cytometry, (CD34 and CD45 –negative; CD29, CD44, CD73, CD90, 
CD105 and CD106 - positive), using a flow cytometer, and differentiation studies into 
osteogenic, chondrogenic, and adipogenic lineage [32]. 
 
2.3. Isolation and expansion of hWJSCs  
 
Human umbilical cords were obtained after obtaining informed consent from full-term 
caesarian sections donors, under the scope of the cooperation agreement of the 3B´s 
Research Group of the University of Minho and the Obstetrics Department of the 
Hospital de São Marcos, Braga, Portugal. Human WJSCs were isolated according to the 
procedure originally described by Sarugaser et al. [13]. Briefly, umbilical cords (UC) 
were cut into 3–5 cm segments. These segments were then dissected by separation of 
the UC section epithelium along its length, exposing the underlying Wharton’s jelly. 
Each vessel, with its surrounding Wharton’s jelly matrix, was pulled away, and the ends 
of each dissected vessel were tied together with a suture creating “loops”. Following, 
the loops were digested using a 1 mg/ml collagenase type I solution (Sigma, C0130) 
prepared with PBS. After 18–24 hours, the loops were removed. The remaining 
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suspension was diluted with PBS to reduce its viscosity, followed by a centrifugation at 
1200 rpm for 5 minutes. Cells were ressuspended in 10 ml culture medium consisting of 
α-MEM medium (Invitrogen, 12000-063), supplemented with antibiotic/ antimycotic 
solution (Gibco, 15240062), 10% fetal bovine serum (Baptista Marques, 
BSC0115/0943k) and counted in a hemocytometer. Finally, cells were plated and 
expanded until reaching 80–90% confluence. The stemness character of these cells was 
previously studied by flow cytometry for MSCs markers (CD34, CD45-negative and 
CD29, CD73, CD90, CD105, CD166-positive cells), using a flow cytometer (FACS 
Calibur (BD Biosciences)), and differentiation studies into osteogenic, chondrogenic, 
and adipogenic lineage [46]. 
 
2.4. Isolation and expansion of human articular chondrocytes 
 
The isolation of human articular chondrocytes (hACs) was performed according to a 
method previously reported in the literature [47]. HACs were isolated from human 
cartilage samples collected under informed consent from patients undergoing knee 
arthroplasties in the Orthopaedics Department of the Hospital de São Marcos, Braga, 
Portugal, under the scope of the previously referred agreement. During surgeries, the 
knee was collected into a container with PBS and maintained in ice until the isolation 
procedure.  Cartilage was dissected in small full-depth pieces and washed twice with 
PBS buffer. Then, it was digested with 0.25% (w/v) of trypsin solution (Sigma, E5134) 
for 30 minutes at 37ºC on a rotator. The solution was removed, cartilage was washed 
again in PBS buffer and then incubated in a 2 mg/ml collagenase type II solution 
(Sigma, E0130) overnight at 37ºC on a rotator. The following day, cells were washed 
twice with PBS, counted and platted at a density of 2x106 cells per Petri dish. Cells 
were cultivated with expansion medium: Dulbecco’s modified Eagle’s medium (Sigma, 
D5671), containing 10 mM Hepes buffer (Sigma, H0887), L-alanyl-L-glutamine 
(Sigma, G8541), Non Essential Aminoacids (Sigma, M7145), antibiotic/ antimycotic 
solution, 10% fetal bovine serum and 10 ng/ml of basic Fibroblast Growth Factor 
(bFGF) (PeproTech, 100-18B).  
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2.5. Co-cultures 
 
Cells were expanded until they reached the needed number. They were then split, 
counted and then seeded onto the CPBS fiber meshes. Two study groups were 
established: direct co-culture using one source of hMSCs (either hBMSCs or hWJSCs) 
and hACs; indirect co-culture using conditioned medium obtained from hACs cultures. 
The indirect co-culture method herein described is a variation of the transwell inserts 
technique [22, 48]. Instead of separating the two cultures with a transwell, we cultured 
separately the chondrocytes and the stem cells. As explained in the introduction, it is 
known that the 3D structure of the scaffolds can positively influence the chondrogenic 
commitment of MSCs. We hypothesised that by providing the microenvironment and 
the soluble factors present in the chondrocytes medium we would be able to influence 
the chondrogenic differentiation of both types of MSCs used in the present work. Thus, 
as the medium provided was previously consumed by the chondrocytes, we used 
conditioned medium mixed (50/50 in volume) with fresh medium. By means of diluting 
the factors secreted by the chondrocytes in fresh medium, it was our intention to provide 
the required nutrients to the MSCs indirect co-cultures, avoiding the risk of nutrient 
deprivation. 
 
2.5.1. Direct co-cultures 
A suspension of 1x106 cells (5x105 hBMSCs and 5x105 hACs) per scaffold was used 
for seeding the fiber meshes, in a rotator inside the incubator at 37ºC and 5% CO2, 
during 24 hours. Basic medium was used: Dulbecco’s modified Eagle’s Medium 
containing 10 mM Hepes solution, L–alanyl–L–glutamine, Non Essential Aminoacids, 
antibiotic/ antimicotic and 10% fetal bovine serum. Afterwards, constructs were 
transferred to new culture plates containing differentiation medium. This medium is a 
modification of the expansion medium: instead of adding bFGF, 1mg/ml of L-ascorbic 
acid (Sigma, A8960) and 50 mg/ml of insulin (Sigma, I5500) were added. Constructs 
were placed inside the incubator under the same conditions and cultured for 28 days. 
Medium was changed every other day. The same procedure was used for the direct co-
cultures of hWJSCs. 
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2.5.2. Indirect co-cultures 
Indirect co-cultures were performed using conditioned medium obtained from the 
chondrocytes in culture. First, a cell suspension containing 1x106 cells per scaffold was 
prepared for each type of cell (hBMSCs or hACs). Each cell type was seeded onto 
different CPBS scaffolds, in different culture plates. The seeding procedure was similar 
to the one described above for the direct co-cultures. Afterwards, cells were placed in 
new culture plates containing differentiation medium. After two days, the medium was 
changed. Human BMSCs medium was completely removed, and replaced by the 
mixture of conditioned and fresh medium. It consisted of a mixture of the medium 
which was removed from the chondrocytes culture, plus fresh differentiation medium 
(50/50). Medium of these cultures (hBMSCs) was changed every other day, using the 
referred mixture of conditioned medium. For the hACs cultures, fresh differentiation 
medium was used, and changed every other day. The two types of cultures were 
maintained for 28 days, in an incubator, at 37ºC and 5% CO2. The same procedure was 
used for the indirect co-cultures of hWJSCs. 
 
2.6. Proliferation assay (DNA quantification) 
 
Evaluation of cells proliferation was performed using the PicoGreen dsDNA 
quantification Kit (Molecular Probes, P7589, Invitrogen), according to the manufacturer 
protocol. Samples from every culture were collected at each time point. Triplicates of 
each time point were produced. A standard curve was established. Fluorescence of both 
samples and standard curve was read with an excitation of 485 nm and an emission of 
528 nm, in a microplate reader (Synergie HT). The DNA concentration was 
extrapolated directly from the standard curve. 
 
2.7. Dimethylmethylene blue (DMB) assay for glycosaminoglycans quantification 
 
Dimethylmethylene blue assay was performed according to the method described by 
Kafienah and Sims, 2004 [49]. Briefly, samples were collected at 1 and 4 weeks of 
culture, frozen overnight and then digested. This digestion allowed separating the 
formed ECM from the scaffold. The digestion solution was prepared by adding 1 
mg/mL of proteinase K (Sigma, P8044) diluted in 50 mM Tris-HCl, at pH of 7.6. Tris-
HCl solution was prepared using the appropriate amount of Tris-HCl, adding sodium 
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azide (Sigma, 13412) to a final concentration of 0.05% (w/v). The pH was corrected to 
obtain the final value of 7.6. Samples were placed in 1.5 mL tubes and incubated with 1 
mL of the referred solution, overnight at 60ºC. Afterwards, samples were centrifuged in 
a bench centrifuge at 13000 rpm for 10 minutes and the supernatant was collected. 
Solutions for this assay were prepared as follows. Dimethymethylene Blue (DMB) 
stock solution was prepared dissolving 16 mg of DMB powder (Aldrich, 34088) in 900 
ml of distilled water containing 3.04 g of glycine (Sigma, G8898) and 2.73 g of NaCl 
(Sigma, S3014). This was mixed for 2 hours, covered with aluminium foil. pH was 
adjusted to 3.0 with HCl (Panreac, 1310202424) and a final volume of 1L. The solution 
was stored at room temperature covered with aluminium foil. Chondroitin sulphate 
(Sigma, C8529) solution was prepared in water, in a 5 mg/ml stock solution and kept 
refrigerated. This solution was diluted with water resulting in 5 unit increments from 0 
μg/ml to 50 μg/ml, in order to make a standard curve. 20 μl of water were added to a 96 
well plate, as a blank. The same quantity of chondroitin sulphate diluted solutions was 
added, in triplicate, and the same was performed with all the samples. DMB solution 
was added, 250 μl to each well, the plates were incubated for 10 minutes and then the 
optical density was measured in a microplate reader, at 525 nm. 
 
2.8. RNA isolation 
 
Samples were collected from all controls at 7 and 28 days of experiment. Samples 
were washed in PBS, immersed in TRIzol reagent (Invitrogen, 15596-018) and kept at -
80ºC for posterior RNA extraction. When the extraction was performed, samples were 
taken from the freezer, in order to thaw. Chloroform (Sigma, C2432) was added; 
samples were vigorously agitated for 15 seconds and then incubated in ice for 15 
minutes. After that incubation, samples were centrifuged at 13000 rpm, for 15 minutes, 
at 4ºC. Afterwards, the supernatant was collected for a sterile 1.5 mL tube, and an 
equivalent volume of isopropanol (Sigma, I9516) was added. Samples were incubated at 
-20ºC overnight, to precipitate the RNA. The next day, samples were centrifuged at 
13000 rpm, for 15 minutes, at 4ºC. Then, the supernatant was taken and 800 μl of 
ethanol 70% was added, in order to wash away the isopropanol. This ethanol 70% 
solution was prepared from absolute ethanol (Merck, 1.00983.2511) and ultra pure 
water. Tubes were agitated vigorously and centrifuged again, at 9000 rpm for 5 minutes, 
at 4ºC. The supernatant was again removed, and the pellet was left to air dry. Finally, 
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the pellet was ressuspended in 50 μl of distilled water DNase, RNase free (Gibco, 
10977-015). The concentration and purity of the extracted RNA was evaluated using the 
NanoDrop ND-1000 Spectrophotometer (NanoDrop Technologies Inc, USA). 
 
2.9. Real-Time PCR 
 
The Real-Time PCR procedure used in the present work consisted of a two step 
fluorogenic assay using the PerfeCta™ SYBR® Green system (Quanta Biosciences, 
95055-100). All reagents used in this procedure were purchased from Quanta 
Biosciences, following the instructions of the manufacturer. Thermocycler reaction 
conditions used were also the ones mentioned in the kits. In the first step, RNA was 
reversed transcribed into cDNA, using the qScript cDNA Synthesis Kit (95047-500). A 
MasterCycler EP Gradient detection system (Eppendorf, USA) was used to perform the 
reaction. Afterwards, the obtained cDNA was used as template for the amplification of 
the targets genes sohwn in Table I, with the PerfeCta™ SYBR® Green FastMix™ kit 
(95072-05K). Tested genes were aggrecan, collagens type I and II and Sox9. GAPDH 
was used as house-keeping gene, and the expression of all target genes was normalized 
against the GAPDH of that sample for each time point of the study. All primer 
sequences were generated using Primer3 software [50] and acquired from MWG 
Biotech AG, Germany. Table I shows the primers sequences used. 
 
Table 7.1 – Primer sequences used for RT-PCR procedures *. 
Gene Forward (5´-3´) Reverse (5´-3´) 
AGC TGAGTCCTCAAGCCTCCTGT TGGTCTGCAGCAGTTGATTC 
COL II CGGTGAGAAGGGAGAAGTTG GACCGGTCACTCCAGTAGGA
COL I AGCCAGCAGATCGAGAACAT ACACAGGTCTCACCGGTTTC 
Sox9 TTCATGAAGATGACCGACGC GTCCAGTCGTAGCCCTTGAG 
GAPDH ACAGTCAGCCGCATCTTCTT ACGACCAAATCCGTTGACTC 
*AGC = Agreccan; COL II = Collagen type II; COL I = Collagen type I; Sox9 = Sry-type high mobility 
group box 9; GAPDH = Glyceraldehyde 3-phosphate dehydrogenase 
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2.10. Histological analysis 
 
Samples were collected at the end of the experiment and processed for histology. 
Samples were then fixed in 10% neutral buffered formalin and then dehydrated through 
crescent concentrations of ethanol, immersed in infiltration solutions, embedded in 
Technovit glycol methacrylate (kit 8100, Heraeus Kulzer, EBSciences, CO, USA) and 
then polymerized. Specimens were cut to obtain longitudinal sections of 7 µm of 
thickness, using a modified microtome equipped with a tungsten blade (Leica RM 
2155). Staining solution for toluidine blue assay was prepared by adding 1% of 
toluidine blue (Sigma, T0394) dissolved in distilled water containing 0.5 g of sodium 
borate, followed by filtering. One drop of this solution was added to each section for 1 
minute. Then, the sections were rinsed with distilled water and let to air dry overnight. 
Sections were cleared in xylene substitute (Sigma, A5597) and mounted in Histo clear 
(Frilabo, HS200). Safranin O staining was performed by washing slides in tap water, 
then immersed in 0.02% fast green solution (Fluka, 44715) for 6 minutes. Then, they 
were immersed in 1% acetic acid (Panreac, 131008) solution for 1 minute. After, slides 
were immersed in 0.1% safranin O (Fluka, 84120) solution for 10 minutes. By the end, 
slides were washed in tap water and let to air dry. Sections were cleared in xylene 
substitute and mounted as previously described. 
 
2.11. Statistical analysis 
 
Statistical analysis was performed using the SPSS statistic software (Release 15.0.0 
for Windows). Firstly, a Shapiro-Wilk test was used to ascertain about the data 
normality and variance equality. The normality condition was rejected and, 
consequently, nonparametric tests were used in further comparisons between direct and 
indirect co-cultures. A Kruskal-Wallis test followed by Tukey’s HSD test was applied 
to compare differences in between the days in culture type. P values lower than 0.001 
were considered statistically significant in the analysis of the results. 
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3. Results 
 
3.1. DNA quantification 
 
The DNA concentration for each type of co-culture was assessed. Samples were 
collected at each time point of the experiment. We determined if there were any 
differences in between the days of culture, for each type of co-culture (direct or 
indirect), and also in the control conditions. 
 
3.1.1. Co-cultures using hBMSCs 
In terms of DNA concentration, both types of co-cultures using hBMSCs seem to 
follow the same trend of proliferation. DNA contents increased with time in both types 
of co-cultures, whereas the positive control shows a decrease at 21 days, increasing 
again towards the end of the experiment (Figure 7.1A). These results indicate that both 
types of co-cultures using hBMSCs were proliferating at a comparable rate, whereas in 
the control conditions (hACs) cell numbers did not increased between 14 and 21 days, 
recovering only in the last time point. Figure 7.1B shows the table of results for the 
statistical analysis concerning the differences between the various time points of the 
experiment, for each type of co-culture using hBMSCs. We found no significant 
differences between the various time points either in direct co-cultures (p=0.172) or 
indirect co-cultures (p=0.062), showing that the proliferation was not very strong during 
the experiment. The control conditions show a significant increase from the 7th to the 
28th day of experiment, as observed in the statistical analysis results in Figure 7.1C. It is 
noteworthy that both the direct and indirect co-cultures show the highest levels of DNA 
concentration when compared to the controls in the last time point. 
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Figure 7.1 - Box plot of the DNA concentration in co-cultures using human bone 
marrow MSCs. A - Box plot of DNA concentration for direct and indirect co-cultures 
with hBMSCs and control conditions (hACs alone). B – Table with the statistical 
analysis results for the between days of culture differences (Kruskal-Wallis test, 
presented as median ± interquartile range (IQR)). C – Table with the statistical analysis 
results for between days differences in the control conditions (Kruskal-Wallis test 
followed by Tukey’s HSD test.). 
 
3.1.2. Co-cultures using hWJSCs 
The trend of DNA concentration of hWJSCs co-cultures is rather different than the 
DNA concentration found for the co-cultures using hBMSCs. Both direct and indirect 
co-cultures show a decreasing tendency in the first days of culture. Then, the DNA 
concentration in direct co-cultures continues decreasing until the 21st day, increasing 
afterwards until the end of the experiment (Figure 7.2A). This result might indicate that 
the proliferation of the direct co-cultures with hWJSCs slowed down up to the 21st day. 
Conversely, indirect co-cultures with hWJSCs show an increase in DNA concentration 
after 14 days of culture, showing a marked decrease towards the last time point. 
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Comparing the various time points, we found no significant differences between the 
days in direct co-cultures (p=0.04) using hWJSCs (Figure 7.2B). At 21 days, indirect 
co-cultures using hWJSCs displayed a significantly higher DNA concentration than in 
the other time points (p<0.001). On the contrary, at 28 days these cultures displayed a 
significantly lower DNA concentration than all the other time points (p<0.001). This 
result seems to indicate that the proliferation is slowing down towards the end of the 
experiment. On the contrary, the control conditions showed a significant increase 
comparing the 7th and 28th day of the experiment (Figure 7.2C). The highest DNA 
concentration after 28 days of culture was obtained by direct co-cultures. 
 
Figure 7.2 - Box plot of the DNA concentration in co-cultures using human WJSCs. 
A - Box plot of DNA concentration for direct and indirect co-cultures with hWJSCs and 
control conditions (hACs alone). B – Table with the statistical analysis results for the 
between days of culture differences (Kruskal-Wallis test, presented as median ± 
interquartile range (IQR)). C – Table with the statistical analysis results for between 
days differences in the indirect co-cultures and in control conditions (Kruskal-Wallis 
test followed by Tukey’s HSD test.). 
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3.2. Glycosaminoglycans quantification 
 
The GAGs content for each type of co-culture was assessed. Samples were collected 
at 7 and 28 days of the experiment. We compared GAGs content between the types of 
co-cultures (direct vs indirect). We also compared the differences between both types of 
co-cultures and our control condition, hACs to determine if the co-cultures were 
accumulating more GAGs than chondrocytes alone. Afterwards, we determined if any 
differences were observed between the different time points, for each type of co-culture 
(direct or indirect). 
 
3.2.1. Co-cultures with hBMSCs 
Both direct and indirect co-cultures with hBMSCs show a small decrease in the GAG 
content from 7 to 28 days of the experiment, whereas control conditions showed the 
expected significant increase in GAGs deposition over time (Figure 7.3A). 
 
 
 
Figure 7.3 - Box plot of the GAGs concentration in both types of co-cultures, along 
the experiment. A - Box plot of GAGs concentration for direct and indirect co-cultures 
with hBMSCs and control conditions (hACs alone). B - Box plot of the GAGs 
concentration for direct and indirect co-cultures using hWJSCs and control conditions 
(hACs alone). Data were analyzed by nonparametric way of a Kruskal-Wallis test 
followed by Tukey’s HSD test. * denotes significant differences compared to direct co-
cultures. 
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No significant difference between direct and indirect co-cultures using hMSCs was 
found for 7 days of culture (p=0.061). At the end of the experiment, direct co-cultures 
displayed a significantly lower amount of GAGs than indirect co-cultures (p=0.006), as 
well as lower than the values for the control conditions (p=0.002). These results show 
that those co-cultures did not deposit more GAGs than the control condition. No 
significant differences between 7 and 28 days were observed in direct co-cultures 
(p=0.534) and in indirect co-cultures with hBMSCs (p=0.963).  
 
3.2.2. Co-cultures using hWJSCs 
In co-cultures using hWJSCs, a consistent trend was observed for all the conditions. 
Direct and indirect co-cultures, as well as the control conditions, show an increase in 
GAGs content along the time in culture (Figure 7.3B). For co-cultures using hWJSCs no 
significant difference between direct and indirect co-cultures was found after 7 days 
(p=0.138) nor after 28 days (p=0.733). Significant differences were found between 7 
and 28 days of culture for both direct and indirect co-cultures. After 28 days, all the 
conditions displayed a significantly higher GAG concentration compared to 7 days 
(p<0.01), meaning that the GAGs accumulation is very alike to the control conditions, 
with native chondrocytes.  
The GAGs concentration values obtained for all the time points for direct or indirect 
co-cultures with hBMSCs show consistently lower values when comparing to the ones 
obtained for the co-cultures with hWJSCs. 
 
3.3. Real-Time PCR 
 
Samples were collected for Real-Time PCR at 7 and 28 days of experiment. The aim 
was to determine the expression of several cartilage-related genes and to compare the 
differences between the expressions in both types of co-cultures, on both time points. 
 
3.3.1. Co-cultures using hBMSCs 
 In both types of co-cultures using hBMSCs, no significant differences were found 
between the cultures for Aggrecan or Sox9, at 7 days (p=0.072 and p=0.868, 
respectively) or 28 days (p=0.183 and p=0.115, respectively), as shown in Figure 7.4. 
Direct co-cultures using hBMSCs expressed significantly higher values of Collagen 
type I, compared either to indirect co-cultures or to the control conditions (p<0.001), 
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indicating the formation of fibrocartilage in direct co-cultures.  Collagen type II 
expression in indirect co-cultures of hBMSCs, displayed a significantly higher 
expression than direct co-cultures and control conditions (p<0.001) at 7 day of culture. 
After 28 days, direct co-cultures displayed a significantly higher Collagen type II 
expression than indirect co-cultures (p=0.009) and control conditions (p=0.002). 
 
 
Figure 7.4 – Bar plots of chondrogenic markers present in direct and indirect co-
cultures using hBMSCs, normalized for the reference gene GAPDH, after 7 and 28 days 
of culture. Data were analyzed by nonparametric way of a Kruskal-Wallis test for 
Aggrecan and Sox9. Data related with Collagen type I and Collagen type II were 
analyzed by nonparametric way of a Kruskal-Wallis test followed by Tukey’s HSD test. 
* denotes significant differences compared to direct co-cultures, # denotes significant 
differences compared to indirect co-cultures. 
 
3.3.2. Co-cultures using hWJSCs 
Statistic analysis of gene expression in direct and indirect co-cultures using hWJSCs 
showed significant differences for almost all the genes (Figure 7.5). For Aggrecan, there 
was a significantly lower expression on the control conditions, when compared to direct 
and indirect co-cultures (p<0.001), at 7 days of culture. However, at 28 days of culture, 
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both types of co-cultures using hBMSCs showed a significantly higher expression of 
Aggrecan than control conditions (p<0.001). Additionally, indirect co-cultures also 
displayed a significantly higher value for Aggrecan expression when compared to direct 
co-cultures (p=0.007). 
Indirect co-cultures also expressed significantly higher values of Sox9 expression, at 
28 days of culture, when compared to direct co-cultures and control conditions 
(p<0.001). For Collagen type I, no significant difference between cell type was found 
either at 7 (p=0.044) or 28 days of culture (p=0.498). However, the trend was to 
decrease its expression for the longer time periods. 
Direct co-cultures using hWJSCs displayed a significantly higher expression of 
Collagen type II than indirect co-cultures, after 7 days in culture. In contrast, indirect 
co-cultures displayed a significantly higher Collagen type II expression than the control 
conditions (p=0.006), and a significant trend to increase the expression of this important 
gene, in contrast to other culture conditions. 
 
 
 
Figure 7.5 – Bar plots of chondrogenic markers present in direct and indirect co-
cultures using hWJSCs, normalized for the reference gene GAPDH, after 7 and 28 days 
of culture. Data were analyzed by nonparametric way of a Kruskal-Wallis test for 
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Collagen type I. Data related to Aggrecan, Sox9 and Collagen type II expressions were 
analyzed by nonparametric way of a Kruskal-Wallis test followed by Tukey’s HSD test. 
* denotes significant differences compared to direct co-cultures, # denotes significant 
differences compared to indirect co-cultures. 
 
3.4. Histological staining 
 
By the end of the experiment, samples of every co-culture were collected for 
histological sectioning. Sections were stained for cartilagineous ECM using toluidine 
blue and safranin O assays (Figure 7.6). Both types of cells, either in direct or indirect 
co-culture, were able to produce ECM, as shown by the positive stain of toluidine blue 
and safranin O for ECM components. The cells were able to proliferate around the fiber 
meshes, and were able to grow in between the fibers inside the structure of the 
scaffolds. For co-cultures using hBMSCs no evident differences in terms of the quantity 
of cartilage ECM formation are observed in the histological staining results, either for 
direct or indirect co-cultures. Nevertheless, positive staining for proteoglycans can be 
observed either with toluidine blue or with safranin O stain. These observations are 
consistent with the previously obtained results for GAGs accumulation, as well as the 
RT-PCR results that showed the expression of cartilage related genes at the end of the 
experiment. 
In the case of co-cultures using hWJSCs, the same observations were made. It is 
possible to state ECM formation both in direct and indirect co-cultures, stained with 
toluidine blue and safranin O. These observations are also consistent with the previously 
obtained results for GAGs accumulation and cartilage related genes expression at 28 
days of culture. 
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Figure 7.6 – Histological sections of direct and indirect co-cultures using human 
BMSCs and WJSCs, stained for ECM localisation. 
 
 
4. Discussion 
 
The use of biomaterial scaffolds to enhance ECM-cell interactions has been reported 
as a very important factor when using stem cells for TE [7, 42, 51]. For detailed 
overview on this matter, please refer to [52, 53]. The positive effect of 3D scaffolds in 
the chondrogenic differentiation of BMSCs [54-56] and UCSCs [32, 57] has been 
reported elsewhere. In the present work we showed that both hBMSCs and hWJSCs 
were able to undergo chondrogenic differentiation when seeded onto CPBS fiber 
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meshes. Polyglycolic acid (PGA) scaffolds were recently used for comparing the 
potential of hBMSCs and hUCSCs for cartilage tissue engineering. The authors 
observed enhanced chondrogenic differentiation of hUCSCs when compared to 
hBMSCs [7]. The chondrogenic differentiation of MSCs on chitosan fibrous scaffolds 
and chitosan sponges was compared, demonstrating that chondrogenesis on chitosan 
scaffolds is superior on microfibers, when compared to sponges [58]. 
Herein, chondrogenic differentiation of human BMSCs and WJSCs was observed 
both in direct and indirect co-cultures. The soluble signals released by articular 
chondrocytes, either by the direct contact or in the form of soluble factors released in 
the culture medium, did effectively promote chondrogenic differentiation of hBMSCs 
and of hWJSCs. A recent study reported similar conclusions for the chondrogenic 
differentiation of adipose stem cells when co-cultured with chondrocytes [59]. In that 
report, adipose stem cells were cultured in pellets either directly or indirectly with 
chondrocytes, and it was concluded that the chondrocytes secreted signals promoted 
chondrogenic differentiation of adipose stem cells. The co-culture systems used in the 
present work were able to provide MSCs with the signals and the stimulation needed for 
their chondrogenic differentiation. A similar result was found when using conditioned 
medium from chondrocytes in the chondrogenic differentiation of embryonic stem cells 
[48]. The authors could show the coordination of signals between the co-cultures, 
suggesting that chondrogenic differentiation of embryonic stem cells can be achieved by 
co-cultures with chondrocytes, without other exogenous growth factors being required. 
No significant differences between the days in culture, in terms of proliferative ability, 
were found for the co-cultures using hBMSCs. Likewise, no significant differences 
were found for direct co-cultures using hWJSCs. However, when analysing the 
proliferative ability of hWJSCs in indirect co-cultures we observed significantly higher 
differences between the 21st day and all the other time points. Moreover, the values 
obtained for the DNA concentration of hWJSCs are higher than the ones obtained for 
the hBMSCs. The higher proliferative potential of hWJSCs compared to hBMSCs has 
been demonstrated earlier [15], as well as their enhanced chondrogenic potential [14]. 
Both types of co-cultures were able to produce and deposit GAGs. For the cultures with 
hBMSCs, a significantly lower GAG concentration value was found for the direct co-
cultures, comparing to the indirect. For the cultures using hWJSCs, no significant 
differences were found in terms of GAGs concentration between direct and indirect co-
cultures. These results show that indirect co-cultures may be more effective in ECM 
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components production, at least in terms of chondrogenic differentiation of hBMSCs, 
since no differences were found for hWJSCs. Our data with co-cultures of hBMSCs are 
similar to the results obtained in a study using passaged chondrocytes and primary 
bovine chondrocytes [19]. In that study, indirect co-cultures of primary and passaged 
chondrocytes were performed using filter inserts and it was found that the passaged 
cells accumulated ECM, when in contact with the conditioned medium produced by the 
primary chondrocytes. Although indirect co-cultures using hBMSCs seem to have an 
advantage in terms of GAGs accumulation, both types of co-cultures using these cells 
displayed a significantly lower value when compared to the chondrocytes culture 
(control condition). These results show that co-cultures with hBMSCs produced and 
accumulated less GAGs than the native chondrocytes cultures. In terms of GAGs, we 
can say that the hBMSCs co-cultures do not show a clear advantage over chondrocytes. 
Interestingly, both direct and indirect co-cultures using hWJSCs displayed a 
significantly higher concentration of GAGs at 28 days of culture, compared to 7 days. 
The values for GAGs concentration were higher in the cultures using hWJSCs than in 
the cultures using hBMSCs, indicating more formation and accumulation of these 
important components of the cartilaginous ECM.  Our results showed enhanced 
chondrogenesis in hWJSCs, when in indirect or direct co-cultures.  
In the histological sections, it is noticeable that both cultures of hBMSCs and of 
hWJSCs were able to produce ECM components, namely proteoglycans. These 
components were stained both with toludine blue and with safranin O, showing ECM 
deposition. ECM accumulation was also observed in passaged human chondrocytes, 
when in co-cultures with bovine chondrocytes [34]. Co-cultures of equine BMSCs with 
equine articular chondrocytes improved the expression of cartilage related genes, and 
induced the production of a more homogeneous ECM within the neo-cartilage [36].  
In terms of gene expression, for the cultures using hBMSCs, direct co-cultures 
showed significantly higher expression of Collagen type I than indirect co-cultures, at 
the end of the experiment. In terms of Collagen type II expression, direct co-cultures 
displayed a significantly higher expression at 7 days of culture than indirect co-cultures. 
On the other hand, towards the end of the experiment, indirect co-cultures showed a 
higher expression of collagen type II compared to the direct co-cultures. Again, the 
positive effect of using conditioned medium is evidenced by the results. For hWJSCs 
co-cultures, a significantly higher expression of Aggrecan was found for indirect co-
cultures of hWJSCs at 28 days, compared to the direct ones. The same significantly 
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higher expression was observed for Sox9 expression. For Collagen type II, there was a 
decrease in the last day of culture for the direct co-cultures. In this last time point, a 
significantly higher expression was found for the indirect co-cultures, when compared 
to the control conditions. Therefore, this system of co-culturing has a considerable 
clinic potential.  
The use of conditioned medium to promote the differentiation of MSCs for further 
implantation is a valuable concept in terms of regenerative medicine, because it will 
allow obtained conditioned medium of unrelated chondrocytes to promote the 
differentiation of autologous stem cells. In the present work, we propose a new strategy 
for cartilage tissue engineering strategies based on the use of conditioned medium, and 
we were able to demonstrate its effect in MSCs chondrogenesis. The positive effect of 
the conditioned medium in osteogenesis and chondrogenesis has been recently 
demonstrated, using MSCs seeded onto polycaprolactone/hydroxyapatite scaffolds and 
on alginate, respectively [60]. In a different approach, using porcine cells for 
chondrogenic differentiation for intervertebral disc repair, notochordal cell conditioned 
medium promoted MSCs differentiation, induced significantly more collagen type II 
expression and GAGs production in MSCs [61]. In the present work, the soluble factors 
released by hACs in culture were able to induce chondrogenic differentiation of both 
hBMSCs and hWJSCs without the addition of growth factors. This is a very interesting 
result, since in a clinical perspective it is preferable to use conditioned medium for 
chondrogenic differentiation of MSCs than to induce it with growth factors or even with 
direct co-cultures. There are many cost associated with the use of growth factors, so this 
cost could be reduced when using conditioned medium. Indeed, this technique should 
be further explored, as some reports show that the use of conditioned medium is very 
versatile. For example, conditioned medium from a human hepatocarcinoma cell line 
(HepG2) enhanced in vitro chondrogenesis of murine embryonic stem cells [62]. 
Therefore, chondrocyte cell lines could be eventually established for conditioned 
medium production, to further induce chondrogenic differentiation of autologous MSCs 
in 3D scaffolds prior to its implantation. However, it is very important to identify, in the 
first place, the soluble factors that are being release into the hACs culture medium and 
that successfully induced the chondrogenic differentiation of hBMSCs and hWJSCs. 
Indirect co-cultures of human MSCs using conditioned medium from hACs seem to 
be more suitable for engineered cartilage formation. The results of indirect co-cultures 
(either with BMSCs or with WJSCs) towards the end of the experiment were 
Co-cultures of hACs and two sources of MSCs for cartilage TE 
 
 
212 
significantly higher for all the tested parameters, namely GAGs accumulation and 
cartilage related-genes expression (Collagen type II, Aggrecan and Sox9). Concerning 
the type of human MSCs tested, we obtained strong evidence that hWJSCs are more 
promising than hBMSCs for cartilage related applications using this strategy. 
Additionally, more GAGs accumulation was measured again for both direct and indirect 
co-cultures using hWJSCs. These cultures also expressed Aggrecan, Sox9 and Collagen 
type II, genes related to articular cartilage. Collagen type I, related to fibrotic cartilage, 
did not have a significant expression in these cultures with hWJSCs. This result may be 
indirectly related to a superior chondrogenic performance of hWJSCs when compared 
to hBMSCs [7]. 
 
 
5. Conclusions 
 
Human adult MSCs were able to differentiate into the chondrogenic lineage, when co-
cultured with hACs in CPBS scaffolds. In terms of type of culture, indirect co-cultures 
(using conditioned medium) seem more effective for chondrogenic differentiation. This 
is a very interesting result to be further explored for clinical translation. In this way, 
conditioned medium without the addition of other supplements or growth factors can be 
employed to enhance MSCs expansion and chondrogenic differentiation, prior to 
implantation. Indirect co-cultures using conditioned medium, using either BMSCs or 
WJSCs, showed significant higher values in terms of GAGs accumulation and cartilage 
related genes expression, when compared to direct co-cultures. In terms of cell source, 
hWJSCs showed higher proliferation rates and higher chondrogenic differentiation 
ability when compared to hBMSCs. Human WJSCs expressed significant higher values 
of DNA concentration, GAGs accumulation and cartilage related genes (Aggrecan, 
Collagen type II and Sox9). Human BMSCs chondrogenic differentiation produced 
fibrous cartilage, as stated by the significantly higher expression of Collagen type I 
when compared to hWJSCs. 
In conclusion, indirect co-cultures of hWJSCs using conditioned medium obtained 
from hACs cultures are a new approach for cartilage tissue engineering that should be 
extensively studied for future clinical applications, as an alternative method for 
expanding autologous cells prior to implantation. 
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Concluding remarks and future work 
 
 
In the present thesis, three distinct TE strategies were tested, based on different in 
vitro models. The rationale of the developed works relied on testing various primary 
cell cultures derived from different sources, combined with nano or macro scaffolds as 
supports for cell chondrogenic differentiation (in the case of adult MSCs) or for 
chondrocytes phenotype maintenance.  
 
 
1. Concluding remarks 
 
In section III of the present thesis, bovine articular chondrocytes (BAC) were cultured 
in vitro, using different scaffolds structures and compositions. In chapter 3 we used this 
model to determine if starch-polycaprolactone (SPCL) and polycaprolactone (PCL) 
electrospun nanofiber meshes would sustain BAC growth and ECM production. In this 
chapter, we confirmed the literature evidences which sustain that PCL nanofiber meshes 
are a valid scaffold for cartilage tissue engineering strategies. Moreover, we propose a 
new electrospun scaffold for this approach: SPCL nanofiber meshes.  
In chapter 4, the BAC in vitro model was applied to microporous scaffolds with 
different pore sizes and geometries. Microporous 80 CPBS scaffolds facilitate the 
formation of cartilage like tissue in a greater extent than in the 60 CPBS scaffolds. The 
larger pores present in microporous 80 CPBS scaffolds may contribute to the enhanced 
ECM deposition. 
From section III we concluded that BAC model is a valuable tool for cartilage tissue 
engineering. A massive colonization by BAC of all the tested structures was observed, 
producing cartilage ECM. We also were able to identify some advantages concerning 
the choice of scaffolds for further studies. Electrospun nanofiber meshes supported 
cartilage formation; therefore it was decided to continue the investigation of these 
structures using other cell types. Microporous scaffolds also supported ECM deposition, 
but we considered that other scaffold morphologies should be used in further studies, 
such as microfiber meshes. Dynamic culture conditions were considered as very 
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interesting for our strategies, as they stimulated ECM formation when using 
microporous scaffolds.  
Section IV of the present thesis discussed the influence of flow perfusion in the 
chondrogenic differentiation of hBMSCs using nano and micro fiber meshes. In chapter 
5 we described the culture of hBMSCs seeded onto electrospun PCL nanofiber meshes. 
We consider that this strategy is very useful in the pre-clinical context, as it can be 
employed in a MACI modified technique, using a bioreactor to expand and differentiate 
cells in the membrane that will be further applied for covering the cartilage defect.  
In chapter 6 we explored chitosan-based microfiber meshes cultures in the referred 
bioreactor. Improved ECM deposition and collagen type II production was found in 
bioreactor samples when compared to static controls. The structure of the microfiber 
meshes seems to be adequate as cells were able to grow and differentiate into the 
CPBTA scaffolds, both in the bioreactor and in static controls. We showed that flow 
perfusion can influence hBMSCs chondrogenic differentiation, inducing cells 
differentiation at early time points than in the static conditions. 
From section IV, we can conclude that perfusion conditions influence hBMSCs 
chondrogenic differentiation, independently of the scaffold formulation, shape or 
structure used for the culture. Indeed, the chondrogenic differentiation started at earlier 
stages of the experiment for cells seeded onto both nanofiber meshes and microfiber 
meshes in dynamic cultures. 
 
Section V is composed by one chapter (chapter 7) referring to the last studied in vitro 
model: co-cultures. In this chapter, adult hMSCs were able to differentiate into 
chondrogenic lineage when co-cultured with hACs, and using CPBS microfiber meshes 
as 3D supports. Indirect co-cultures using conditioned medium obtained from the hACs 
cultures was more effective for chondrogenic differentiation. Human WJSCs showed 
enhanced chondrogenic differentiation ability when compared to hBMSCs.  
 
All the referred results found during this PhD work allowed us to draw some key 
conclusions that will be very valuable for the future work. In terms of electrospun 
nanofiber meshes, we showed that both PCL and SPCL structures supported both BAC 
and hBMSCs models could be used for cartilage TE strategies. In all tested scaffolds, it 
was possible to produce cartilagineous ECM in vitro, therefore validating our proposed 
models. The use of chitosan-based scaffolds in different morphologies proved to 
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support the referred ECM formation in a greater extent than the one obtained with the 
other scaffolds tested. Our results evidenced the advantages of using chitosan blends for 
the models proposed herein. 
 
Static and dynamic culture conditions showed different effects in our models, 
depending on the structure used as scaffold or on the type of cell used. We can state that 
nanofiber meshes cultures may be negatively affected by the stirring. On the other hand, 
the cultures using the flow perfusion bioreactor were positively affected, as enhanced 
chondrogenic differentiation was observed. Dynamic culture conditions effect in 
cartilage production in vitro was more pronounced in the cultures using microporous 
structures or microfiber meshes. Stirred conditions significantly enhanced ECM 
deposition by BAC. When CPBTA microfibrous meshes were cultured in the flow 
perfusion bioreactor, enhanced chondrogenic differentiation of hBMSCs was also 
observed. Results of these experiments revealed the important effect of the flow 
perfusion in our cultures. In the overall, we consider that dynamic stimulus is beneficial 
for the strategies proposed herein.  
 
The final work describes a new approach that puts together the best features of all the 
previous works. Indirect co-cultures using conditioned medium from hACs cultures 
showed more ECM accumulation when compared to direct contact co-cultures. This 
strategy is a promising alternative method of expanding cells and mature constructs in 
vitro prior to implantation. The use of conditioned medium to enhance mesenchymal 
stem cells chondrogenic differentiation is, in our perspective, a very interesting tool to 
explore. This method could be applied in the clinic, avoiding the use of growth factors 
to induce chondrogenic differentiation, which is economically advantageous. Further 
studies and optimization of the method will be conducted in the future, having in mind 
its translation into the clinic. 
 
 
2. Future work 
 
After compiling all the results obtained in the 5 years of this PhD we have a 
perspective of what features could be further explored to optimize our models. In our 
future experiments, we will study some modifications of electrospun nanofiber meshes 
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to enhance chondrogenic differentiation, such as surface plasma modifications, 
combining nanofiber meshes with micro and macrostructures or incorporating bioactive 
agents. Moreover, in vivo studies are planned in order to study the nanofiber meshes in 
a large animal model.  
Concerning the flow perfusion bioreactor herein described, it is our belief that further 
experiments will allow optimizing the dynamic conditions. A detailed study using 
several flow velocities and their effects either in electrospun nanofiber meshes or fiber 
meshes cultures, using the models herein described is required. 
Further work will be pivotal to consolidate our last in vitro strategy, the co-cultures. 
We believe this is a very promising model in terms of its clinical translation potential. 
Therefore, extensive studies will be conducted for identification of the mechanisms 
underlying the conditioned medium potential to induce chondrogenic differentiation 
without the use of growth factors. 
 
 
 
  
